CHEMICAL CHEMICAL	180
GENE GENE	140
GENE	118
CHEMICAL -induced DISEASE	99
CHEMICAL DISEASE	55
GENE activated GENE	38
GENE CHEMICAL	36
GENE in DISEASE	24
GENE DISEASE	24
VARIANT VARIANT	19
DISEASE is characterized detected report identified include mutations VARIANT	18
CHEMICAL on DISEASE	16
DISEASE is characterized detected report identified include mutations VARIANT deletions VARIANT	15
GENE antagonist CHEMICAL	14
DISEASE GENE	14
GENE GENE GENE	13
CHEMICAL CHEMICAL CHEMICAL	13
GENE responsible for phosphorylation of GENE	12
GENE induced revealed with signs of apoptosis as GENE cleavage staining GENE	12
GENE induced revealed with signs of apoptosis as GENE cleavage GENE	12
GENE induced revealed with signs of apoptosis as GENE	12
GENE demonstrate suggest contributing signaling GENE	12
GENE activate GENE	12
DISEASE is characterized detected report identified include mutations mutations VARIANT	12
DISEASE is characterized detected report identified include mutations VARIANT VARIANT VARIANT VARIANT	12
CHEMICAL on CHEMICAL	11
GENE signaling promotes inhibits activity GENE	9
DISEASE is characterized detected report identified include mutations VARIANT deletions VARIANT VARIANT	9
DISEASE is characterized detected report identified include mutations VARIANT VARIANT	9
DISEASE CHEMICAL	9
GENE activation inhibits promotes signaling GENE	8
GENE activation inhibits activity GENE	8
DISEASE of studies in used polymorphisms identifying resequenced genes GENE	8
DISEASE induced by CHEMICAL	8
DISEASE induce molecules signaling of class are GENE	8
VARIANT DISEASE	7
GENE inhibitor CHEMICAL	7
CHEMICAL GENE	7
GENE turnover depended on GENE	6
GENE subunits with accumulated GENE	6
GENE of regulation with associated GENE	6
GENE mediates regulated by GENE	6
GENE induced transcription of GENE GENE GENE	6
GENE induced transcription of GENE GENE	6
GENE induced transcription of GENE	6
GENE induced GENE	6
GENE in induced GENE	6
GENE in cells DISEASE	6
GENE gene DISEASE	6
DISEASE patients in detected report identified include mutations VARIANT	6
DISEASE of studies in used polymorphisms identifying resequenced produced provided VARIANT VARIANT	6
DISEASE of studies in used polymorphisms identifying resequenced are GENE	6
DISEASE of GENE	6
DISEASE is characterized detected report identified include mutations VARIANT VARIANT VARIANT VARIANT VARIANT	6
CHEMICAL of prodrug is shown in DISEASE	6
CHEMICAL is shown in DISEASE	6
CHEMICAL in CHEMICAL	6
GENE in patients DISEASE	5
GENE exerts by binding to GENE	5
GENE comprising activate CHEMICAL CHEMICAL	5
GENE comprising activate CHEMICAL	5
DISEASE with patients had GENE GENE	5
DISEASE patients in detected report identified include mutations VARIANT deletions VARIANT	5
DISEASE genes GENE	5
CHEMICAL inhibitor GENE	5
CHEMICAL induced DISEASE	5
CHEMICAL in DISEASE	5
VARIANT VARIANT variants associated with DISEASE	4
VARIANT VARIANT variants associated DISEASE	4
GENE with interacts modulate secretion GENE	4
GENE were colocalized with GENE GENE	4
GENE were colocalized coimmunoprecipitated with GENE	4
GENE stimulated were required action of GENE GENE GENE GENE GENE	4
GENE stimulated were required action of GENE	4
GENE snp associated was DISEASE DISEASE	4
GENE partner GENE	4
GENE of transcription induced in GENE	4
GENE of transcription induced GENE	4
GENE of blockade revealed with signs of apoptosis as GENE cleavage staining GENE	4
GENE of blockade revealed with signs of apoptosis as GENE cleavage GENE	4
GENE of blockade revealed with signs of apoptosis as GENE	4
GENE mutations in DISEASE	4
GENE mutations associated with DISEASE	4
GENE mice displayed DISEASE	4
GENE mediates phosphorylation GENE	4
GENE in induced revealed with signs of apoptosis as GENE cleavage staining GENE	4
GENE in induced revealed with signs of apoptosis as GENE cleavage GENE	4
GENE in induced revealed with signs of apoptosis as GENE	4
GENE had were required action of GENE GENE GENE GENE GENE	4
GENE had were required action of GENE	4
GENE gene with DISEASE	4
GENE gene in DISEASE	4
GENE engaged in transmission of stimuli in DISEASE	4
GENE encoding that exhibited increased GENE	4
GENE complexes in cells DISEASE	4
GENE by modulation be growth DISEASE	4
GENE associated with DISEASE	4
GENE activation suppressed showed were GENE	4
GENE ablation had attenuated GENE	4
GENE GENE snp associated was DISEASE DISEASE	4
GENE GENE of transcription induced in GENE	4
GENE GENE of transcription induced GENE	4
GENE GENE GENE of transcription induced in GENE	4
GENE GENE GENE of transcription induced GENE	4
GENE GENE GENE GENE	4
GENE CHEMICAL CHEMICAL cotransport CHEMICAL	4
GENE -induced increases attenuated GENE	4
GENE -generated CHEMICAL	4
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE	4
DISEASE type of DISEASE associated with dysfunction of system GENE	4
DISEASE reduces inhibition of GENE	4
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE	4
DISEASE patients in detected report identified include mutations mutations VARIANT	4
DISEASE patients in detected report identified include mutations VARIANT VARIANT VARIANT VARIANT	4
DISEASE models in effects exerts GENE	4
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE variants VARIANT GENE	4
DISEASE induced hypothesized prevent disrupting GENE	4
DISEASE in GENE	4
DISEASE exhibited increased GENE	4
DISEASE caused by CHEMICAL	4
DISEASE by inhibiting GENE	4
DISEASE GENE GENE	4
DISEASE -induced CHEMICAL	4
CHEMICAL with treatment ameliorate DISEASE of matrix components including GENE GENE	4
CHEMICAL treatment induced increased increased demonstrated revealed decreased abundances GENE	4
CHEMICAL treatment for DISEASE	4
CHEMICAL on production GENE	4
CHEMICAL on activities GENE	4
CHEMICAL of DISEASE	4
CHEMICAL led suppressed secretion of GENE	4
CHEMICAL increased GENE	4
CHEMICAL attenuated DISEASE	4
CHEMICAL antagonist GENE	4
CHEMICAL -sensitive GENE	4
CHEMICAL -related DISEASE	4
VARIANT mutation accounted found include identified report detected characterized is DISEASE	3
VARIANT VARIANT VARIANT	3
GENE variations associated with snp VARIANT GENE	3
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE	3
GENE signalling impaired GENE	3
GENE signalling as kinase for GENE	3
GENE signaling response CHEMICAL	3
GENE signaling -mediated identified with DISEASE	3
GENE secretion encoding GENE	3
GENE regulates identity trimethylation GENE	3
GENE proteins of loss was inhibition of genes as GENE GENE GENE	3
GENE proteins of loss was inhibition of genes as GENE	3
GENE proteins of loss was inhibition of genes GENE	3
GENE production GENE	3
GENE pathway CHEMICAL	3
GENE on dependent are expression of GENE	3
GENE of targeting expression -induced DISEASE	3
GENE of region screened prepared had DISEASE	3
GENE of modulation by GENE	3
GENE mutations identify undertaken consisted had DISEASE	3
GENE motility in mutations reveal suggest underlie DISEASE	3
GENE is for uptake CHEMICAL	3
GENE interacts with GENE	3
GENE in DISEASE DISEASE	3
GENE genes of phosphorylation of GENE	3
GENE expression of downregulation in resulted revealed downregulation GENE GENE GENE	3
GENE expression increased with agonists GENE	3
GENE expression increased conclude signaling GENE	3
GENE expression increased conclude associated GENE	3
GENE expression decreased accompanied inhibited is decreases expression GENE	3
GENE encoding that exhibited increased GENE GENE GENE GENE GENE	3
GENE complex in abnormalities due is receptor GENE	3
GENE complex in abnormalities due is DISEASE	3
GENE cause in mutations DISEASE	3
GENE associated expression GENE	3
GENE are receptors activated by CHEMICAL CHEMICAL	3
GENE are receptors activated by CHEMICAL	3
GENE are molecules of tract activate defences DISEASE	3
GENE are molecules of tract activate after binding to CHEMICAL	3
GENE agonist CHEMICAL	3
GENE activated by GENE	3
GENE ablation had attenuated increases in expression of GENE GENE	3
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE	3
GENE VARIANT DISEASE	3
GENE GENE of expression are dependent on GENE	3
GENE GENE measured reflect level of GENE	3
GENE GENE measured demonstrated augments -induced GENE	3
GENE GENE displayed introduced increased expression of GENE	3
GENE GENE GENE of expression are dependent on GENE	3
GENE GENE GENE in patients DISEASE	3
GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	3
GENE GENE -induced GENE	3
GENE -mediated signaling GENE	3
GENE -mediated DISEASE	3
GENE -involved altered signaling including GENE GENE	3
GENE -induced increases in expression of GENE GENE	3
GENE -induced GENE	3
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE	3
DISEASE with associations showed allele in GENE	3
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE	3
DISEASE produce generation CHEMICAL	3
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE	3
DISEASE patients receiving CHEMICAL	3
DISEASE patients in reported were mutations VARIANT VARIANT	3
DISEASE patients in detected report identified include mutations VARIANT deletions VARIANT VARIANT	3
DISEASE patients in detected report identified include mutations VARIANT VARIANT	3
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE	3
DISEASE on CHEMICAL	3
DISEASE of mechanism on perspective -mediated signaling GENE	3
DISEASE is characterized detected report identified include mutations mutations mutations VARIANT	3
DISEASE is characterized detected report identified include mutations VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT	3
DISEASE is characterized detected report identified include mutations VARIANT VARIANT VARIANT	3
DISEASE is DISEASE of metabolism CHEMICAL	3
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE variants VARIANT	3
DISEASE individuals of experiences examined were CHEMICAL CHEMICAL	3
DISEASE individuals of experiences examined were CHEMICAL	3
DISEASE exhibited increased GENE GENE GENE GENE GENE	3
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE	3
DISEASE VARIANT	3
DISEASE GENE GENE GENE GENE GENE GENE	3
CHEMICAL related genes demonstrated lipolysis GENE	3
CHEMICAL reduces DISEASE	3
CHEMICAL reduced DISEASE	3
CHEMICAL prevents DISEASE	3
CHEMICAL on expression GENE	3
CHEMICAL is therapy for DISEASE	3
CHEMICAL is DISEASE	3
CHEMICAL inhibited demonstrates activate GENE	3
CHEMICAL inhibited activation GENE	3
CHEMICAL inhibited GENE GENE	3
CHEMICAL induces DISEASE	3
CHEMICAL in models of DISEASE	3
CHEMICAL in GENE	3
CHEMICAL group reported DISEASE	3
CHEMICAL for DISEASE	3
CHEMICAL factors GENE activate GENE	3
CHEMICAL decreases expression GENE	3
CHEMICAL ameliorate DISEASE	3
CHEMICAL altered signaling including GENE GENE	3
CHEMICAL GENE activate GENE	3
CHEMICAL -treated expression of molecules GENE GENE	3
CHEMICAL -induced DISEASE DISEASE	3
CHEMICAL -associated DISEASE	3
CHEMICAL	3
VARIANT variants associated with DISEASE	2
VARIANT variants associated DISEASE	2
VARIANT synthesized CHEMICAL	2
VARIANT substitution contains suggested increase risk DISEASE	2
VARIANT snps revealed was snp with DISEASE	2
VARIANT snps revealed associated with independent DISEASE	2
VARIANT snp associated was DISEASE DISEASE	2
VARIANT rt VARIANT associated changes in gene VARIANT VARIANT	2
VARIANT rt VARIANT associated changes in gene VARIANT	2
VARIANT rt VARIANT	2
VARIANT polymorphism with DISEASE	2
VARIANT polymorphism shown is aims aimed czechs with with DISEASE	2
VARIANT polymorphism shown associate with risk for DISEASE	2
VARIANT polymorphism risk of DISEASE	2
VARIANT polymorphism of prevalence investigated found showed observed frequency of genotypes in patients with DISEASE	2
VARIANT polymorphism found in DISEASE	2
VARIANT polymorphism DISEASE	2
VARIANT of allele allele showed associations with DISEASE	2
VARIANT mutations occurred carried were performed identified in database DISEASE	2
VARIANT mutations occurred carried were performed identified children with DISEASE DISEASE	2
VARIANT mutations occurred carried were performed identified children with DISEASE	2
VARIANT mutations identified obtained results performed associated with DISEASE brainstem DISEASE	2
VARIANT mutations identified obtained results performed associated DISEASE	2
VARIANT mutations identified found are suggests represent leading compared with phenotype DISEASE	2
VARIANT mutations identified examining DISEASE	2
VARIANT mutation DISEASE	2
VARIANT modify risk DISEASE	2
VARIANT frequencies with DISEASE	2
VARIANT for were was risk of developing DISEASE	2
VARIANT for were suggest associated with DISEASE	2
VARIANT for were associated with conversion to DISEASE	2
VARIANT for homozygous had DISEASE	2
VARIANT allele between reported genes DISEASE	2
VARIANT accounted found occurred had DISEASE	2
VARIANT VARIANT was reported is DISEASE	2
VARIANT VARIANT mutations identified obtained results performed associated with DISEASE brainstem DISEASE	2
VARIANT VARIANT mutations identified obtained results performed associated DISEASE	2
VARIANT VARIANT mutations identified found are suggests represent leading compared with phenotype DISEASE	2
VARIANT VARIANT mutations identified examining DISEASE	2
VARIANT VARIANT associated with DISEASE	2
VARIANT VARIANT GENE displays behavior with CHEMICAL	2
VARIANT DISEASE with associated DISEASE	2
VARIANT > found presented with manifestation of DISEASE	2
GENE with patients DISEASE	2
GENE with colocalized were GENE	2
GENE with binding in system elevates levels CHEMICAL	2
GENE with CHEMICAL	2
GENE were present in invadopodia DISEASE	2
GENE were colocalized with GENE	2
GENE were GENE stimulated migration DISEASE	2
GENE variants of risk DISEASE	2
GENE variants association of variant with DISEASE	2
GENE upregulated inhibited by administration GENE	2
GENE tyrosine phosphorylation activation of signaling GENE	2
GENE to bind CHEMICAL CHEMICAL	2
GENE to bind CHEMICAL	2
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE GENE GENE GENE	2
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE GENE GENE	2
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE	2
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE	2
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE GENE	2
GENE to activity highlight investigated show molecules involved in inhibition GENE	2
GENE to GENE	2
GENE tg mice developed DISEASE	2
GENE system involved in growth DISEASE	2
GENE system followed via CHEMICAL	2
GENE synthesize CHEMICAL detected recruits adaptors GENE	2
GENE synthesize CHEMICAL CHEMICAL	2
GENE synthesize CHEMICAL	2
GENE suggested play role in regulating DISEASE	2
GENE stimulating via induced models DISEASE	2
GENE stimulating via induced by CHEMICAL CHEMICAL	2
GENE stimulating via induced by CHEMICAL	2
GENE stimulated were required action of GENE GENE GENE	2
GENE stimulated were -dependent GENE	2
GENE stimulated migration DISEASE	2
GENE stimulated GENE were GENE	2
GENE stimulated GENE	2
GENE status DISEASE	2
GENE snp associated with DISEASE	2
GENE sirna with treatment following found enhanced weakened upregulation of GENE	2
GENE sirna with treatment following found GENE downregulation of GENE	2
GENE sirna with treatment following found GENE	2
GENE signalling impaired chondrocytes evidenced by expression of phosphorylation of GENE	2
GENE signaling in cells DISEASE	2
GENE signaling in DISEASE	2
GENE signaling by caused indicate displayed GENE GENE	2
GENE shown control switch of DISEASE	2
GENE shown control switch in DISEASE	2
GENE show activity at antagonists involve increase in levels CHEMICAL	2
GENE required for signalling as kinase for GENE	2
GENE required for GENE	2
GENE release observed in airways during DISEASE	2
GENE related with GENE GENE	2
GENE regulation was included GENE GENE GENE	2
GENE regulation was included GENE GENE	2
GENE regulates is associated with DISEASE DISEASE	2
GENE regulates is associated with DISEASE	2
GENE regulated restrained phosphorylation transsituation of GENE	2
GENE region of DISEASE	2
GENE reduced express was GENE	2
GENE reduced activation GENE	2
GENE recognized tested drugs CHEMICAL	2
GENE receptors distributed causes stimulates GENE secretion GENE	2
GENE receptors distributed causes stimulates GENE	2
GENE receptors distributed causes DISEASE DISEASE	2
GENE receptors distributed causes DISEASE	2
GENE receptors GENE were GENE	2
GENE receptors GENE	2
GENE proteins GENE GENE	2
GENE proteins GENE	2
GENE protects during DISEASE	2
GENE production expression increases DISEASE	2
GENE polymorphisms demonstrated supports activation GENE	2
GENE polymorphisms DISEASE	2
GENE polymorphism polymorphism polymorphism polymorphisms determined assessed results associated excluded role to DISEASE	2
GENE polymorphism in users CHEMICAL	2
GENE polymorphism associated linked with gene GENE	2
GENE plays role in DISEASE	2
GENE phosphorylation induced by GENE	2
GENE phosphorylation indicating activation of signalling GENE	2
GENE pathway regulates growth DISEASE	2
GENE participates are is DISEASE	2
GENE participates apoptosis of DISEASE	2
GENE overexpression in DISEASE	2
GENE overexpression blocked triggered GENE	2
GENE overexpression altered showed included increases in GENE GENE	2
GENE of roles understood mechanisms involved in DISEASE	2
GENE of loss expression altered GENE GENE	2
GENE of inhibitor CHEMICAL	2
GENE of inhibition reduces confirm increases activity CHEMICAL CHEMICAL	2
GENE of inhibition reduces confirm increases activity CHEMICAL	2
GENE of inhibition abrogated were transcripts GENE	2
GENE of inhibition abrogated effect of GENE	2
GENE of expression protects from DISEASE	2
GENE of expression in fibroblasts from DISEASE	2
GENE of carriers exon showed increased GENE	2
GENE of block to attributed is drug used for treatment of DISEASE	2
GENE of antagonists of action on influence CHEMICAL CHEMICAL	2
GENE of antagonists of action on influence CHEMICAL	2
GENE of absence protein of effect due is DISEASE	2
GENE of GENE of upregulation involves correlation with DISEASE	2
GENE mutations causing DISEASE	2
GENE mutations associated with DISEASE DISEASE	2
GENE mutation carriers in risk DISEASE	2
GENE mutagenesis genes including GENE	2
GENE mice with DISEASE	2
GENE mice subjected evaluate DISEASE	2
GENE mice displayed levels of GENE GENE GENE GENE	2
GENE mice displayed DISEASE including DISEASE DISEASE	2
GENE mice displayed DISEASE including DISEASE	2
GENE mediates -induced GENE	2
GENE mediated effects by activating GENE	2
GENE locus at allele causing DISEASE	2
GENE like involved in DISEASE	2
GENE ligand attenuates after DISEASE	2
GENE ligand attenuates DISEASE	2
GENE levels studied included given CHEMICAL	2
GENE levels oxidation expression served CHEMICAL	2
GENE levels in cells DISEASE	2
GENE levels GENE on infusion of effects studied carried study to GENE	2
GENE levels GENE on infusion of effects studied -induced response to GENE	2
GENE level was showed implanted DISEASE	2
GENE lenses showed proliferation with increases in expression GENE	2
GENE kotg mice levels of GENE	2
GENE ko mice in observed observed expression of GENE GENE GENE	2
GENE known represents DISEASE	2
GENE knockout mice CHEMICAL protected defines DISEASE	2
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	2
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE GENE	2
GENE knockdown enhanced expression of GENE	2
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	2
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE GENE	2
GENE isotype associated with DISEASE	2
GENE isoforms activated was upregulation of genes associated with GENE GENE	2
GENE isoforms activated was GENE	2
GENE isoforms activated exhibited GENE GENE	2
GENE isoforms activated exhibited GENE	2
GENE isoform by activated GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
GENE isoform by activated GENE GENE GENE GENE GENE GENE GENE	2
GENE isoform by activated GENE GENE GENE	2
GENE is results involved CHEMICAL CHEMICAL	2
GENE is regulator of GENE	2
GENE is occurs DISEASE	2
GENE is is DISEASE DISEASE	2
GENE is investigated association between DISEASE	2
GENE is induced CHEMICAL	2
GENE is increases via GENE	2
GENE is identified in DISEASE	2
GENE is factor with domains include tracts CHEMICAL	2
GENE is expressed indicated indicated involved in metabolism GENE GENE GENE	2
GENE is causing onset DISEASE	2
GENE is are revealed demonstrated proteins GENE	2
GENE is -induced DISEASE	2
GENE involves correlation with DISEASE	2
GENE involved in patients DISEASE	2
GENE involved contributing to DISEASE	2
GENE interact stabilize GENE GENE GENE	2
GENE inhibits expression release GENE	2
GENE inhibitors GENE GENE	2
GENE in polymorphisms associated with DISEASE	2
GENE in patients with DISEASE	2
GENE in GENE	2
GENE identifying as antagonist of signaling GENE	2
GENE identified effects by activating GENE	2
GENE has shows remains conducted showed showed revealed found for DISEASE	2
GENE haploinsufficiency compromises revealed DISEASE	2
GENE had were required action of GENE GENE GENE	2
GENE had were -dependent GENE	2
GENE genotype phenotype DISEASE	2
GENE genes with DISEASE	2
GENE genes of phosphorylation GENE GENE	2
GENE genes genotyped with DISEASE	2
GENE genes cases of DISEASE	2
GENE gene reported to DISEASE	2
GENE gene of screening in patients with DISEASE	2
GENE gene of polymorphism of roles on DISEASE	2
GENE gene of VARIANT with associated is DISEASE	2
GENE gene is linked to DISEASE	2
GENE gene in polymorphisms study prevention DISEASE	2
GENE gene in polymorphisms associated to DISEASE	2
GENE gene in polymorphisms associated is DISEASE	2
GENE gene in patients with DISEASE	2
GENE gene in mutation with DISEASE	2
GENE gene identified as responsible for DISEASE DISEASE divided in categories DISEASE form of DISEASE	2
GENE gene identified as responsible for DISEASE DISEASE divided in categories DISEASE	2
GENE gene identified as responsible for DISEASE	2
GENE gene encodes GENE acts as receptor for GENE	2
GENE gene associated with DISEASE	2
GENE gene associated are DISEASE	2
GENE form linked to progression of diseases including DISEASE DISEASE	2
GENE form linked to progression of diseases including DISEASE	2
GENE for six characterized reported among patients DISEASE	2
GENE for five six characterized reported among patients DISEASE	2
GENE expression of silencing had altered were infected observed release network including GENE GENE	2
GENE expression of silencing had altered were infected observed release GENE	2
GENE expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE	2
GENE expression of downregulation in resulted revealed downregulation GENE	2
GENE expression of GENE	2
GENE expression increases DISEASE	2
GENE expression in cortex medulla of CHEMICAL	2
GENE expression examined found features reminiscent of mouse DISEASE	2
GENE expression GENE inhibited by levels CHEMICAL	2
GENE expression DISEASE	2
GENE engaged suggest conclusions intensify activity of CHEMICAL CHEMICAL	2
GENE engaged suggest conclusions intensify activity of CHEMICAL	2
GENE engaged suggest conclusions intensify activity in DISEASE	2
GENE downregulation prevent investigated treated started CHEMICAL	2
GENE downregulation prevent investigated possesses characterized CHEMICAL	2
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	2
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE GENE	2
GENE dephosphorylation by growth DISEASE	2
GENE deficiency reduced activity production expression marker GENE	2
GENE decreased levels of GENE	2
GENE cornea in upregulated regulators of signaling GENE GENE	2
GENE cells lacked produced level of GENE	2
GENE by drugs DISEASE	2
GENE by drugs CHEMICAL CHEMICAL	2
GENE by drugs CHEMICAL	2
GENE blockade proposed for treating DISEASE	2
GENE blockade proposed corrects DISEASE	2
GENE binds reduced activity production expression marker GENE	2
GENE bind to factor GENE	2
GENE background is results DISEASE	2
GENE background is enzyme of cycle CHEMICAL	2
GENE associated with DISEASE DISEASE	2
GENE as transcripts involved in mechanism of re GENE	2
GENE are known shown leads to reaction characterized by DISEASE	2
GENE are is removed DISEASE	2
GENE are found in cells of patients have DISEASE	2
GENE are found cause DISEASE	2
GENE antagonist CHEMICAL restores antagonists involve increase in levels CHEMICAL	2
GENE analysis in patient DISEASE	2
GENE agonist reduced increased demonstrated proteins GENE	2
GENE agonist reduced increased concentration CHEMICAL	2
GENE activity through reactivated promote defines DISEASE	2
GENE activity stress activity evaluated is understood causes CHEMICAL	2
GENE activity stress activity evaluated is understood behaviour CHEMICAL	2
GENE activity stress activity GENE	2
GENE activities following DISEASE	2
GENE activities DISEASE	2
GENE activator enhances via augmentation of production of CHEMICAL	2
GENE activation to response by limiting activation of GENE	2
GENE activation suppressed showed were involved in metabolism GENE GENE GENE	2
GENE activation supports development DISEASE	2
GENE activation in response to engagement GENE	2
GENE activation by induced genes involved in metabolism GENE GENE GENE	2
GENE activation by CHEMICAL	2
GENE activates mediates to behavior DISEASE	2
GENE activates combination of CHEMICAL	2
GENE activated by binding of GENE	2
GENE activate failed CHEMICAL	2
GENE activate GENE GENE	2
GENE actions are DISEASE	2
GENE abundance play role promote excretion CHEMICAL	2
GENE abolished CHEMICAL	2
GENE ablation had attenuated increases in expression of GENE GENE GENE	2
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE	2
GENE VARIANT using investigated revealed expression revealed downregulation GENE	2
GENE VARIANT using investigated revealed expression of machinery including GENE GENE	2
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE	2
GENE VARIANT synthesized CHEMICAL DISEASE	2
GENE VARIANT synthesized CHEMICAL	2
GENE VARIANT snp associated was DISEASE DISEASE	2
GENE VARIANT of carriers had increased GENE	2
GENE GENE were euthanized exposed to CHEMICAL	2
GENE GENE were euthanized collected -treated CHEMICAL	2
GENE GENE system involved in growth DISEASE	2
GENE GENE suppressors DISEASE	2
GENE GENE of levels associated associated with predisposition recurrence of DISEASE	2
GENE GENE of levels associated associated linked linked to predisposition DISEASE	2
GENE GENE of block to attributed is drug used for treatment of DISEASE	2
GENE GENE of block to attributed is CHEMICAL	2
GENE GENE like involved in DISEASE	2
GENE GENE involved in patients DISEASE	2
GENE GENE including network release observed in airways during DISEASE	2
GENE GENE in were infected GENE	2
GENE GENE in polymorphisms associated with DISEASE	2
GENE GENE in patients DISEASE	2
GENE GENE genes related DISEASE	2
GENE GENE genes of expression upregulated validated modulated induced CHEMICAL	2
GENE GENE cornea in upregulated regulators of signaling GENE GENE	2
GENE GENE components GENE GENE GENE in mutations lack alterations in DISEASE	2
GENE GENE components GENE GENE GENE in mutations lack % pediatric DISEASE	2
GENE GENE complexes in cells DISEASE	2
GENE GENE bep2d in stimulated CHEMICAL	2
GENE GENE as transcripts involved in mechanism of re GENE	2
GENE GENE are involved in DISEASE	2
GENE GENE GENE upregulated in DISEASE	2
GENE GENE GENE snp associated was DISEASE DISEASE	2
GENE GENE GENE shown were fed leads diet CHEMICAL	2
GENE GENE GENE shown were fed developed diet CHEMICAL	2
GENE GENE GENE in were infected GENE	2
GENE GENE GENE genes related DISEASE	2
GENE GENE GENE genes of expression upregulated validated modulated induced CHEMICAL	2
GENE GENE GENE GENE GENE GENE GENE upregulated in DISEASE	2
GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	2
GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	2
GENE GENE GENE GENE GENE GENE GENE GENE GENE upregulated in DISEASE	2
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	2
GENE GENE -induced stimulation of GENE secretion GENE	2
GENE DISEASE ligation of models in increased modulate GENE	2
GENE DISEASE ligation of models in increased activated GENE	2
GENE -stimulated synthesis GENE	2
GENE -stimulated phosphorylation of GENE	2
GENE -stimulated phosphorylation GENE	2
GENE -reconstituted cells GENE	2
GENE -modulated mediators included GENE GENE GENE	2
GENE -modulated mediators included GENE GENE	2
GENE -induced was included GENE GENE GENE	2
GENE -induced was included GENE GENE	2
GENE -induced stimulation of GENE secretion GENE	2
GENE -induced increases in expression of GENE GENE GENE	2
GENE -induced activation GENE	2
GENE -induced DISEASE	2
GENE -dependent were stimulated migration DISEASE	2
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE	2
GENE -binding site in mutation found increase affinity of GENE	2
GENE -binding site in mutation found cause DISEASE	2
GENE -associated polymorphisms as xmni GENE polymorphisms GENE	2
GENE -associated polymorphisms as xmni GENE	2
DISEASE with women were were linked performed analyze biomarkers GENE	2
DISEASE with woman scheduled for injection CHEMICAL	2
DISEASE with patients in polymorphism VARIANT	2
DISEASE with patients in performed subjected identified detected VARIANT VARIANT	2
DISEASE with patients from automated assessed presented were heterozygotes one with VARIANT	2
DISEASE with patients from automated assessed presented mutations cousins one with VARIANT	2
DISEASE with patients assessed methods genotyped for VARIANT conversion within GENE VARIANT	2
DISEASE with mutation VARIANT	2
DISEASE with gene GENE	2
DISEASE with families in identified had occurred found accounted VARIANT	2
DISEASE with consistent diagnosis with patients randomized to CHEMICAL	2
DISEASE with child in expression are GENE	2
DISEASE with associated results assessed genotyped for VARIANT conversion within GENE VARIANT	2
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE	2
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE	2
DISEASE with % in in identified had occurred found accounted VARIANT	2
DISEASE v growth inhibited accompanied decreased expression GENE	2
DISEASE type of DISEASE associated demonstrated decreased metabolism CHEMICAL	2
DISEASE tested users CHEMICAL	2
DISEASE stereotypy CHEMICAL	2
DISEASE signaling by inhibiting pathway of GENE GENE	2
DISEASE secondary to CHEMICAL	2
DISEASE scores were with CHEMICAL	2
DISEASE risk increase polymorphisms GENE	2
DISEASE required treatment with CHEMICAL	2
DISEASE reported occurred % at bid CHEMICAL	2
DISEASE reported -induced CHEMICAL	2
DISEASE rats sensitized revealed decreased decreased stress leading to upregulation of GENE	2
DISEASE protect decreased activities GENE	2
DISEASE progression promotion inhibition GENE GENE GENE GENE	2
DISEASE progression promotion inhibition GENE GENE	2
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE	2
DISEASE polymorphisms between associations assessed genotyped for VARIANT conversion within GENE VARIANT	2
DISEASE polymorphisms GENE GENE	2
DISEASE phenotypes caused by signaling GENE	2
DISEASE persists evaluated was methods genotyped for VARIANT conversion within GENE VARIANT	2
DISEASE patients with mutations GENE	2
DISEASE patients of samples samples samples used detected identified established method for detecting snps VARIANT VARIANT VARIANT	2
DISEASE patients in detected report identified include mutations VARIANT VARIANT VARIANT VARIANT VARIANT	2
DISEASE patients homozygous for mutation VARIANT	2
DISEASE patient in gene GENE	2
DISEASE pathogenesis during aids resulted revealed expression of machinery including GENE GENE	2
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE	2
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE	2
DISEASE pathogenesis during aids resulted revealed downregulation GENE	2
DISEASE of treatment initiating associated conclusions decreased with CHEMICAL	2
DISEASE of studies in used polymorphisms identifying resequenced produced provided VARIANT VARIANT VARIANT	2
DISEASE of studies in used polymorphisms identifying resequenced produced provided VARIANT	2
DISEASE occurred appear therapy CHEMICAL	2
DISEASE mutation report identified showed CHEMICAL	2
DISEASE markers GENE	2
DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	2
DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
DISEASE like GENE GENE GENE GENE GENE GENE	2
DISEASE is reported was VARIANT	2
DISEASE is reported mutation VARIANT	2
DISEASE is failure suppress secretion GENE	2
DISEASE is detected developed established designed used detected identified established method for detecting snps VARIANT VARIANT VARIANT	2
DISEASE is described examined analysed amplified detected identified reported carried found polymorphism VARIANT	2
DISEASE is are carry VARIANT in gene GENE	2
DISEASE is are carry VARIANT	2
DISEASE is are are heterozygous for mutations in gene GENE	2
DISEASE involves include release GENE	2
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE inhibitors VARIANT	2
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE VARIANT	2
DISEASE individuals GENE	2
DISEASE including demonstrated is investigated revealed expression of machinery including GENE GENE	2
DISEASE including demonstrated is investigated revealed downregulation of GENE GENE GENE	2
DISEASE in were in patients VARIANT	2
DISEASE in users CHEMICAL	2
DISEASE in role plays is GENE	2
DISEASE in role elucidated is GENE	2
DISEASE in polymorphisms GENE	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected substitutions VARIANT VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected substitutions VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found pattern mutation VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations in region VARIANT VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations in region VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations VARIANT VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated changes in gene VARIANT VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated changes in gene VARIANT	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated changes in gene GENE	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated VARIANT rt patients with pattern substitution GENE	2
DISEASE in mutations of frequency analyzed conducted provided determined subgenotypes detected mutations GENE	2
DISEASE in found identified mutations VARIANT VARIANT	2
DISEASE in found identified mutations VARIANT	2
DISEASE in described mutations in GENE	2
DISEASE hypothesized include release GENE	2
DISEASE harbored fusions GENE	2
DISEASE genotype GENE	2
DISEASE from CHEMICAL	2
DISEASE for undergoing patients in resolution association within GENE	2
DISEASE for found revealed indicate contributes VARIANT	2
DISEASE examined found covered gene GENE	2
DISEASE examined found covered detected mutation VARIANT	2
DISEASE effects of CHEMICAL	2
DISEASE downstream of GENE	2
DISEASE developed -treated associated with expression of GENE	2
DISEASE developed -treated associated with expression activation translocation of GENE	2
DISEASE developed -treated associated with expression activation of GENE	2
DISEASE cytokines of release GENE GENE GENE	2
DISEASE cytokines of release GENE GENE	2
DISEASE cytokines of release GENE	2
DISEASE characterized by dysfunction associated with deficiency CHEMICAL	2
DISEASE cells release network including GENE GENE	2
DISEASE cells release GENE	2
DISEASE cells import CHEMICAL	2
DISEASE cause yielded suggests are found identified mutations VARIANT VARIANT	2
DISEASE cause yielded suggests are found identified mutations VARIANT	2
DISEASE associated with dysfunction of system GENE	2
DISEASE associated with CHEMICAL	2
DISEASE angiogenesis with inhibitors GENE	2
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE	2
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE	2
DISEASE ameliorates GENE	2
DISEASE ameliorate show suppresses reduces revealed GENE p- GENE	2
DISEASE DISEASE with child in expression are GENE	2
DISEASE DISEASE in found identified mutations VARIANT VARIANT	2
DISEASE DISEASE in found identified mutations VARIANT	2
DISEASE DISEASE as DISEASE DISEASE cause are GENE as GENE associated with GENE	2
DISEASE DISEASE DISEASE with identified novo of studies report disruption of GENE	2
DISEASE DISEASE , identified mutation VARIANT	2
DISEASE -related is encodes gene GENE	2
DISEASE -related genes were factors GENE	2
DISEASE -induced changes in GENE	2
CHEMICAL with treatment ameliorate DISEASE of matrix components including GENE	2
CHEMICAL with treated DISEASE hypothesized include release GENE	2
CHEMICAL with hazard was decreased with CHEMICAL	2
CHEMICAL with challenged together showed peroxidation CHEMICAL	2
CHEMICAL with administration of CHEMICAL	2
CHEMICAL with DISEASE of treatment initiating associated conclusions decreased with CHEMICAL	2
CHEMICAL with DISEASE	2
CHEMICAL were results -induced DISEASE	2
CHEMICAL users in DISEASE	2
CHEMICAL users display DISEASE	2
CHEMICAL use recognized is DISEASE	2
CHEMICAL upregulated were factors GENE	2
CHEMICAL upregulated downregulated het-1a GENE	2
CHEMICAL treatment suppressed secretion GENE	2
CHEMICAL treatment induced DISEASE	2
CHEMICAL treatment increased expression of GENE	2
CHEMICAL treatment decreases inhibits GENE GENE	2
CHEMICAL treatment cells undergo upregulation -dependent GENE	2
CHEMICAL treatment cells pa-1 DISEASE	2
CHEMICAL tract in gene GENE	2
CHEMICAL to incubation upregulated showed expression of genes GENE	2
CHEMICAL therapy with treated remained was reported DISEASE	2
CHEMICAL therapy for DISEASE	2
CHEMICAL suppressed effects by activating GENE	2
CHEMICAL suppressed DISEASE signaling by inhibiting pathway of GENE GENE	2
CHEMICAL substrate GENE	2
CHEMICAL stimulated were factors GENE	2
CHEMICAL shown damage neurons CHEMICAL	2
CHEMICAL secretion under stimulation CHEMICAL	2
CHEMICAL reversed prevented DISEASE	2
CHEMICAL reversed decreased CHEMICAL	2
CHEMICAL reversed DISEASE	2
CHEMICAL reversed -induced DISEASE	2
CHEMICAL restrained phosphorylation transsituation of GENE	2
CHEMICAL resistance in DISEASE	2
CHEMICAL related genes demonstrated lipolysis GENE GENE markers GENE GENE	2
CHEMICAL related genes GENE GENE	2
CHEMICAL related genes GENE	2
CHEMICAL reduces used correct DISEASE	2
CHEMICAL reduces suppresses evidenced by expression of GENE GENE expression of GENE	2
CHEMICAL reduces suppresses evidenced by expression of GENE GENE GENE GENE GENE	2
CHEMICAL reduces suppresses evidenced by expression of GENE GENE GENE GENE	2
CHEMICAL reduces suppresses evidenced by expression of GENE GENE GENE	2
CHEMICAL reduces suppresses evidenced by expression of GENE GENE	2
CHEMICAL reduces suppresses evidenced by expression of GENE	2
CHEMICAL reduces revealed GENE p- GENE	2
CHEMICAL reduces revealed GENE	2
CHEMICAL reduces oxygenation following DISEASE	2
CHEMICAL reduces decreases release GENE GENE GENE	2
CHEMICAL reduces decreases release GENE GENE	2
CHEMICAL reduces decreases release GENE	2
CHEMICAL reduced decreased phosphorylation GENE	2
CHEMICAL reduced CHEMICAL	2
CHEMICAL received increased GENE CHEMICAL CHEMICAL	2
CHEMICAL randomized hg msdbp mean patients with DISEASE	2
CHEMICAL protected defines DISEASE	2
CHEMICAL prolongs is DISEASE	2
CHEMICAL production closed with GENE GENE	2
CHEMICAL produced suggest abolished GENE	2
CHEMICAL prevents binding to GENE	2
CHEMICAL prevents -induced DISEASE	2
CHEMICAL prevented prevented increase in peroxidation CHEMICAL	2
CHEMICAL prevented increased rate of uptake CHEMICAL	2
CHEMICAL prevented increased rate of uptake -stimulated CHEMICAL	2
CHEMICAL prevented DISEASE	2
CHEMICAL prevent downregulation GENE	2
CHEMICAL pretreatment counteracted increased GENE CHEMICAL CHEMICAL	2
CHEMICAL possesses characterized by dysfunction associated with deficiency CHEMICAL	2
CHEMICAL on CHEMICAL of effect -induced DISEASE	2
CHEMICAL of potential DISEASE	2
CHEMICAL of levels associated with response to therapy CHEMICAL	2
CHEMICAL of effects peroxidation CHEMICAL	2
CHEMICAL of effects characterize CHEMICAL model depletion CHEMICAL	2
CHEMICAL of effects by activating GENE	2
CHEMICAL of effects abolished GENE	2
CHEMICAL of effect induced DISEASE	2
CHEMICAL of conversion to CHEMICAL	2
CHEMICAL of blockade by accompanied DISEASE detected decrease in expression GENE	2
CHEMICAL of analysis kinetic showed decreased VARIANT	2
CHEMICAL neurons damage shown known function polymorphism GENE	2
CHEMICAL mutations in group of DISEASE	2
CHEMICAL mutations in DISEASE	2
CHEMICAL metabolism GENE GENE GENE	2
CHEMICAL mediates CHEMICAL	2
CHEMICAL led level of GENE	2
CHEMICAL led accompanied GENE	2
CHEMICAL is metabolite responsible for DISEASE	2
CHEMICAL is inhibitor of GENE	2
CHEMICAL is factor DISEASE	2
CHEMICAL is agent used for treating DISEASE	2
CHEMICAL intoxication CHEMICAL after DISEASE	2
CHEMICAL injected assigned assessed has treatment signaling GENE	2
CHEMICAL inhibited accompanied decreased expression GENE	2
CHEMICAL induced suppressed secretion of GENE	2
CHEMICAL induced measured GENE GENE	2
CHEMICAL induced damage production CHEMICAL	2
CHEMICAL induced GENE	2
CHEMICAL increases were with CHEMICAL with CHEMICAL	2
CHEMICAL increases were with CHEMICAL	2
CHEMICAL increases expression GENE	2
CHEMICAL increased treated DISEASE	2
CHEMICAL increased decreased phosphorylation GENE	2
CHEMICAL increased GENE GENE	2
CHEMICAL in role plays hypothesized include release GENE	2
CHEMICAL improved showed sought characterize CHEMICAL model depletion CHEMICAL	2
CHEMICAL implicated developed DISEASE	2
CHEMICAL has given to patients with age DISEASE	2
CHEMICAL has are DISEASE DISEASE	2
CHEMICAL has are DISEASE	2
CHEMICAL growth by dephosphorylation GENE	2
CHEMICAL group with compared showed peroxidation CHEMICAL	2
CHEMICAL given after CHEMICAL CHEMICAL	2
CHEMICAL given after CHEMICAL	2
CHEMICAL exposure produced DISEASE	2
CHEMICAL exposure CHEMICAL	2
CHEMICAL export binding to GENE	2
CHEMICAL enhanced found following treatment with sirna GENE	2
CHEMICAL endings CHEMICAL	2
CHEMICAL depleted CHEMICAL	2
CHEMICAL decreased overexpression of GENE GENE	2
CHEMICAL decreased growth of GENE	2
CHEMICAL decreased growth DISEASE	2
CHEMICAL decreased GENE GENE	2
CHEMICAL decreased CHEMICAL	2
CHEMICAL compounds is result of binding in system elevates levels CHEMICAL	2
CHEMICAL characterized by dysfunction associated with deficiency CHEMICAL	2
CHEMICAL causes DISEASE	2
CHEMICAL cause DISEASE	2
CHEMICAL by prevention involvement CHEMICAL causes DISEASE	2
CHEMICAL by inhibited showed restored CHEMICAL	2
CHEMICAL blocks GENE	2
CHEMICAL binding from subtypes GENE	2
CHEMICAL atypical CHEMICAL antipsychotics were produce DISEASE	2
CHEMICAL atypical CHEMICAL antipsychotics were mice failed affect DISEASE	2
CHEMICAL attenuates DISEASE	2
CHEMICAL approved in adults for treatment of DISEASE of episodes associated with without features DISEASE	2
CHEMICAL approved in adults for treatment of DISEASE of episodes DISEASE	2
CHEMICAL ameliorates GENE	2
CHEMICAL ameliorates DISEASE by inhibiting GENE	2
CHEMICAL ameliorates -induced DISEASE	2
CHEMICAL alleviated reported -induced DISEASE	2
CHEMICAL agonists GENE	2
CHEMICAL agonist GENE	2
CHEMICAL against DISEASE	2
CHEMICAL after present is DISEASE	2
CHEMICAL after DISEASE	2
CHEMICAL administration suppresses evidenced by expression of GENE GENE expression of GENE	2
CHEMICAL administration suppresses evidenced by expression of GENE GENE GENE GENE GENE	2
CHEMICAL administration suppresses evidenced by expression of GENE GENE GENE GENE	2
CHEMICAL administration suppresses evidenced by expression of GENE GENE GENE	2
CHEMICAL administration suppresses evidenced by expression of GENE GENE	2
CHEMICAL administration suppresses evidenced by expression of GENE	2
CHEMICAL administration showed peroxidation CHEMICAL	2
CHEMICAL administration resulted in DISEASE	2
CHEMICAL administration resulted accompanied with activity content CHEMICAL	2
CHEMICAL administration increased GENE CHEMICAL CHEMICAL	2
CHEMICAL administration in patient with DISEASE	2
CHEMICAL activation GENE	2
CHEMICAL DISEASE DISEASE	2
CHEMICAL CHEMICAL protected defines DISEASE	2
CHEMICAL CHEMICAL of potential DISEASE	2
CHEMICAL CHEMICAL is therapy for DISEASE	2
CHEMICAL CHEMICAL intensify conclusions participates be in alleviation of DISEASE	2
CHEMICAL CHEMICAL group with compared improved decreased activities GENE	2
CHEMICAL CHEMICAL cause DISEASE	2
CHEMICAL CHEMICAL binding from subtypes GENE	2
CHEMICAL CHEMICAL are limit DISEASE DISEASE	2
CHEMICAL CHEMICAL agonists GENE	2
CHEMICAL CHEMICAL -induced DISEASE	2
CHEMICAL -treated developed DISEASE	2
CHEMICAL -salt DISEASE	2
CHEMICAL -mediated abrogated by inhibitors including CHEMICAL	2
CHEMICAL -induced surge CHEMICAL	2
CHEMICAL -induced sensitization of DISEASE	2
CHEMICAL -induced overexpression of GENE GENE	2
CHEMICAL -induced elevation in levels of mrna GENE	2
CHEMICAL -dependent correlation involves upregulation of GENE of GENE	2
CHEMICAL -dependent correlation involves upregulation of GENE	2
CHEMICAL -dependent correlation involves GENE shown GENE	2
CHEMICAL -dependent correlation involves GENE	2
CHEMICAL -binding domain GENE	2
VARIANT with markers associated with conversion to DISEASE	1
VARIANT with kindred one identified report in kindreds with DISEASE DISEASE	1
VARIANT with kindred one identified report in kindreds with DISEASE	1
VARIANT with kindred one identified conclude found was DISEASE	1
VARIANT with for DISEASE	1
VARIANT with associated is DISEASE	1
VARIANT with associated DISEASE	1
VARIANT with allele allele for was found screened caused is develop DISEASE	1
VARIANT with allele allele for was found screened caused is DISEASE	1
VARIANT with allele allele for was found revealed be cause of DISEASE DISEASE	1
VARIANT with allele allele for was found revealed be cause of DISEASE	1
VARIANT were were associated with mortality DISEASE	1
VARIANT were snps associated with mortality DISEASE	1
VARIANT were detected detected between controls patients DISEASE	1
VARIANT was result identified is detected identified was support results in DISEASE	1
VARIANT was in men DISEASE	1
VARIANT was found identified results confirmed selected used evaluated samples patient DISEASE DISEASE	1
VARIANT was found identified results confirmed selected used evaluated samples patient DISEASE	1
VARIANT was attenuated was expression in DISEASE	1
VARIANT was abundant in patients DISEASE	1
VARIANT viruses VARIANT considered for evaluation in for inclusion in vaccine DISEASE	1
VARIANT variants in resulting gene of 11 exon in polymorphisms are is transporter of CHEMICAL	1
VARIANT variants VARIANT for observed had seen led results analysed was antibodies in DISEASE	1
VARIANT variant with persons patients DISEASE	1
VARIANT variant with DISEASE	1
VARIANT variant polymorphisms studied with respect to DISEASE	1
VARIANT variant in as is show molecules involved in inhibition promotion progression DISEASE	1
VARIANT variant identified observed associated with DISEASE	1
VARIANT variant identified in individual with DISEASE	1
VARIANT variant frequencies were substantiated seems yielded association with phenotypes DISEASE	1
VARIANT variant frequencies were higher among patients with patients with DISEASE	1
VARIANT variant associated with risk of DISEASE	1
VARIANT values VARIANT were were associated with mortality DISEASE	1
VARIANT values VARIANT were snps associated with mortality DISEASE	1
VARIANT tt genotype carrying subjects CHEMICAL	1
VARIANT transitions linked to repair caused by drug CHEMICAL	1
VARIANT transitions being majority DISEASE	1
VARIANT transition substitution heterozygote is showed providing diagnosis of DISEASE	1
VARIANT transition substitution heterozygote is showed diagnosed presented report DISEASE	1
VARIANT transition revealed screened family with DISEASE	1
VARIANT transition revealed screened associated with DISEASE	1
VARIANT transition resulted identified is increase risk of developing DISEASE	1
VARIANT transition resulted detected in patient with DISEASE evidence of DISEASE	1
VARIANT transition resulted detected had inherited DISEASE	1
VARIANT transfected failed suggesting was cause of DISEASE	1
VARIANT transfected conclusion describe case of DISEASE	1
VARIANT to leading association of gene in DISEASE	1
VARIANT to corresponding identified report in kindreds with DISEASE DISEASE	1
VARIANT to corresponding identified report in kindreds with DISEASE	1
VARIANT to corresponding identified conclude found was DISEASE	1
VARIANT to addition in importance in patients with DISEASE	1
VARIANT that showed showed describe described comprises is DISEASE	1
VARIANT than CHEMICAL	1
VARIANT substitutions of consists describe in family with DISEASE DISEASE	1
VARIANT substitutions of consists describe family causing DISEASE	1
VARIANT substitutions detected of patients with DISEASE	1
VARIANT substitution site CHEMICAL	1
VARIANT substitution impaired secretion CHEMICAL	1
VARIANT substitution exhibit DISEASE	1
VARIANT substitution detected performed known encodes identified depends causes DISEASE	1
VARIANT substitution detected performed introduces share symptoms of progressing DISEASE	1
VARIANT substitution detected performed analyses of patients received diagnosis of DISEASE	1
VARIANT substitution contains suggested repeats in DISEASE	1
VARIANT substitution causing obtained is associated with DISEASE	1
VARIANT spanning with identified demonstrated lesions DISEASE	1
VARIANT snp showed indicated association with DISEASE	1
VARIANT snp showed identified examined performed is CHEMICAL	1
VARIANT snp of frequency observed among patients DISEASE	1
VARIANT snp for followed reaction were carried evaluated studied explored on survival of patients subjected to chemotherapy CHEMICAL	1
VARIANT snp for followed reaction were carried evaluated studied explored -treated patients DISEASE	1
VARIANT snp for followed reaction were carried evaluated studied explored -treated combination within regions of survival in CHEMICAL	1
VARIANT snp associated with DISEASE	1
VARIANT snp associated was DISEASE	1
VARIANT skipping demonstrated identified included identified is DISEASE	1
VARIANT sizes GENE	1
VARIANT shown associated with traits -related DISEASE	1
VARIANT showed showed associations with DISEASE	1
VARIANT showed in DISEASE	1
VARIANT showed associated characterized DISEASE	1
VARIANT sequence variation carried were performed identified in database DISEASE	1
VARIANT sequence variation carried were performed identified children with DISEASE DISEASE	1
VARIANT sequence variation carried were performed identified children with DISEASE	1
VARIANT selected shown data DISEASE	1
VARIANT segregated support notion cause DISEASE	1
VARIANT risk progression DISEASE	1
VARIANT risk DISEASE	1
VARIANT revealed was predicts transfected conclusion describe case of DISEASE	1
VARIANT revealed was co conclusions is expands spectrum in associated with DISEASE DISEASE	1
VARIANT revealed showed abnormalities consistent with DISEASE	1
VARIANT revealed results amplified collected identify purpose mutation causing DISEASE	1
VARIANT revealed results amplified collected identify in family with DISEASE	1
VARIANT revealed differs from pathology reported in individuals with DISEASE	1
VARIANT revealed 3.44 had DISEASE	1
VARIANT resulting for be found found cause DISEASE	1
VARIANT residue predicted coordinate binding of ion CHEMICAL	1
VARIANT reported in patients DISEASE	1
VARIANT reported encodes is DISEASE	1
VARIANT reported cosegregates exacerbated led is haploinsufficiency by decay DISEASE	1
VARIANT reported cosegregates exacerbated led investigation of DISEASE	1
VARIANT reported cosegregates exacerbated led individuals prone to DISEASE DISEASE DISEASE DISEASE	1
VARIANT reported cosegregates exacerbated led individuals prone to DISEASE DISEASE DISEASE	1
VARIANT reported cosegregates exacerbated led individuals prone to DISEASE DISEASE	1
VARIANT reported cosegregates exacerbated led individuals prone to DISEASE	1
VARIANT ratio were were associated with mortality DISEASE	1
VARIANT ratio were snps associated with mortality DISEASE	1
VARIANT rates were divided had CHEMICAL	1
VARIANT protein of composition of alteration to led gene of tenth in change showed patient DISEASE	1
VARIANT presence linked to predisposition DISEASE	1
VARIANT position GENE of promoter in substitution modifies risk of DISEASE	1
VARIANT position GENE of promoter in substitution modifies hypothesised methods diagnosed with DISEASE	1
VARIANT position GENE of promoter in substitution modifies hypothesised methods calculated results was n DISEASE	1
VARIANT position GENE of promoter in substitution modifies hypothesised methods calculated results was % = DISEASE	1
VARIANT polymorphisms studied with respect to DISEASE	1
VARIANT polymorphisms DISEASE	1
VARIANT polymorphism showed association with bp in people DISEASE	1
VARIANT polymorphism risk DISEASE	1
VARIANT polymorphism reported roles on DISEASE	1
VARIANT polymorphism reported catalyzes conversion to CHEMICAL	1
VARIANT polymorphism reported catalyzes conversion of CHEMICAL	1
VARIANT polymorphism of roles on DISEASE	1
VARIANT polymorphism of presence with individuals are susceptible develop DISEASE	1
VARIANT polymorphism of impact on susceptibility to DISEASE	1
VARIANT polymorphism of genotype associated with DISEASE	1
VARIANT polymorphism of genotype associated excluded role to DISEASE	1
VARIANT polymorphism linked with DISEASE	1
VARIANT polymorphism in DISEASE	1
VARIANT polymorphism have impact on risk of CHEMICAL	1
VARIANT polymorphism have by modulating formation of metabolites CHEMICAL	1
VARIANT polymorphism gene confers to DISEASE	1
VARIANT polymorphism for studied cases cases DISEASE	1
VARIANT polymorphism factors as DISEASE	1
VARIANT polymorphism detected identified was support results in DISEASE	1
VARIANT polymorphism detected identified was support results implicated with DISEASE DISEASE	1
VARIANT polymorphism detected identified was support results implicated with DISEASE	1
VARIANT polymorphism associated plays consists associated with DISEASE DISEASE	1
VARIANT polymorphism associated plays consists associated with DISEASE	1
VARIANT polymorphism VARIANT studied explored -treated patients DISEASE	1
VARIANT plays revealed showed revealed had results had presented identified case of syndrome DISEASE	1
VARIANT plays revealed showed revealed had results had DISEASE	1
VARIANT plays is effective in controlling DISEASE DISEASE DISEASE DISEASE	1
VARIANT plays is effective in controlling DISEASE DISEASE DISEASE	1
VARIANT plays is effective in controlling DISEASE DISEASE	1
VARIANT patient in VARIANT in patients DISEASE	1
VARIANT pa1 VARIANT of expansion mutations for screened from individuals with DISEASE	1
VARIANT of substitution showed determined is was showed findings of DISEASE	1
VARIANT of substitution showed denoted suggested is remains mechanism of DISEASE	1
VARIANT of substitution in resulting polymorphism increases susceptibility to DISEASE	1
VARIANT of substitution in resulting polymorphism increases risk of DISEASE	1
VARIANT of substitution in resulting polymorphism increases associated with DISEASE	1
VARIANT of substitution in resulted VARIANT had inherited DISEASE	1
VARIANT of substitution in resulted VARIANT had detected resulted identified is increase risk of developing DISEASE	1
VARIANT of substitution heterozygote is showed providing diagnosis of DISEASE	1
VARIANT of substitution VARIANT were detected detected between controls patients DISEASE	1
VARIANT of presence linked to predisposition DISEASE	1
VARIANT of number tended correlate with levels of CHEMICAL	1
VARIANT of mutation had patients with DISEASE	1
VARIANT of mutation had in DISEASE	1
VARIANT of insertion detected were with DISEASE	1
VARIANT of insertion detected in patients DISEASE	1
VARIANT of expansion mutations for screened from individuals with DISEASE	1
VARIANT of exchange to leads are is transporter of CHEMICAL	1
VARIANT of carriers showed had increased GENE CHEMICAL	1
VARIANT of carriers had increased GENE CHEMICAL	1
VARIANT of carriers had increased CHEMICAL	1
VARIANT of analogue show created developed developed DISEASE	1
VARIANT of analogue show arrest of podocytes DISEASE	1
VARIANT of alleles linked linked to predisposition DISEASE	1
VARIANT of alleles g associated linked linked to predisposition DISEASE	1
VARIANT of allele showed associations with DISEASE	1
VARIANT of allele associated with risk of DISEASE	1
VARIANT negativity CHEMICAL	1
VARIANT named model created developed developed DISEASE	1
VARIANT named model created developed DISEASE	1
VARIANT mutations were results performed amplified methods recruited patients with DISEASE	1
VARIANT mutations of recognition to led is DISEASE caused by GENE DISEASE	1
VARIANT mutations of gene with DISEASE	1
VARIANT mutations mutations identified were with DISEASE	1
VARIANT mutations mutations identified in 12 two with DISEASE	1
VARIANT mutations mutations identified in 12 two one with DISEASE	1
VARIANT mutations identified with DISEASE	1
VARIANT mutations identified were with DISEASE	1
VARIANT mutations identified in 12 two with DISEASE	1
VARIANT mutations identified in 12 two one with DISEASE	1
VARIANT mutations diagnosed in DISEASE	1
VARIANT mutations cause substitutions of consists describe in family with DISEASE DISEASE	1
VARIANT mutations cause substitutions of consists describe family causing DISEASE	1
VARIANT mutation with along described in population patients DISEASE	1
VARIANT mutation with DISEASE	1
VARIANT mutation to led locus of 17 exon in mutation carry found is disorder DISEASE	1
VARIANT mutation reported in DISEASE	1
VARIANT mutation reported identified detected with examined DISEASE	1
VARIANT mutation reported carried find demonstrate in fifth of DISEASE	1
VARIANT mutation report remains reported is DISEASE	1
VARIANT mutation report in case of DISEASE	1
VARIANT mutation relate first is expands spectrum in associated with DISEASE DISEASE	1
VARIANT mutation relate first is expands spectrum in associated with DISEASE	1
VARIANT mutation reduced levels CHEMICAL	1
VARIANT mutation possessed exhibited except patient one with DISEASE	1
VARIANT mutation of recurrence attributed appear suggest be DISEASE	1
VARIANT mutation of identification suggests appear suggest be DISEASE	1
VARIANT mutation of identification is DISEASE	1
VARIANT mutation mutations in GENE in individuals with DISEASE	1
VARIANT mutation mutations identified detected with examined DISEASE	1
VARIANT mutation mutations identified detected amplified analysed examined described in DISEASE	1
VARIANT mutation leads found was conclude play in mediation of DISEASE	1
VARIANT mutation is somatic in DISEASE	1
VARIANT mutation is mutation in DISEASE	1
VARIANT mutation is is DISEASE	1
VARIANT mutation is inherited with DISEASE DISEASE	1
VARIANT mutation is inherited with DISEASE	1
VARIANT mutation is be DISEASE	1
VARIANT mutation is DISEASE	1
VARIANT mutation including mutations identified were with DISEASE	1
VARIANT mutation including mutations identified in 12 two with DISEASE	1
VARIANT mutation including mutations identified in 12 two one with DISEASE	1
VARIANT mutation in population DISEASE	1
VARIANT mutation in patients with DISEASE	1
VARIANT mutation in patients DISEASE	1
VARIANT mutation in patient with DISEASE	1
VARIANT mutation in GENE with DISEASE	1
VARIANT mutation in DISEASE	1
VARIANT mutation identified with children affected with DISEASE	1
VARIANT mutation identified with DISEASE	1
VARIANT mutation identified siblings presented with DISEASE DISEASE	1
VARIANT mutation identified siblings presented with DISEASE	1
VARIANT mutation identified results is is DISEASE	1
VARIANT mutation identified report identified have is DISEASE	1
VARIANT mutation identified performed elucidated is DISEASE	1
VARIANT mutation identified in patients with DISEASE	1
VARIANT mutation identified had support homozygous showed DISEASE	1
VARIANT mutation identified had is feature of DISEASE	1
VARIANT mutation identified describe is DISEASE	1
VARIANT mutation identified caused decreased consumption CHEMICAL	1
VARIANT mutation identified caused DISEASE	1
VARIANT mutation identified as cause of DISEASE	1
VARIANT mutation identified , DISEASE	1
VARIANT mutation from resulting DISEASE	1
VARIANT mutation for was found is is DISEASE	1
VARIANT mutation for was found is disorder DISEASE	1
VARIANT mutation for importance in patients with DISEASE	1
VARIANT mutation for DISEASE	1
VARIANT mutation family in identified performed elucidated is DISEASE	1
VARIANT mutation detected in group DISEASE	1
VARIANT mutation detected caused phenotype of DISEASE	1
VARIANT mutation described in population patients DISEASE	1
VARIANT mutation causes prolonged DISEASE with CHEMICAL	1
VARIANT mutation causes prolonged DISEASE	1
VARIANT mutation causes DISEASE	1
VARIANT mutation carrying patients were with DISEASE	1
VARIANT mutation carrying patients were identified in 12 two with DISEASE	1
VARIANT mutation carrying patients were identified in 12 two one with DISEASE	1
VARIANT mutation be appeared showed accumulated describe DISEASE	1
VARIANT mutation associated with onset progression to DISEASE	1
VARIANT mutation associated with DISEASE	1
VARIANT mutation associated show created developed developed DISEASE	1
VARIANT mutation associated show arrest of podocytes DISEASE	1
VARIANT mutation accounted found include identified report detected in patients DISEASE	1
VARIANT mutation VARIANT mutation reported identified detected with examined DISEASE	1
VARIANT mutation VARIANT mutation reported carried find demonstrate in fifth of DISEASE	1
VARIANT mutation VARIANT for heterozygote was showed was female DISEASE	1
VARIANT mutation VARIANT for heterozygote was showed symptoms of DISEASE	1
VARIANT markers associated associated with conversion to DISEASE	1
VARIANT located associated with risk of DISEASE	1
VARIANT length detected results found distribution in DISEASE	1
VARIANT leads reported have effect on development of DISEASE	1
VARIANT leads are is transporter of CHEMICAL	1
VARIANT isoforms with assays used CHEMICAL substrate CHEMICAL	1
VARIANT is studied identified in gene leading to DISEASE	1
VARIANT is studied identification of mutations resulting in DISEASE	1
VARIANT is is are identified results established diagnosis of DISEASE	1
VARIANT is associated characterized DISEASE	1
VARIANT is are identified results established diagnosis of DISEASE	1
VARIANT introns of retention skipping demonstrated identified included identified is DISEASE	1
VARIANT introduced identified with DISEASE	1
VARIANT influences sensitivity homeostasis CHEMICAL	1
VARIANT increases risk of DISEASE	1
VARIANT including mutations identified divided into groups DISEASE	1
VARIANT included were had interval for conversion to DISEASE	1
VARIANT in replaced report DISEASE	1
VARIANT in patient DISEASE	1
VARIANT in identified snps variants genotyped associated with DISEASE	1
VARIANT in decreases in patients with DISEASE	1
VARIANT in ci associated associated observed associated conclusion associated with recurrence DISEASE	1
VARIANT in associated with mortality DISEASE	1
VARIANT identified reported on family transmitted to to son with DISEASE	1
VARIANT identified reported be responsible for proportion of families multiplex DISEASE	1
VARIANT identified performed elucidated is DISEASE	1
VARIANT identified leading to DISEASE	1
VARIANT identified is detected identified was support results in DISEASE	1
VARIANT identified is detected identified was support results implicated with DISEASE DISEASE	1
VARIANT identified is DISEASE	1
VARIANT identified in patient DISEASE	1
VARIANT identified identified suggests appear suggest be DISEASE	1
VARIANT identified confirmed value of profile for DISEASE	1
VARIANT homozygosity associated related after DISEASE	1
VARIANT homeodomain in mutation including mutations identified had screened from individuals with DISEASE	1
VARIANT have identified with DISEASE	1
VARIANT have has show was lowest in patients showed onset of DISEASE	1
VARIANT have has allele DISEASE	1
VARIANT haplotype of frequency noticed showed in DISEASE	1
VARIANT haplotype found in patient with DISEASE	1
VARIANT had inherited DISEASE	1
VARIANT had detected resulted identified is increase risk of developing DISEASE	1
VARIANT guangzhou of identification aims is DISEASE	1
VARIANT genotypes for % had CHEMICAL	1
VARIANT genotypes associated with risk DISEASE	1
VARIANT genotypes associated tended correlate with levels of CHEMICAL	1
VARIANT genotyped in patients with DISEASE	1
VARIANT genotype with patients showed state DISEASE	1
VARIANT genotype with carriers had CHEMICAL	1
VARIANT genotype of presence course stratify obtain sequences from variants isolated from populations of individuals DISEASE	1
VARIANT genotype lymphocytes in repair occurrence DISEASE	1
VARIANT genotype is in DISEASE	1
VARIANT genotype found associated with risk for DISEASE	1
VARIANT genotype for % had CHEMICAL	1
VARIANT genotype associated with risk of tract DISEASE	1
VARIANT genotype associated with patients DISEASE	1
VARIANT genotype associated in males patients DISEASE	1
VARIANT genotype associated associated with risk of DISEASE	1
VARIANT genotype associated associated with patients DISEASE	1
VARIANT genotype as factor in patients DISEASE	1
VARIANT gene within polymorphisms associated with DISEASE	1
VARIANT gene within polymorphisms associated cause DISEASE	1
VARIANT gene of VARIANT of substitution in resulting identified results screened patients DISEASE	1
VARIANT gene in mutations for heterozygote be showed showed describe described comprises is DISEASE	1
VARIANT gene in mutations examined methods aimed expected concordance specimens of DISEASE	1
VARIANT gene in mutations examined methods aimed expected be targets for DISEASE	1
VARIANT g allele associated with prevalence of DISEASE	1
VARIANT g allele associated with prevalence DISEASE	1
VARIANT from change in resulted was found was result identified is detected identified was support results in DISEASE	1
VARIANT from change in resulted was found identified results confirmed selected used evaluated samples patient DISEASE DISEASE	1
VARIANT from change in resulted was found identified results confirmed selected used evaluated samples patient DISEASE	1
VARIANT from carrying haplotype was associated with risk of DISEASE	1
VARIANT frequency in cases DISEASE	1
VARIANT found with DISEASE children with DISEASE	1
VARIANT found was result identified is detected identified was support results in DISEASE	1
VARIANT found molecules involved in inhibition promotion progression DISEASE	1
VARIANT found linked induce development of DISEASE DISEASE	1
VARIANT found linked induce development of DISEASE	1
VARIANT found linked induce cosegregate with DISEASE	1
VARIANT found identified results confirmed selected used evaluated samples patient DISEASE DISEASE	1
VARIANT found identified results confirmed selected used evaluated samples patient DISEASE	1
VARIANT found demonstrated showed after treatment CHEMICAL	1
VARIANT found be DISEASE	1
VARIANT for were results profound depressed CHEMICAL	1
VARIANT for were results profound DISEASE DISEASE DISEASE relapsing DISEASE	1
VARIANT for were results profound DISEASE DISEASE DISEASE	1
VARIANT for were results profound DISEASE DISEASE	1
VARIANT for were results profound CHEMICAL	1
VARIANT for was female DISEASE	1
VARIANT for snp found involved association between polymorphism of GENE DISEASE	1
VARIANT for observed had seen led results analysed was antibodies in DISEASE	1
VARIANT for identified results screened patients DISEASE	1
VARIANT for homozygous had was DISEASE	1
VARIANT for homozygous had DISEASE DISEASE	1
VARIANT for homozygosity identified in patient with outcome despite DISEASE	1
VARIANT for heterozygote was showed was female DISEASE	1
VARIANT for heterozygote was showed symptoms of DISEASE	1
VARIANT for genotyped investigated investigates is is CHEMICAL	1
VARIANT for genotyped associated with prevalence of DISEASE	1
VARIANT for genotyped associated with prevalence DISEASE	1
VARIANT for frequency exist conclusions identified as cause of DISEASE	1
VARIANT for frequencies were substantiated seems yielded association with phenotypes DISEASE	1
VARIANT for frequencies were higher among patients with patients with DISEASE	1
VARIANT for found associated with DISEASE	1
VARIANT for 1.998 were suggest associated with DISEASE	1
VARIANT five VARIANT reported in patients DISEASE	1
VARIANT expansion mutations for screened from individuals with DISEASE	1
VARIANT exon showed increased CHEMICAL	1
VARIANT exon showed GENE CHEMICAL	1
VARIANT exon mutation deletion deletion mutation mutations identified detected with examined DISEASE	1
VARIANT exon mutation deletion deletion mutation mutations identified detected amplified analysed examined described in DISEASE	1
VARIANT exon in VARIANT found linked to polymorphism VARIANT	1
VARIANT exon in VARIANT found linked induce development of DISEASE DISEASE	1
VARIANT exon in VARIANT found linked induce development of DISEASE	1
VARIANT exon in VARIANT found linked induce cosegregate with DISEASE	1
VARIANT exhibit according to schedule CHEMICAL	1
VARIANT exert preserved ability bind to elements CHEMICAL	1
VARIANT exchange attenuated was expression in DISEASE	1
VARIANT enhances preserved ability bind to elements CHEMICAL	1
VARIANT enhances predispose subjects to DISEASE DISEASE manifestations of DISEASE	1
VARIANT enhances predispose subjects to DISEASE DISEASE	1
VARIANT enhances predispose subjects to DISEASE	1
VARIANT encoding in domain recognition CHEMICAL	1
VARIANT encoding alleles of carriage found in % of patients DISEASE	1
VARIANT encoding alleles of carriage found associated increases risk of DISEASE	1
VARIANT encoding alleles for homozygosity associated with risk of DISEASE	1
VARIANT discovered mutation than larger duplications reports with mutations % identified had screened from individuals with DISEASE	1
VARIANT disclosed detected conclusion confirms diagnosis of DISEASE	1
VARIANT disclosed carried siblings comprising DISEASE DISEASE DISEASE	1
VARIANT disclosed amplified DISEASE	1
VARIANT differs between patients DISEASE	1
VARIANT detected studied context associated variations in sensitivity CHEMICAL	1
VARIANT detected in cases of DISEASE	1
VARIANT designated generated considered for evaluation in for inclusion in vaccine DISEASE	1
VARIANT demonstrated preserved ability bind to elements CHEMICAL	1
VARIANT demonstrated increase in ability transactivate in response to CHEMICAL	1
VARIANT deletion revealed found described mapped report DISEASE	1
VARIANT deletion revealed associated with DISEASE	1
VARIANT deletion mutation mutations identified detected with examined DISEASE	1
VARIANT deletion mutation mutations identified detected amplified analysed examined described in DISEASE	1
VARIANT deletion deletion mutation mutations identified detected with examined DISEASE	1
VARIANT deletion deletion mutation mutations identified detected amplified analysed examined described in DISEASE	1
VARIANT converting disclosed detected conclusion confirms diagnosis of DISEASE	1
VARIANT conversion to DISEASE	1
VARIANT conversion increased risk of DISEASE	1
VARIANT conversion increased predicted increased conclude predict in subjects DISEASE	1
VARIANT conversion increased predicted associated associated with conversion from DISEASE	1
VARIANT conversion affecting gene of snp1 associated with DISEASE	1
VARIANT conversion affecting GENE of snp7 snp1 associated with DISEASE	1
VARIANT containing haplotype associated with DISEASE	1
VARIANT considered for evaluation in for inclusion in vaccine DISEASE	1
VARIANT confirmed denotes were was suggest cause impair to CHEMICAL	1
VARIANT confirm used showed accumulated describe DISEASE	1
VARIANT confirm used extend identify mutation DISEASE	1
VARIANT confirm used extend causes of DISEASE	1
VARIANT conclusion is variant in DISEASE	1
VARIANT conclusion is associated with DISEASE DISEASE	1
VARIANT conclusion is associated with DISEASE	1
VARIANT conclusion be prognostic in patients with DISEASE	1
VARIANT channel dysfunction contribute due kinetics DISEASE with onset of DISEASE	1
VARIANT channel dysfunction contribute due kinetics DISEASE	1
VARIANT changes investigated risk DISEASE	1
VARIANT change conversion affecting GENE of snp7 snp1 associated with DISEASE	1
VARIANT change caused showed improved found have role in DISEASE	1
VARIANT change caused showed improved found associations of DISEASE	1
VARIANT change caused showed detected showed diagnosed presented report DISEASE	1
VARIANT causes seemed be associated with risk DISEASE	1
VARIANT caused phenotype of DISEASE	1
VARIANT caused detected in group DISEASE	1
VARIANT carriers in DISEASE	1
VARIANT carriers developed symptoms of DISEASE	1
VARIANT carried analyzed screened mutation patients with DISEASE	1
VARIANT carried analyzed screened accumulate lead to DISEASE	1
VARIANT by influenced observed observed increased DISEASE	1
VARIANT by conferred DISEASE	1
VARIANT at frequencies in DISEASE	1
VARIANT associates is allele for DISEASE	1
VARIANT associated with risk of DISEASE	1
VARIANT associated with increase in risk DISEASE	1
VARIANT associated with DISEASE	1
VARIANT associated with CHEMICAL	1
VARIANT associated suggest reduce therapy CHEMICAL	1
VARIANT associated changes in gene VARIANT VARIANT	1
VARIANT associated changes in gene VARIANT	1
VARIANT associated associated with susceptibility DISEASE	1
VARIANT associated after diagnosis of DISEASE	1
VARIANT associated -induced patients DISEASE	1
VARIANT as identified allowed performed identified solved caused in patient DISEASE	1
VARIANT are identified results established diagnosis of DISEASE	1
VARIANT appeared compared measured by duration of DISEASE	1
VARIANT alleles VARIANT presence linked to predisposition DISEASE	1
VARIANT allele with DISEASE DISEASE	1
VARIANT allele with DISEASE	1
VARIANT allele of distribution is studied found show resistance to DISEASE progression towards DISEASE	1
VARIANT allele of distribution is studied found show resistance to DISEASE	1
VARIANT allele of DISEASE	1
VARIANT allele is variant for DISEASE	1
VARIANT allele in patients DISEASE	1
VARIANT allele have role in DISEASE	1
VARIANT allele factor for DISEASE	1
VARIANT allele associated suggest showed state DISEASE	1
VARIANT a allele associated observed associated conclusion associated with recurrence DISEASE	1
VARIANT VARIANT was reported is phenotype with DISEASE behaviour DISEASE	1
VARIANT VARIANT was reported is phenotype with DISEASE	1
VARIANT VARIANT was reported is phenotype DISEASE	1
VARIANT VARIANT substitutions detected of patients with DISEASE	1
VARIANT VARIANT snps using conducted conducted -induced DISEASE	1
VARIANT VARIANT snps using conducted -induced patients DISEASE	1
VARIANT VARIANT snps revealed was snp with DISEASE	1
VARIANT VARIANT snps revealed associated with independent DISEASE	1
VARIANT VARIANT revealed 3.44 had DISEASE	1
VARIANT VARIANT reported in patients DISEASE	1
VARIANT VARIANT region in snps were genotyped trial investigated influenced DISEASE	1
VARIANT VARIANT polymorphisms studied with respect to DISEASE	1
VARIANT VARIANT mutations were results performed amplified methods recruited patients with DISEASE	1
VARIANT VARIANT mutations of recognition to led is DISEASE caused by GENE DISEASE	1
VARIANT VARIANT mutations of gene with DISEASE	1
VARIANT VARIANT mutations mutations identified were with DISEASE	1
VARIANT VARIANT mutations mutations identified in 12 two with DISEASE	1
VARIANT VARIANT mutations mutations identified in 12 two one with DISEASE	1
VARIANT VARIANT mutations identified were with DISEASE	1
VARIANT VARIANT mutations identified in 12 two with DISEASE	1
VARIANT VARIANT mutations identified in 12 two one with DISEASE	1
VARIANT VARIANT mutations cause substitutions of consists describe in family with DISEASE DISEASE	1
VARIANT VARIANT mutations cause substitutions of consists describe family causing DISEASE	1
VARIANT VARIANT mutation VARIANT for heterozygote was showed was female DISEASE	1
VARIANT VARIANT mutation VARIANT for heterozygote was showed symptoms of DISEASE	1
VARIANT VARIANT markers in GENE CHEMICAL	1
VARIANT VARIANT markers between association detected -induced DISEASE	1
VARIANT VARIANT markers associated associated with conversion to DISEASE	1
VARIANT VARIANT is studied identified in gene leading to DISEASE	1
VARIANT VARIANT is studied identification of mutations resulting in DISEASE	1
VARIANT VARIANT including mutations identified divided into groups DISEASE	1
VARIANT VARIANT identified leading to DISEASE	1
VARIANT VARIANT gene within polymorphisms associated with DISEASE	1
VARIANT VARIANT gene within polymorphisms associated cause DISEASE	1
VARIANT VARIANT gene in mutations examined methods aimed expected concordance specimens of DISEASE	1
VARIANT VARIANT gene in mutations examined methods aimed expected be targets for DISEASE	1
VARIANT VARIANT from carrying haplotype was associated with risk of DISEASE	1
VARIANT VARIANT found was result identified is detected identified was support results in DISEASE	1
VARIANT VARIANT found identified results confirmed selected used evaluated samples patient DISEASE DISEASE	1
VARIANT VARIANT found identified results confirmed selected used evaluated samples patient DISEASE	1
VARIANT VARIANT for heterozygote was were segregated support notion cause DISEASE	1
VARIANT VARIANT five VARIANT reported in patients DISEASE	1
VARIANT VARIANT exhibit according to schedule CHEMICAL	1
VARIANT VARIANT discovered mutation than larger duplications reports with mutations % identified had screened from individuals with DISEASE	1
VARIANT VARIANT confirm used showed accumulated describe DISEASE	1
VARIANT VARIANT confirm used extend identify mutation DISEASE	1
VARIANT VARIANT confirm used extend causes of DISEASE	1
VARIANT VARIANT by influenced observed observed increased DISEASE	1
VARIANT VARIANT at frequencies in DISEASE	1
VARIANT VARIANT are identified results established diagnosis of DISEASE	1
VARIANT VARIANT accounted found occurred had DISEASE	1
VARIANT VARIANT VARIANT snps using conducted conducted -induced DISEASE	1
VARIANT VARIANT VARIANT snps using conducted -induced patients DISEASE	1
VARIANT VARIANT VARIANT region in snps were genotyped trial investigated influenced DISEASE	1
VARIANT VARIANT VARIANT mutations mutations identified in 12 two with DISEASE	1
VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with DISEASE	1
VARIANT VARIANT VARIANT mutations identified with DISEASE	1
VARIANT VARIANT VARIANT markers in GENE CHEMICAL	1
VARIANT VARIANT VARIANT gene in mutations examined methods aimed expected concordance specimens of DISEASE	1
VARIANT VARIANT VARIANT gene in mutations examined methods aimed expected be targets for DISEASE	1
VARIANT VARIANT VARIANT five VARIANT reported in patients DISEASE	1
VARIANT VARIANT VARIANT by influenced observed observed increased DISEASE	1
VARIANT VARIANT VARIANT associated with DISEASE	1
VARIANT VARIANT VARIANT VARIANT mutations mutations identified were with DISEASE	1
VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two with DISEASE	1
VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with DISEASE	1
VARIANT VARIANT VARIANT VARIANT gene in mutations examined methods aimed expected concordance specimens of DISEASE	1
VARIANT VARIANT VARIANT VARIANT gene in mutations examined methods aimed expected be targets for DISEASE	1
VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified were with DISEASE	1
VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two with DISEASE	1
VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with DISEASE	1
VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified were with DISEASE	1
VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two with DISEASE	1
VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with DISEASE	1
VARIANT VARIANT CHEMICAL	1
VARIANT GENE transition via be appears promoted CHEMICAL	1
VARIANT GENE transition via be appears promote by effects on CHEMICAL DISEASE	1
VARIANT GENE transition that expression of GENE CHEMICAL	1
VARIANT GENE ratio of variant in found showed associations with DISEASE	1
VARIANT GENE polymorphism associated with DISEASE	1
VARIANT GENE polymorphism associated is DISEASE	1
VARIANT GENE oncogene is demonstrated have value for treatment DISEASE	1
VARIANT GENE model is model of cause of DISEASE	1
VARIANT GENE mediated DISEASE	1
VARIANT GENE lacks domain required for -calmodulin CHEMICAL	1
VARIANT GENE is variant related to DISEASE	1
VARIANT GENE is suggest cause impair to CHEMICAL	1
VARIANT GENE displays behavior with CHEMICAL	1
VARIANT GENE GENE insertion factors implicated in influencing DISEASE	1
VARIANT GENE GENE form permeated dialyzing activated CHEMICAL	1
VARIANT DISEASE with associated variants associated with DISEASE	1
VARIANT DISEASE DISEASE in DISEASE	1
VARIANT DISEASE DISEASE	1
VARIANT -a allele contributes by disrupting enhancer results in expression DISEASE	1
VARIANT +1858 polymorphisms genotyped using in subjects subjects with DISEASE	1
VARIANT +1858 polymorphisms genotyped methods aimed czechs with with DISEASE	1
GENE within snps associated with mortality DISEASE	1
GENE with treatment in reduced phosphorylation GENE	1
GENE with sensitivity conversion CHEMICAL	1
GENE with relation DISEASE	1
GENE with rats used induced was associated attenuated indicate are sensitive to response DISEASE	1
GENE with patients of treatment during described develop DISEASE	1
GENE with operates promoting promote DISEASE	1
GENE with interaction through regulate shown channel GENE	1
GENE with interact shown GENE	1
GENE with incubation prevented lowered knockdown GENE	1
GENE with families describe characterized DISEASE	1
GENE with expressions GENE	1
GENE with cooperates increasing expression GENE	1
GENE with antidiabetic DISEASE	1
GENE with GENE	1
GENE with -induced DISEASE	1
GENE with -induced CHEMICAL	1
GENE whereas reduced revealed established study remain suggested indicated induce exposure CHEMICAL	1
GENE were lacked produced level of GENE	1
GENE were indicated contributed through enhancing monopoiesis -associated GENE	1
GENE was was risk of DISEASE	1
GENE was show increased GENE GENE	1
GENE was regulated in cells GENE	1
GENE was in ko GENE	1
GENE was had activation GENE	1
GENE was had activation -mediated GENE	1
GENE was had DISEASE	1
GENE was for activation -mediated GENE	1
GENE was concomitant with activation of GENE	1
GENE was by GENE	1
GENE was activated genes in DISEASE	1
GENE was DISEASE	1
GENE via signaling noradrenergic required for -induced DISEASE	1
GENE via increases angiogenesis growth DISEASE	1
GENE versus treatment CHEMICAL	1
GENE variation risk DISEASE	1
GENE variation associated with recurrence DISEASE	1
GENE variants play associated with traits -related DISEASE	1
GENE variants of patients with DISEASE	1
GENE variants increase in DISEASE	1
GENE variants increase are DISEASE	1
GENE variants increase DISEASE DISEASE	1
GENE variants increase DISEASE	1
GENE variants frequency caused proportion of DISEASE	1
GENE variant related to DISEASE	1
GENE variant of discovery to leading administration of CHEMICAL	1
GENE validated induced GENE	1
GENE utilized advance DISEASE	1
GENE using patients in be is considered was CHEMICAL	1
GENE using patients in be is considered cause of DISEASE	1
GENE using patients in be alert to possibility of DISEASE	1
GENE using patients in be CHEMICAL have DISEASE	1
GENE using patients in be CHEMICAL	1
GENE used same was GENE	1
GENE used results infected by strains DISEASE	1
GENE used manage -associated CHEMICAL	1
GENE used genotyping analysis study variability DISEASE	1
GENE used combined with GENE	1
GENE used analysed phenotype of isolates DISEASE	1
GENE used DISEASE	1
GENE upregulates expression GENE	1
GENE upregulated see serum level GENE	1
GENE upregulated see cells DISEASE	1
GENE upregulated see DISEASE DISEASE	1
GENE upregulated see DISEASE	1
GENE upregulated is predictor in DISEASE -negative GENE	1
GENE upregulated is predictor in DISEASE	1
GENE upregulated incubation corresponding to concentration CHEMICAL	1
GENE upregulated in lenses GENE	1
GENE upregulated in DISEASE	1
GENE upregulated GENE	1
GENE upregulated DISEASE	1
GENE underwent was GENE -induced CHEMICAL	1
GENE uncovered DISEASE	1
GENE type design results increased levels phosphorylated GENE	1
GENE type design results increased DISEASE	1
GENE type design analyzed for markers GENE GENE	1
GENE type design analyzed for markers GENE	1
GENE turnover depended formed with GENE	1
GENE trinucleotide repeats in DISEASE	1
GENE triggered GENE increased DISEASE	1
GENE treatment perturbed evidenced by myeloid GENE	1
GENE treatment perturbed decreased reduced phosphorylation GENE	1
GENE treatment perturbed decreased lymphoid t GENE	1
GENE treatment perturbed decreased b GENE	1
GENE treatment increased decreased reduced phosphorylation GENE	1
GENE treatment increased decreased lymphoid t GENE	1
GENE treatment increased decreased b GENE	1
GENE transporter demonstrated decreased metabolism CHEMICAL	1
GENE translation mutation kindred DISEASE	1
GENE transcripts were detected levels GENE	1
GENE transcripts in GENE	1
GENE transcripts GENE GENE	1
GENE transcripts GENE	1
GENE transcript of levels DISEASE	1
GENE transcript of expression associated with survival DISEASE	1
GENE trafficking caused localization with GENE	1
GENE toward cells DISEASE	1
GENE to studying at aimed used rats with GENE	1
GENE to studying at aimed shown -induced with GENE	1
GENE to response in increased produced GENE GENE GENE	1
GENE to response in increased produced GENE GENE	1
GENE to response in increased produced GENE	1
GENE to response in increased GENE	1
GENE to response during CHEMICAL	1
GENE to proximal located demonstrated noted CHEMICAL	1
GENE to activity highlight investigated show molecules involved in inhibition promotion progression DISEASE	1
GENE to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE GENE	1
GENE to GENE of expression GENE	1
GENE thymus node of index abundance reduced in mice -deficient GENE	1
GENE thought linked in models of DISEASE	1
GENE targets among identified inhibited vivo DISEASE	1
GENE targets GENE	1
GENE targeting provide therapy for DISEASE	1
GENE targeting provide in patients DISEASE	1
GENE targeting prevent DISEASE	1
GENE targeting demonstrated have value for treatment DISEASE	1
GENE targeting by CHEMICAL	1
GENE targeted by generation as CHEMICAL CHEMICAL	1
GENE targeted by generation as CHEMICAL	1
GENE targeted by generation CHEMICAL	1
GENE targeted -induced corrected DISEASE	1
GENE target GENE	1
GENE t cells restricted to phenotype -producing GENE	1
GENE t cells restricted altered affects required GENE	1
GENE t cells restricted altered affects -deficiency GENE	1
GENE system is modulates GENE	1
GENE system is inhibits promotes signaling GENE	1
GENE system is inhibits activity GENE	1
GENE synthesize is found led to remodeling GENE	1
GENE suppressors DISEASE	1
GENE suppressor ameliorated phenotype GENE	1
GENE suppresses recognition included increased produced GENE GENE GENE	1
GENE suppresses recognition included increased produced GENE GENE	1
GENE suppresses recognition included increased produced GENE	1
GENE suppresses recognition included increased GENE	1
GENE suppresses recognition included cells GENE	1
GENE suppresses progression DISEASE	1
GENE suppressed in ko GENE	1
GENE suppressed depleted inhibitor CHEMICAL	1
GENE suppress failed increased increased decreased accumulation of CHEMICAL	1
GENE supports phenotype in GENE	1
GENE suggests pathway associated with storage CHEMICAL	1
GENE suggests pathway GENE	1
GENE suggested confer protection against DISEASE	1
GENE subunits formed with GENE	1
GENE subunit site contains contains site phosphorylation GENE	1
GENE subunit site contains contains site make candidates for studies in patients DISEASE	1
GENE subunit gene found in patients with DISEASE DISEASE	1
GENE substitution pattern with patients rt VARIANT associated changes in gene GENE	1
GENE study DISEASE	1
GENE stimulation following attenuated activation GENE	1
GENE stimulated CHEMICAL	1
GENE specific CHEMICAL	1
GENE snps GENE for genotyped stimulated cbmcs stimuli GENE	1
GENE snps GENE for genotyped stimulated CHEMICAL	1
GENE snp risk DISEASE	1
GENE snp affects regulation CHEMICAL	1
GENE sirna attenuates CHEMICAL	1
GENE signalling in pairs of DISEASE	1
GENE signalling impaired in -deficient GENE	1
GENE signalling impaired chondrocytes evidenced by expression of genes GENE	1
GENE signalling impaired GENE phosphorylation GENE	1
GENE signaling via effects on GENE	1
GENE signaling via CHEMICAL	1
GENE signaling treatment has by suppression of responses DISEASE	1
GENE signaling symbiosis associated with upregulation of GENE	1
GENE signaling proteins GENE GENE GENE GENE GENE	1
GENE signaling proteins GENE GENE GENE GENE	1
GENE signaling proteins GENE GENE GENE	1
GENE signaling proteins GENE GENE	1
GENE signaling proteins GENE	1
GENE signaling on effects of CHEMICAL	1
GENE signaling is overexpression GENE	1
GENE signaling in reduction observed in knockdowns GENE	1
GENE signaling in reduction observed associated depletion GENE	1
GENE signaling despite treatment with CHEMICAL	1
GENE signaling by GENE	1
GENE shown leads DISEASE	1
GENE shown GENE	1
GENE showed increased CHEMICAL	1
GENE serves suggesting associated contribute to invasion DISEASE	1
GENE serves as antagonist GENE	1
GENE serve for DISEASE	1
GENE sequenced demonstrated lesions DISEASE	1
GENE sequenced conclude be DISEASE	1
GENE sensitized inhibited growth of xenografts in mice DISEASE	1
GENE sensitized cells DISEASE	1
GENE sensitivity with GENE in snps association of DISEASE	1
GENE sensitivity with GENE	1
GENE seems evolution DISEASE	1
GENE secretion with associated promotes used remains variation at GENE	1
GENE secretion with associated mimicking effects of therapy CHEMICAL	1
GENE secretion regulating genes in investigate was associated [ encoding GENE GENE GENE	1
GENE secretion regulating genes in investigate was associated [ encoding GENE GENE	1
GENE secretion regulating genes in investigate was associated [ encoding GENE	1
GENE secretion regulating genes in investigate was GENE	1
GENE secretion after -stimulation CHEMICAL	1
GENE secretion GENE -stimulation CHEMICAL	1
GENE secreted facilitate transformation DISEASE	1
GENE rush is DISEASE	1
GENE roles understood mechanisms involved in DISEASE	1
GENE roles of GENE	1
GENE risk of DISEASE	1
GENE rises prevent DISEASE	1
GENE response genes are during DISEASE	1
GENE response DISEASE	1
GENE resequence was reveals variants for DISEASE	1
GENE required show increased GENE GENE	1
GENE required show document show expressed genes GENE GENE GENE GENE	1
GENE required show document show expressed genes GENE GENE GENE	1
GENE required show document show expressed genes GENE GENE	1
GENE required show document show expressed genes GENE	1
GENE required renew drive DISEASE	1
GENE required is CHEMICAL	1
GENE required for uptake CHEMICAL	1
GENE required for signalling GENE	1
GENE required for expression of GENE GENE GENE	1
GENE required for expression of GENE GENE	1
GENE required for expression of GENE	1
GENE required for GENE activation GENE	1
GENE required convert CHEMICAL used in for fortification CHEMICAL	1
GENE required convert CHEMICAL	1
GENE required confirm relieved cells of need for GENE	1
GENE required are cells t -producing GENE	1
GENE represses genes associated with CHEMICAL hormone CHEMICAL	1
GENE represses genes associated with CHEMICAL	1
GENE repressed by GENE	1
GENE reported polymorphism risk DISEASE	1
GENE repletion using expression in DISEASE	1
GENE released GENE	1
GENE release loss of evidence resulted in DISEASE	1
GENE release is tested displayed levels CHEMICAL	1
GENE release is remain factors regulating CHEMICAL	1
GENE release controlled by CHEMICAL	1
GENE relationship related with DISEASE DISEASE	1
GENE relationship related with DISEASE	1
GENE related with GENE	1
GENE related upregulated validated modulated induced CHEMICAL	1
GENE related upregulated expression of genes related DISEASE	1
GENE related to survival DISEASE	1
GENE related to protein GENE	1
GENE related to protein DISEASE	1
GENE related to administration GENE	1
GENE related led to production CHEMICAL	1
GENE regulation was included included GENE GENE GENE GENE GENE GENE GENE	1
GENE regulation was included included GENE GENE GENE GENE GENE GENE	1
GENE regulation was included included GENE GENE GENE GENE GENE	1
GENE regulation was included included GENE GENE GENE GENE	1
GENE regulation was included included GENE GENE GENE	1
GENE regulation was included included GENE GENE	1
GENE regulation was included included GENE	1
GENE regulation was included GENE GENE GENE GENE	1
GENE regulation was included GENE	1
GENE regulates suggesting increased with GENE	1
GENE regulates remain is DISEASE	1
GENE regulates independently of GENE GENE	1
GENE regulates independently of GENE	1
GENE regulates identified in DISEASE	1
GENE regulates genes in DISEASE	1
GENE regulates expression GENE	1
GENE regulates by promoting promote by activating pathways via degradation of substrates including GENE GENE GENE GENE	1
GENE regulates by promoting promote by activating pathways via degradation of substrates including GENE GENE GENE	1
GENE regulates by promoting promote by activating pathways via degradation of substrates including GENE GENE	1
GENE regulates by promoting promote by activating pathways GENE	1
GENE regulates by promoting promote DISEASE	1
GENE regulates by promoting degradation of GENE GENE	1
GENE regulates by promoting degradation of GENE	1
GENE regulates by modulating pathway GENE GENE	1
GENE regulated were shown inhibited promoted apoptosis cell DISEASE	1
GENE regulated by CHEMICAL	1
GENE regulate growth DISEASE	1
GENE regulate by modulating GENE	1
GENE regulate -mediated GENE	1
GENE region assessed studied in in DISEASE	1
GENE region assessed included treated patients patients DISEASE	1
GENE reducing disrupting CHEMICAL	1
GENE reduced revealed exhibited DISEASE	1
GENE reduced phosphorylation GENE	1
GENE reduced decreased expression GENE	1
GENE reduced GENE	1
GENE receptor is DISEASE	1
GENE receptor expression GENE	1
GENE proved comprise genes are during DISEASE	1
GENE proved -induced GENE	1
GENE proteolysis to susceptible is mutation be reported VARIANT type with those from shifted indicated was secretion GENE	1
GENE proteins of dysfunction mutations implicated is DISEASE	1
GENE proteins levels of GENE GENE GENE	1
GENE proteins levels of GENE GENE	1
GENE proteins levels of GENE	1
GENE protein to fused was remain proteins GENE	1
GENE protein to fused comprised fragment of GENE	1
GENE protein overexpression enhance proteins GENE GENE	1
GENE protein overexpression enhance proteins GENE	1
GENE protein overexpression enhance marker of GENE	1
GENE protein expression excretion CHEMICAL	1
GENE protein associated with DISEASE	1
GENE protein associated detected in DISEASE DISEASE	1
GENE protein associated be treatment of patients DISEASE	1
GENE protein assessed studied in in DISEASE	1
GENE protein DISEASE	1
GENE protects is DISEASE DISEASE	1
GENE protects demonstrate regulated abolished displayed reduced sensitivity GENE	1
GENE protects against DISEASE	1
GENE protects GENE	1
GENE protects DISEASE -induced CHEMICAL	1
GENE protects DISEASE	1
GENE promotes phenotype in GENE	1
GENE promotes DISEASE	1
GENE promoter observed exhibited mutant GENE	1
GENE promoter in mutation by by inhibition of GENE with CHEMICAL	1
GENE promoter VARIANT of carriers showed reduced reduced GENE GENE secretion GENE	1
GENE promoter VARIANT of carriers showed GENE GENE	1
GENE promoter VARIANT of carriers showed GENE	1
GENE promoted via regulating GENE	1
GENE promoted indicated contributed through enhancing monopoiesis -associated GENE	1
GENE promoted enhancing migration on GENE	1
GENE proliferation DISEASE	1
GENE production via induces suggest provide cells DISEASE	1
GENE production via induces dcs in conditions DISEASE	1
GENE production showed through activation of GENE GENE	1
GENE production showed through activation of GENE	1
GENE production gene GENE	1
GENE production during DISEASE	1
GENE produced cells DISEASE	1
GENE prevents affect CHEMICAL	1
GENE prevented reduced pressure of CHEMICAL	1
GENE prevented reduced CHEMICAL	1
GENE prevented DISEASE	1
GENE prevented -induced DISEASE	1
GENE prevented -induced CHEMICAL	1
GENE prevent failed findings with induced DISEASE	1
GENE predicted promote act GENE	1
GENE precedes onset of DISEASE DISEASE	1
GENE precedes onset of DISEASE	1
GENE potency of CHEMICAL	1
GENE polymorphisms with associated DISEASE	1
GENE polymorphisms shown associated with DISEASE	1
GENE polymorphisms showed risks of DISEASE	1
GENE polymorphisms demonstrated supports development DISEASE	1
GENE polymorphisms associated with metabolism CHEMICAL	1
GENE polymorphisms associated with GENE	1
GENE polymorphism with DISEASE DISEASE	1
GENE polymorphism with DISEASE	1
GENE polymorphism of DISEASE	1
GENE polymorphism associated with DISEASE	1
GENE polymorphism associated is DISEASE	1
GENE point mutation detected in DISEASE DISEASE	1
GENE plays shown showed emerged show resistance to DISEASE progression towards DISEASE	1
GENE plays shown showed emerged show resistance to DISEASE	1
GENE plays role in perception DISEASE	1
GENE plays role in modulating in number of diseases including DISEASE DISEASE DISEASE	1
GENE plays role in modulating in number of diseases including DISEASE DISEASE	1
GENE plays role in modulating in number of diseases including DISEASE	1
GENE plays overexpressed in tissue DISEASE	1
GENE plays leads reported have effect on development of DISEASE	1
GENE plays known affect development of DISEASE	1
GENE plays implicated to DISEASE	1
GENE plays hypothesized treated depleted CHEMICAL	1
GENE plays hypothesized is DISEASE	1
GENE plays had had DISEASE	1
GENE plays exhibit DISEASE	1
GENE plays enhanced in DISEASE	1
GENE plays enhanced by mediating signalling GENE GENE	1
GENE plays enhanced by mediating signalling GENE	1
GENE plays -induced DISEASE	1
GENE plays -induced CHEMICAL	1
GENE play role promote excretion CHEMICAL	1
GENE play role in effects of loading through series of events including activation inactivation GENE	1
GENE play conclusion -induced DISEASE	1
GENE phosphorylation site make candidates for studies in patients DISEASE	1
GENE phosphorylation site contains contains site make candidates for studies in patients DISEASE	1
GENE phosphorylation reversed reversed modulates GENE	1
GENE phosphorylation reversed reversed expressing GENE	1
GENE phosphorylation reversed by antagonist GENE	1
GENE phosphorylation by GENE	1
GENE phosphorylation analyzed induced behavior -like DISEASE	1
GENE phosphorylation GENE	1
GENE phosphorylated levels increased DISEASE	1
GENE pathways activating by promote promoting operates with GENE	1
GENE pathway increased suppressed with CHEMICAL	1
GENE pathology reported in individuals with DISEASE	1
GENE participates seemed GENE	1
GENE participates in DISEASE	1
GENE participates are DISEASE	1
GENE overexpression resulted in invasion associated with upregulation of GENE GENE	1
GENE overexpression resulted in invasion associated with upregulation of GENE	1
GENE overexpression including DISEASE	1
GENE overexpression in stress -induced DISEASE	1
GENE overexpression blocked triggered GENE GENE	1
GENE overexpression altered with representation of genes affect function of GENE	1
GENE overexpression altered showed included increases in GENE GENE GENE	1
GENE overexpression altered showed included increases in GENE	1
GENE overexpression altered showed included in GENE GENE GENE	1
GENE overexpression altered showed included in GENE GENE	1
GENE overexpression altered showed included in GENE	1
GENE overexpression DISEASE	1
GENE overexpressed indicated analysis number DISEASE	1
GENE one of proteins -binding CHEMICAL	1
GENE oncogene is demonstrated have value for treatment DISEASE	1
GENE on migration enhancing promoted found GENE were colocalized with GENE GENE	1
GENE on migration enhancing promoted found GENE were colocalized coimmunoprecipitated with GENE	1
GENE on functions DISEASE	1
GENE on force been emerged show resistance to DISEASE progression towards DISEASE	1
GENE on force been emerged show resistance to DISEASE	1
GENE on activation GENE	1
GENE on CHEMICAL	1
GENE oligomerises binds to GENE	1
GENE of variations associated with snp VARIANT GENE	1
GENE of variant with DISEASE	1
GENE of upregulation with associated GENE GENE in cells DISEASE	1
GENE of upregulation genes regulates GENE GENE	1
GENE of upregulation genes regulates GENE	1
GENE of upregulation due is activity GENE	1
GENE of translocation was evidence resulted in DISEASE	1
GENE of that levels increased GENE model DISEASE	1
GENE of subunits formed with GENE	1
GENE of substrate factor drives transcription GENE	1
GENE of spectrum in associated with DISEASE DISEASE	1
GENE of spectrum in associated with DISEASE	1
GENE of spectrum DISEASE	1
GENE of snps predict in subjects with DISEASE	1
GENE of snps predict in subjects DISEASE	1
GENE of snps predict conversion to DISEASE	1
GENE of significance investigated -induced DISEASE	1
GENE of roles GENE	1
GENE of role underscore in regulation of metabolism CHEMICAL	1
GENE of role support results in DISEASE	1
GENE of role revealed demonstrated proteins GENE	1
GENE of role revealed decreased demonstrated by secretion expression of GENE GENE GENE	1
GENE of role revealed decreased demonstrated by secretion expression of GENE GENE	1
GENE of role revealed decreased demonstrated by secretion expression of GENE	1
GENE of role assessed to DISEASE	1
GENE of resequencing reveals variants for DISEASE	1
GENE of removal that GENE	1
GENE of properties on haplotype found in patient with DISEASE	1
GENE of precursor CHEMICAL	1
GENE of polymorphisms influenced DISEASE	1
GENE of polymorphisms are in preventing DISEASE	1
GENE of polymorphism associated with DISEASE	1
GENE of polymorphism associated suggest is indicated is finding of frequencies with DISEASE finding with for DISEASE	1
GENE of polymorphism associated associated with DISEASE	1
GENE of phosphorylation altered in neutrophils GENE	1
GENE of participation in DISEASE	1
GENE of overexpression led led to increase in number of DISEASE	1
GENE of overexpression associated contribute to invasion DISEASE	1
GENE of over-)expression limit availability of arginine for synthesis CHEMICAL	1
GENE of ortholog GENE identified are subunits GENE	1
GENE of of GENE	1
GENE of occupation by CHEMICAL	1
GENE of mutations identified DISEASE	1
GENE of mutations found in DISEASE DISEASE	1
GENE of mutations found in DISEASE	1
GENE of mutations found identified examining DISEASE	1
GENE of mutations by caused DISEASE is background DISEASE	1
GENE of mutation describe in family with DISEASE DISEASE	1
GENE of mutation describe family causing DISEASE	1
GENE of mutation associated with DISEASE	1
GENE of methylation patients type died as result of DISEASE	1
GENE of loss induces is mechanism DISEASE	1
GENE of loss induces correlation with DISEASE	1
GENE of loss in results rats explain changes related to DISEASE	1
GENE of loss expression altered induction of GENE	1
GENE of loss expression altered GENE GENE GENE	1
GENE of loss expression altered GENE	1
GENE of localisation suggests kindreds study in DISEASE	1
GENE of levels suppressed in ko GENE	1
GENE of levels associated with DISEASE DISEASE	1
GENE of levels associated with DISEASE	1
GENE of levels associated associated with predisposition recurrence of DISEASE	1
GENE of levels associated associated linked linked to predisposition DISEASE	1
GENE of level produced in response to CHEMICAL	1
GENE of knockdown results confirm document loss of trimethylation lysine GENE	1
GENE of knockdown results confirm document loss of trimethylation k36me3 GENE	1
GENE of knockdown GENE	1
GENE of involvement CHEMICAL	1
GENE of injection induces effects DISEASE -like DISEASE	1
GENE of injection induces effects DISEASE	1
GENE of injection decreased implanted DISEASE	1
GENE of inhibitor CHEMICAL shown phase efficacy in DISEASE	1
GENE of inhibition to induce DISEASE	1
GENE of inhibition report identified reveal conformation CHEMICAL	1
GENE of inhibition reduced production GENE GENE	1
GENE of inhibition reduced production GENE	1
GENE of inhibition delayed resolution of GENE	1
GENE of inhibition by CHEMICAL	1
GENE of induction reported following DISEASE	1
GENE of induction by induced through signaling GENE	1
GENE of induction altered were infected GENE	1
GENE of inactivation involved in development of DISEASE	1
GENE of implication in DISEASE	1
GENE of identification performed identify in DISEASE	1
GENE of group bind modulate signaling of ligands -like GENE	1
GENE of form one of causes of DISEASE	1
GENE of five --ranked accumulation CHEMICAL	1
GENE of expression tissues DISEASE	1
GENE of expression resulted in downregulation of expression GENE	1
GENE of expression regulating by induced inhibited sensitized cells DISEASE	1
GENE of expression regulating by induced correlated in patients DISEASE	1
GENE of expression regulating by induced apoptosis of cells DISEASE	1
GENE of expression regulating by induced GENE	1
GENE of expression reduced is activation GENE	1
GENE of expression reduced in corneas GENE	1
GENE of expression protects induces counter DISEASE	1
GENE of expression promoted decreased demonstrated by secretion expression of GENE GENE GENE	1
GENE of expression promoted decreased demonstrated by secretion expression of GENE GENE	1
GENE of expression promoted decreased demonstrated by secretion expression of GENE	1
GENE of expression performed raised flux CHEMICAL	1
GENE of expression observed observed indicate plays role in DISEASE	1
GENE of expression increased demonstrated proteins GENE	1
GENE of expression increased concentration CHEMICAL	1
GENE of expression increase resulting in DISEASE	1
GENE of expression in DISEASE	1
GENE of expression for required repressed by expression of antagonist GENE	1
GENE of expression exhibited DISEASE	1
GENE of expression demonstrate repatterns during differentiation DISEASE	1
GENE of expression decreased demonstrated proteins GENE	1
GENE of expression caused decreased consumption stabilization of GENE	1
GENE of expression caused decreased consumption CHEMICAL	1
GENE of expression caused DISEASE	1
GENE of expression brain DISEASE	1
GENE of expression altered is in CHEMICAL	1
GENE of expression altered is -induced DISEASE	1
GENE of expression altered by CHEMICAL	1
GENE of expression GENE	1
GENE of elevation features DISEASE -induced CHEMICAL	1
GENE of elevation features DISEASE	1
GENE of effect on DISEASE	1
GENE of effect highlights on aspects of DISEASE	1
GENE of effect DISEASE	1
GENE of disruption causes DISEASE	1
GENE of disruption associated with DISEASE	1
GENE of depletion led to remodeling GENE	1
GENE of depletion by injection CHEMICAL	1
GENE of deletion corrects DISEASE	1
GENE of deficiency increase markers of DISEASE	1
GENE of decrease secondary to DISEASE	1
GENE of concentrations as markers of DISEASE	1
GENE of colocalization with membranes containing markers GENE GENE	1
GENE of colocalization with membranes containing markers GENE	1
GENE of change cause impair to CHEMICAL	1
GENE of carriers exon showed increased GENE decreased secretion GENE	1
GENE of carriers exon showed increased CHEMICAL	1
GENE of carriers exon showed GENE CHEMICAL	1
GENE of carriers exon showed GENE	1
GENE of blockade deletion restored GENE increased levels that of GENE	1
GENE of blockade deletion restored GENE increased levels GENE GENE	1
GENE of blockade deletion restored GENE increased levels GENE	1
GENE of block to attributed is CHEMICAL	1
GENE of association with DISEASE DISEASE	1
GENE of association with DISEASE	1
GENE of antagonists produce observation led symptoms DISEASE	1
GENE of antagonists produce observation led associated DISEASE	1
GENE of analysis revealed associated with DISEASE	1
GENE of analyses studied in in DISEASE	1
GENE of analyses associated with DISEASE	1
GENE of affinity increase found cause DISEASE	1
GENE of activity with CHEMICAL	1
GENE of activity supported by signaling GENE	1
GENE of activity fit kinetic report case of DISEASE	1
GENE of activation through occur invasion DISEASE	1
GENE of activation expression with associated -treated CHEMICAL	1
GENE of activation decreased by GENE	1
GENE of accumulation caused substrate of GENE GENE	1
GENE of accumulation caused rescued senescence gene GENE	1
GENE of abundance play role promote excretion CHEMICAL	1
GENE of absence protein of effect due is phenotype with DISEASE behaviour DISEASE	1
GENE of absence protein of effect due is phenotype with DISEASE	1
GENE of absence protein of effect due is phenotype DISEASE	1
GENE of absence attenuates induces DISEASE	1
GENE of absence attenuates induces CHEMICAL	1
GENE of absence attenuates -induced DISEASE	1
GENE of absence attenuates -induced CHEMICAL	1
GENE of ablation preserves -induced GENE expression GENE	1
GENE of ablation preserves -induced DISEASE	1
GENE of VARIANT of significance needs induce development of DISEASE DISEASE	1
GENE of VARIANT of significance needs induce development of DISEASE	1
GENE of GENE	1
GENE of 49 exon in mutations with associated DISEASE with DISEASE	1
GENE of 49 exon in mutations with associated DISEASE	1
GENE of 10 helix in mutation causes DISEASE	1
GENE of -activation required activation high- -state GENE	1
GENE occurs DISEASE	1
GENE objectives is associated with susceptibility to DISEASE	1
GENE null mice treated with CHEMICAL	1
GENE nonsense mutation is DISEASE	1
GENE mutations shown result in DISEASE DISEASE DISEASE	1
GENE mutations shown result in DISEASE	1
GENE mutations shown resembles cause DISEASE	1
GENE mutations reported studied screened identified were with DISEASE	1
GENE mutations reported studied screened identified in 12 two with DISEASE	1
GENE mutations reported studied screened identified in 12 two one with DISEASE	1
GENE mutations reported in DISEASE	1
GENE mutations provide patients DISEASE	1
GENE mutations provide associated due levels GENE	1
GENE mutations promote by effects on CHEMICAL DISEASE	1
GENE mutations presented assessed automated from patients with DISEASE	1
GENE mutations of role been identified cause DISEASE	1
GENE mutations of database DISEASE	1
GENE mutations novel identified DISEASE	1
GENE mutations localized focused was DISEASE	1
GENE mutations lacked be DISEASE	1
GENE mutations known performed analyses of patients received diagnosis of DISEASE	1
GENE mutations is is disorder DISEASE	1
GENE mutations is DISEASE	1
GENE mutations involved in DISEASE	1
GENE mutations in patients with DISEASE	1
GENE mutations identified with DISEASE	1
GENE mutations identified in domain GENE	1
GENE mutations identified in domain -binding CHEMICAL	1
GENE mutations gene -susceptibility DISEASE	1
GENE mutations from patients DISEASE	1
GENE mutations found shows detected DISEASE	1
GENE mutations found in % DISEASE	1
GENE mutations found germline patients DISEASE	1
GENE mutations found are linked to repair caused by drug CHEMICAL	1
GENE mutations expected concordance specimens of DISEASE	1
GENE mutations expected be targets for DISEASE	1
GENE mutations enhanced reduced levels CHEMICAL	1
GENE mutations enhanced reduced enhance resulted resistance CHEMICAL	1
GENE mutations detected with examined DISEASE	1
GENE mutations detected in DISEASE	1
GENE mutations detected are linked to repair caused by drug CHEMICAL	1
GENE mutations detect in patients with DISEASE	1
GENE mutations deletion GENE	1
GENE mutations cause ranging to DISEASE	1
GENE mutations cause is represent DISEASE DISEASE DISEASE	1
GENE mutations cause is represent DISEASE	1
GENE mutations cause is DISEASE	1
GENE mutations cause DISEASE	1
GENE mutations by caused form is DISEASE	1
GENE mutations by caused DISEASE	1
GENE mutations between concordance specimens of DISEASE	1
GENE mutations are events in patients with DISEASE	1
GENE mutations GENE be provide symptoms of DISEASE	1
GENE mutations GENE be explanation for DISEASE	1
GENE mutation with DISEASE	1
GENE mutation is DISEASE	1
GENE mutation interactions with predisposition DISEASE	1
GENE mutation identified siblings presented with DISEASE DISEASE	1
GENE mutation identified siblings presented with DISEASE	1
GENE mutation identified in patients with DISEASE	1
GENE mutation deletion due DISEASE	1
GENE mutation database database DISEASE	1
GENE mutation causes DISEASE	1
GENE mutation carriers in penetrance DISEASE	1
GENE mutation carried characterized by DISEASE DISEASE DISEASE	1
GENE mutation carried characterized by DISEASE	1
GENE mutation associated with onset progression to DISEASE	1
GENE mutation associated show created developed developed DISEASE	1
GENE mutation associated show created developed DISEASE	1
GENE mutation associated show arrest of podocytes DISEASE	1
GENE mutation VARIANT found with DISEASE children with DISEASE	1
GENE mutation VARIANT found with DISEASE	1
GENE mutants decreased reveal suggest underlie DISEASE	1
GENE mutant shown develop DISEASE	1
GENE mutagenesis genes including GENE GENE	1
GENE mrna of levels increased failed suppress GENE	1
GENE mrna assessed assessed measured started CHEMICAL	1
GENE monotherapy to alternative as proposed for treating DISEASE	1
GENE modulates signaling GENE	1
GENE modification is associated with DISEASE DISEASE	1
GENE modification is associated with DISEASE	1
GENE model created developed developed DISEASE	1
GENE model created developed DISEASE	1
GENE mice reversed , DISEASE	1
GENE mice protected from DISEASE	1
GENE mice had DISEASE	1
GENE mice displayed levels of GENE GENE GENE	1
GENE mice displayed levels of GENE GENE	1
GENE mice displayed levels of GENE	1
GENE mice GENE	1
GENE mediates transport of GENE	1
GENE mediates reported understood mechanisms involved in DISEASE	1
GENE mediates reported demonstrate involved GENE	1
GENE mediates regulation of GENE	1
GENE mediates of programming unassigned indicated induce exposure CHEMICAL	1
GENE mediated effects suppressed DISEASE	1
GENE mediated effects by activating GENE targets GENE	1
GENE mediated DISEASE	1
GENE marker of DISEASE	1
GENE mapping presents subjects DISEASE	1
GENE manner in counter induces protects expression of GENE	1
GENE manner in counter DISEASE	1
GENE maintained increased suppressed with CHEMICAL	1
GENE lowered increased CHEMICAL	1
GENE lowered -induced DISEASE	1
GENE lowered -induced CHEMICAL	1
GENE loop in observed identified reveal conformation CHEMICAL	1
GENE locus of region in deletions have found individuals with DISEASE	1
GENE locus member involved in DISEASE	1
GENE like dorsalizes cleaved by GENE	1
GENE ligands shown in models of DISEASE	1
GENE ligands shown DISEASE	1
GENE ligand attenuates is DISEASE	1
GENE ligand CHEMICAL	1
GENE levels were attenuated DISEASE	1
GENE levels than patients DISEASE	1
GENE levels percentage weight displayed increased mice with gene GENE	1
GENE levels percentage weight displayed increased in females ko GENE	1
GENE levels percentage weight displayed increased generated mice -knockout GENE	1
GENE levels percentage weight displayed increased generated have confers GENE	1
GENE levels percentage weight displayed increased generated determine actions GENE	1
GENE levels percentage weight displayed abolished regulated demonstrate protects GENE	1
GENE levels patients DISEASE	1
GENE levels in DISEASE	1
GENE levels elevated by day corresponded shown by incidence of DISEASE	1
GENE levels due associated with DISEASE	1
GENE levels confer acquired cells DISEASE	1
GENE levels associated associated with predisposition recurrence of DISEASE	1
GENE levels associated associated linked linked to predisposition DISEASE	1
GENE level activity is due upregulation of GENE	1
GENE kotg mice levels of GENE GENE GENE	1
GENE kotg mice levels at molecules as GENE GENE GENE GENE	1
GENE kotg mice levels at molecules as GENE GENE GENE	1
GENE kotg mice levels at molecules as GENE GENE	1
GENE kotg mice levels at molecules as GENE	1
GENE kotg mice had DISEASE	1
GENE kotg DISEASE	1
GENE ko mice wt in CHEMICAL	1
GENE ko mice treated with CHEMICAL	1
GENE ko mice in observed observed expression of GENE GENE GENE GENE	1
GENE ko in was observed with expression GENE	1
GENE ko females in increased displayed reduced sensitivity GENE	1
GENE knockout mice yield litters show DISEASE DISEASE	1
GENE knockout mice yield litters show DISEASE	1
GENE knockout mice present with DISEASE	1
GENE knockout mice present in combination with DISEASE	1
GENE knockout mice have DISEASE	1
GENE knockout in mediators DISEASE	1
GENE knocked incubated with GENE	1
GENE knocked -induced DISEASE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE GENE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE	1
GENE knockdowns in observed identified list p included genes known involved in DISEASE like GENE	1
GENE knockdown treatment CHEMICAL	1
GENE knockdown resulted increased with GENE	1
GENE knockdown resulted in phosphorylation GENE	1
GENE knockdown resulted attenuated following stimulation GENE	1
GENE knockdown resulted attenuated activation GENE	1
GENE knockdown reduced phosphorylation of target GENE	1
GENE knockdown reduced phosphorylation GENE	1
GENE knockdown reduced GENE GENE	1
GENE knockdown reduced GENE	1
GENE knockdown enhanced exhibited levels of GENE GENE	1
GENE knockdown embryos including GENE GENE GENE	1
GENE knockdown embryos including GENE GENE	1
GENE knockdown embryos including GENE	1
GENE knockdown embryos in reduced expressed GENE GENE GENE GENE GENE	1
GENE knockdown embryos in reduced expressed GENE GENE GENE GENE	1
GENE knockdown embryos in reduced expressed GENE GENE GENE	1
GENE knockdown embryos in reduced expressed GENE GENE	1
GENE knockdown embryos in reduced expressed GENE	1
GENE knockdown diminished GENE reduced DISEASE	1
GENE knockdown alleviated reversed activations of GENE GENE GENE	1
GENE knockdown alleviated reversed activations of GENE GENE	1
GENE knockdown alleviated reversed activations of GENE	1
GENE knockdown alleviated DISEASE DISEASE	1
GENE knockdown alleviated DISEASE	1
GENE knockdown after found decreased demonstrated by secretion expression of GENE GENE GENE	1
GENE knockdown after found decreased demonstrated by secretion expression of GENE GENE	1
GENE knockdown after found decreased demonstrated by secretion expression of GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE	1
GENE kds of comparisons identified list p included genes known involved in DISEASE like GENE	1
GENE itself GENE targeting provide in patients DISEASE	1
GENE isolated from DISEASE	1
GENE isoforms overexpressing cells DISEASE	1
GENE isoforms investigated is regulates GENE GENE	1
GENE isoforms investigated is regulates GENE	1
GENE isoform in cells DISEASE	1
GENE isoform by activated GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
GENE isoform by activated GENE GENE GENE GENE GENE GENE GENE GENE	1
GENE isoform by activated GENE GENE GENE GENE GENE	1
GENE isoform by activated GENE GENE GENE GENE	1
GENE isoform by activated GENE GENE	1
GENE isoform by activated GENE	1
GENE is suppressor DISEASE	1
GENE is suggest cause impair to CHEMICAL	1
GENE is shown is blockade GENE	1
GENE is shown halted growth DISEASE	1
GENE is shown associate with risk for DISEASE	1
GENE is shown are prone to DISEASE DISEASE	1
GENE is shown are prone to DISEASE	1
GENE is serves as biomarker for DISEASE	1
GENE is revealed occurred reduced rats explain changes related to DISEASE	1
GENE is revealed occurred reduced expressions GENE	1
GENE is revealed occurred reduced after lysis of myofilaments GENE GENE GENE	1
GENE is revealed occurred reduced after lysis of myofilaments GENE GENE	1
GENE is revealed occurred reduced after lysis of myofilaments GENE	1
GENE is reported is polymorphism showed association with bp in people DISEASE	1
GENE is reported in patient DISEASE	1
GENE is related with DISEASE DISEASE	1
GENE is related with DISEASE	1
GENE is regulator of metabolism CHEMICAL	1
GENE is receptor for GENE is has role in response DISEASE	1
GENE is receptor for GENE	1
GENE is protein with function in transmission CHEMICAL	1
GENE is polymorphism susceptibility to DISEASE	1
GENE is plays -mediated transport CHEMICAL	1
GENE is plays -mediated GENE	1
GENE is oncogene GENE	1
GENE is mirna levels in mps correlated with gene GENE	1
GENE is ligand of family GENE	1
GENE is is lead to outcomes as fluctuations DISEASE	1
GENE is is background chelated CHEMICAL	1
GENE is is DISEASE	1
GENE is is CHEMICAL	1
GENE is involved in response DISEASE DISEASE	1
GENE is involved in response DISEASE	1
GENE is involved CHEMICAL	1
GENE is investigates investigated genotyped associated with prevalence DISEASE	1
GENE is investigated influenced DISEASE	1
GENE is increase risk of developing DISEASE	1
GENE is in signaling cascades activated by stimuli mediate be target for development in DISEASE as DISEASE	1
GENE is in signaling cascades activated by stimuli mediate be target for development in DISEASE	1
GENE is identified in domain GENE	1
GENE is identified in domain -binding CHEMICAL	1
GENE is has role in response DISEASE	1
GENE is gene upregulated via GENE	1
GENE is gene upregulated by GENE	1
GENE is function as sensors link changes in levels CHEMICAL	1
GENE is found segregate with DISEASE	1
GENE is found reviewed had revealed indicated sign of DISEASE	1
GENE is found reviewed had revealed indicated showed DISEASE	1
GENE is for uptake CHEMICAL GENE	1
GENE is factor in treatment of DISEASE	1
GENE is expressed indicated indicated involved in metabolism metabolism GENE GENE GENE	1
GENE is expressed indicated indicated involved in metabolism metabolism GENE GENE	1
GENE is expressed indicated indicated involved in metabolism metabolism GENE	1
GENE is expressed indicated indicated involved in metabolism GENE GENE	1
GENE is expressed indicated indicated involved in metabolism GENE	1
GENE is expressed indicated indicated involved in metabolism CHEMICAL	1
GENE is enzyme of CHEMICAL metabolism CHEMICAL	1
GENE is enzyme of CHEMICAL	1
GENE is enzyme in conversion of CHEMICAL	1
GENE is enzyme in GENE	1
GENE is enzyme for synthesis CHEMICAL	1
GENE is documented in DISEASE	1
GENE is described to DISEASE	1
GENE is described is DISEASE	1
GENE is demonstrated have value for treatment DISEASE	1
GENE is causes seemed be associated with risk DISEASE	1
GENE is cause ranging to DISEASE	1
GENE is associated with risk of DISEASE	1
GENE is associated with DISEASE	1
GENE is associated CHEMICAL	1
GENE is are in development DISEASE	1
GENE is are GENE	1
GENE is agonist to GENE	1
GENE is able rescue deficiency GENE	1
GENE is GENE	1
GENE is DISEASE	1
GENE involved leads diet CHEMICAL	1
GENE involved indicate confirmed caused resistance to CHEMICAL	1
GENE involved in development DISEASE	1
GENE involved in aspects of DISEASE	1
GENE involved contributing to DISEASE DISEASE	1
GENE involved background cause DISEASE DISEASE	1
GENE investigated in adults DISEASE	1
GENE intron of carriers in showed GENE	1
GENE intron GENE included was are defined consist influenced polymorphisms implicated in influencing DISEASE	1
GENE interacts with with GENE	1
GENE interacts with GENE GENE	1
GENE interactions dose to variability % of attribution allowed is contribute dose presence of CHEMICAL	1
GENE interact stabilize GENE GENE GENE GENE GENE	1
GENE interact stabilize GENE GENE	1
GENE interact stabilize GENE	1
GENE injected observed DISEASE DISEASE	1
GENE inhibits molecule as identified reveal conformation CHEMICAL	1
GENE inhibits expression mrna GENE	1
GENE inhibitors recognized are carries carry in CHEMICAL CHEMICAL	1
GENE inhibitors recognized are carries carry in CHEMICAL	1
GENE inhibitors recognized are carries carry CHEMICAL	1
GENE inhibitors enter is blockade GENE	1
GENE inhibitors chemotherapy with treated patients with DISEASE	1
GENE inhibitors GENE	1
GENE inhibitors CHEMICAL CHEMICAL	1
GENE inhibitors CHEMICAL	1
GENE inhibitor depleted suppressed induced GENE	1
GENE inhibitor depleted suppressed cells GENE	1
GENE inhibitor depleted suppressed GENE GENE	1
GENE inhibitor depleted suppressed GENE	1
GENE inhibitor depleted inhibited vivo DISEASE	1
GENE inhibitor depleted inhibited identified GENE	1
GENE inhibitor depleted inhibited cells GENE	1
GENE inhibition on expression GENE	1
GENE inhibition caused ameliorating DISEASE	1
GENE inhibition abrogated were transcripts GENE	1
GENE inhibition abrogated effect of GENE	1
GENE inhibited shown were regulated GENE	1
GENE inhibited shown in DISEASE	1
GENE inhibited phosphorylation of GENE	1
GENE inhibited generation CHEMICAL	1
GENE inhibited by levels CHEMICAL	1
GENE influence investigate was antibodies in DISEASE	1
GENE induction preceded was evidence resulted in DISEASE	1
GENE induces via mechanism -independent GENE	1
GENE induces via GENE GENE	1
GENE induces is is DISEASE	1
GENE induces in cells DISEASE	1
GENE induces formation DISEASE	1
GENE induces develop DISEASE	1
GENE induces death cell DISEASE	1
GENE induces are DISEASE	1
GENE induces activation in microenvironment resistance CHEMICAL	1
GENE induces activation GENE	1
GENE induces CHEMICAL	1
GENE induced uptake CHEMICAL	1
GENE induced synthesis of GENE	1
GENE induced measured reflect level of GENE	1
GENE induced measured demonstrated augments -induced GENE	1
GENE induced inhibited growth of xenografts in mice DISEASE	1
GENE induced in fashion -dependent GENE	1
GENE induced expression of GENE GENE	1
GENE induced expression of GENE	1
GENE induced DISEASE	1
GENE induce show is DISEASE	1
GENE induce emt DISEASE	1
GENE increases is DISEASE	1
GENE increases affect levels CHEMICAL	1
GENE increased with GENE	1
GENE increased rate release GENE	1
GENE increased increased degeneration -treated CHEMICAL	1
GENE increased in segments -treated CHEMICAL	1
GENE increased GENE decreased downregulated pathway GENE GENE	1
GENE increased GENE decreased downregulated pathway GENE	1
GENE increased DISEASE	1
GENE increased CHEMICAL	1
GENE increase in serum of patients DISEASE	1
GENE including substrates DISEASE	1
GENE including genes involving VARIANT for was female DISEASE	1
GENE including gene -related DISEASE	1
GENE including components are involve pathogenesis of DISEASE	1
GENE in were infected GENE	1
GENE in were attenuated DISEASE	1
GENE in variation associated with recurrence DISEASE	1
GENE in suppressed increasing levels GENE	1
GENE in suppressed growth DISEASE	1
GENE in release of GENE activation GENE	1
GENE in release of GENE	1
GENE in polymorphisms influenced secretion GENE GENE	1
GENE in polymorphisms influenced secretion GENE	1
GENE in polymorphisms influenced after -stimulation CHEMICAL	1
GENE in polymorphisms -related DISEASE	1
GENE in polymorphisms -related CHEMICAL	1
GENE in phenotype promotes DISEASE	1
GENE in occurence DISEASE	1
GENE in mutations with family causing DISEASE	1
GENE in mutations reported in patients with DISEASE	1
GENE in mutations cause is DISEASE	1
GENE in mutations cause DISEASE DISEASE	1
GENE in mutations cause DISEASE	1
GENE in mutations account are DISEASE	1
GENE in mutation report DISEASE	1
GENE in mutation is mutation for DISEASE	1
GENE in mutation is DISEASE	1
GENE in mutation identify indicates associated characterized by age of onset penetrance prognosis including DISEASE	1
GENE in mutation identified compared disrupted in line DISEASE	1
GENE in mutation due report family with DISEASE	1
GENE in mutation due report confirms is DISEASE	1
GENE in mutation described in family with DISEASE	1
GENE in mutation cosegregated with DISEASE	1
GENE in mutation causing DISEASE	1
GENE in mutation causes DISEASE	1
GENE in mutation associated with DISEASE	1
GENE in microenvironment DISEASE	1
GENE in lines DISEASE	1
GENE in japanese DISEASE	1
GENE in is variant in DISEASE	1
GENE in individuals with DISEASE	1
GENE in increase -immunoreactivity prevents affect CHEMICAL	1
GENE in in genes with DISEASE	1
GENE in identified alterations DISEASE	1
GENE in downregulated lines DISEASE	1
GENE in downregulated is DISEASE	1
GENE in detected performed analyses of patients received diagnosis of DISEASE	1
GENE in decrease prevents affect CHEMICAL	1
GENE in changes promoting by plays role in DISEASE	1
GENE in changes from patients DISEASE	1
GENE in cases DISEASE	1
GENE in by reducing levels of GENE GENE	1
GENE in by reducing levels of GENE	1
GENE in astrocytes DISEASE	1
GENE in apoptosis -induced DISEASE	1
GENE in GENE GENE	1
GENE in CHEMICAL	1
GENE improved attenuated DISEASE	1
GENE implicated with DISEASE DISEASE	1
GENE implicated with DISEASE	1
GENE identifies is CHEMICAL	1
GENE identified inhibited vivo DISEASE	1
GENE identified hypothesized treated depleted CHEMICAL	1
GENE identified hypothesized is DISEASE	1
GENE identified have is DISEASE	1
GENE identified effects suppressed DISEASE	1
GENE identified effects by activating GENE targets GENE	1
GENE identified as mediator of DISEASE -induced CHEMICAL	1
GENE identified are subunits GENE	1
GENE hyperactivate motility GENE	1
GENE hormone include remain factors regulating CHEMICAL	1
GENE homozygote carrier in observed symptoms of DISEASE	1
GENE heterozygous mutation patients with DISEASE	1
GENE heterozygosity is indicates found in population with DISEASE	1
GENE heterozygosity is factor for DISEASE	1
GENE helps alongside GENE	1
GENE have led to upregulation of GENE GENE GENE GENE	1
GENE have led to upregulation of GENE GENE GENE	1
GENE have led to upregulation of GENE GENE	1
GENE have led to upregulation of GENE	1
GENE have known represents DISEASE	1
GENE have exerts by binding to GENE	1
GENE has shows remains conducted showed showed revealed indicate contributes to risk of DISEASE	1
GENE has shows remains conducted showed showed revealed associated with DISEASE	1
GENE has shows remains conducted showed showed association with DISEASE	1
GENE has shows remains conducted showed showed association association with DISEASE	1
GENE has polymorphism of DISEASE	1
GENE has is tested displayed levels CHEMICAL	1
GENE has is remain factors regulating CHEMICAL	1
GENE haploinsufficiency leads to DISEASE	1
GENE haploinsufficiency leads due occupation of GENE	1
GENE haploinsufficiency leads demonstrated DISEASE	1
GENE haploinsufficiency is led investigation of DISEASE	1
GENE haploinsufficiency is led individuals prone to DISEASE DISEASE DISEASE DISEASE	1
GENE haploinsufficiency is led individuals prone to DISEASE	1
GENE haploinsufficiency is DISEASE	1
GENE haploinsufficiency compromises sensitivity CHEMICAL	1
GENE haploinsufficiency compromises represent cause of DISEASE	1
GENE haploinsufficiency by decay DISEASE	1
GENE had pretreated with GENE	1
GENE had levels than patients DISEASE	1
GENE h insertion GENE included was are defined consist influenced polymorphisms implicated in influencing DISEASE	1
GENE guangzhou variant cause impair to CHEMICAL	1
GENE germline activating because be conclusions found in addition to DISEASE	1
GENE germline activating because be DISEASE	1
GENE genotypes stage DISEASE	1
GENE genotyped explored in DISEASE	1
GENE genotype is in DISEASE	1
GENE genotype associated with risk of tract DISEASE	1
GENE genotype associated associated with risk of DISEASE	1
GENE genotype associated associated be exhibit according to schedule CHEMICAL	1
GENE genotype arm in associated were results analyzed extracted design was induction CHEMICAL	1
GENE genotype arm in associated associated associated be exhibit according to schedule CHEMICAL	1
GENE genotype % versus VARIANT GENE	1
GENE genes responsible for DISEASE	1
GENE genes related DISEASE	1
GENE genes regulate mutated in DISEASE	1
GENE genes of phosphorylation GENE	1
GENE genes of expression upregulated validated modulated induced CHEMICAL	1
GENE genes of anomalies related to occurrence of DISEASE	1
GENE genes in patients DISEASE	1
GENE genes in mutations of influence investigate was antibodies in DISEASE	1
GENE genes examined associations with DISEASE	1
GENE genes as GENE GENE GENE	1
GENE genes as GENE GENE	1
GENE genes as GENE	1
GENE genes GENE in mutations account are DISEASE	1
GENE generated produced identified expressed GENE GENE	1
GENE generated produced GENE	1
GENE gene within detected identified DISEASE	1
GENE gene with study DISEASE	1
GENE gene with patients DISEASE	1
GENE gene with mice increased displayed reduced sensitivity GENE	1
GENE gene to linked DISEASE DISEASE	1
GENE gene susceptibility DISEASE	1
GENE gene regulated GENE	1
GENE gene production of GENE	1
GENE gene polymorphism with DISEASE	1
GENE gene polymorphism be suggest modulate free CHEMICAL	1
GENE gene polymorphism be suggest % had CHEMICAL	1
GENE gene polymorphism association with autoantibodies GENE	1
GENE gene polymorphism DISEASE	1
GENE gene of sequencing showed accumulated showed used extend causes of DISEASE	1
GENE gene of sequencing disclosed carried siblings comprising DISEASE DISEASE DISEASE	1
GENE gene of sequence known affect site GENE homologue of GENE	1
GENE gene of sequence known affect site GENE	1
GENE gene of screening for patients with DISEASE	1
GENE gene of screening background identified cause DISEASE	1
GENE gene of regulation CHEMICAL	1
GENE gene of polymorphisms of effect explored -treated patients DISEASE	1
GENE gene of polymorphism reported roles on DISEASE	1
GENE gene of polymorphism reported realized objective decided design analyzed population of patients with DISEASE	1
GENE gene of polymorphism reported realized objective decided DISEASE to modification diet in patients DISEASE	1
GENE gene of polymorphism of role investigate decided design analyzed population of patients with DISEASE	1
GENE gene of polymorphism of role investigate decided DISEASE to modification diet in patients DISEASE	1
GENE gene of mutations described in DISEASE	1
GENE gene of mutation in associated identified have has show was lowest in patients showed onset of DISEASE	1
GENE gene of loh play in formation DISEASE	1
GENE gene of deletions revealed in gastric line DISEASE	1
GENE gene of cloning despite eventuated was DISEASE	1
GENE gene of analysis performed diagnosed with DISEASE	1
GENE gene of analysis is DISEASE	1
GENE gene of ablation indicate causes DISEASE DISEASE	1
GENE gene of ablation indicate causes DISEASE	1
GENE gene of 49 exon affecting mutations by caused DISEASE	1
GENE gene of 1 exon in deletion records in patient with DISEASE	1
GENE gene near VARIANT are determinants of concentration GENE	1
GENE gene mutations occur DISEASE	1
GENE gene mutation in family with DISEASE	1
GENE gene mutation associated with DISEASE	1
GENE gene mutated in DISEASE	1
GENE gene modulates survival in CHEMICAL	1
GENE gene modulated displayed in region elongation DISEASE	1
GENE gene locus reported associated with response to therapy GENE	1
GENE gene locus reported affect efficacy of therapy in DISEASE	1
GENE gene locus reported affect efficacy of therapy CHEMICAL GENE	1
GENE gene locus reported affect efficacy of therapy CHEMICAL	1
GENE gene located suggests kindreds study in DISEASE	1
GENE gene leading to DISEASE	1
GENE gene is cause for DISEASE	1
GENE gene involved in biosynthesis CHEMICAL	1
GENE gene involved in DISEASE including DISEASE	1
GENE gene involved in DISEASE	1
GENE gene inhibited by pce associated with repression of expression of GENE	1
GENE gene increase in DISEASE	1
GENE gene increase are DISEASE	1
GENE gene increase DISEASE DISEASE	1
GENE gene increase DISEASE	1
GENE gene in variants associated with DISEASE	1
GENE gene in polymorphism of genotype associated with DISEASE	1
GENE gene in polymorphism of genotype associated associated associated excluded role to DISEASE	1
GENE gene in patients DISEASE	1
GENE gene in mutations with DISEASE	1
GENE gene in mutations known result with onset DISEASE DISEASE	1
GENE gene in mutations known result with onset DISEASE	1
GENE gene in mutations characterized DISEASE	1
GENE gene in mutations background DISEASE DISEASE DISEASE	1
GENE gene in mutations background DISEASE	1
GENE gene in mutation is somatic in DISEASE	1
GENE gene in mutation is mutation in DISEASE	1
GENE gene in mutation in family with DISEASE	1
GENE gene in mutation conducted selected analysed for CHEMICAL	1
GENE gene in mutation between correlation support shown possessed exhibited except patient one with DISEASE	1
GENE gene in found contribute to DISEASE	1
GENE gene in deletions cause DISEASE	1
GENE gene in defects with mice exhibit phenotypes including DISEASE	1
GENE gene in defects with mice exhibit background associated with DISEASE	1
GENE gene in VARIANT in inpatients DISEASE	1
GENE gene in DISEASE children DISEASE	1
GENE gene had results had presented with DISEASE associated with DISEASE DISEASE	1
GENE gene had results had presented with DISEASE associated with DISEASE	1
GENE gene had results had presented with DISEASE	1
GENE gene had results had DISEASE	1
GENE gene encodes GENE	1
GENE gene deleted replaced with CHEMICAL	1
GENE gene covered detected suggested was suggesting difference in DISEASE	1
GENE gene contains has GENE	1
GENE gene confers to DISEASE	1
GENE gene associated -induced DISEASE	1
GENE gene alterations is described in DISEASE	1
GENE gene alterations is DISEASE	1
GENE gene alterations in DISEASE	1
GENE gene abnormalities of observation was suggesting difference in DISEASE	1
GENE gene GENE	1
GENE gene -suppressor DISEASE	1
GENE g3 domain GENE	1
GENE fusion responded GENE	1
GENE functions suppressed growth DISEASE	1
GENE functions on development DISEASE	1
GENE functions exert suppression DISEASE	1
GENE function of loss results in DISEASE	1
GENE from recovered regulated GENE	1
GENE frame of constructs with determined is genotyped humans with DISEASE	1
GENE fragments separated on gels CHEMICAL	1
GENE found expression demonstrate repatterns during differentiation DISEASE	1
GENE found exhibited resistance to drugs as CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
GENE found exhibited resistance to drugs as CHEMICAL CHEMICAL CHEMICAL	1
GENE found exhibited resistance to drugs as CHEMICAL CHEMICAL	1
GENE found exhibited resistance to drugs as CHEMICAL	1
GENE found exhibited confirmed caused resistance to CHEMICAL	1
GENE form linked report identified reveal conformation CHEMICAL	1
GENE for were were found were among clones DISEASE	1
GENE for were found were among clones DISEASE	1
GENE for used evaluated samples patient DISEASE DISEASE	1
GENE for used evaluated samples patient DISEASE	1
GENE for genotyped stimulated with innate CHEMICAL	1
GENE for genotyped compared CHEMICAL	1
GENE for except described comprises is receptor GENE	1
GENE for except described comprises is DISEASE	1
GENE for except as cause of DISEASE	1
GENE for coding in mutation by caused DISEASE are DISEASE	1
GENE for cause associated with DISEASE DISEASE DISEASE	1
GENE for cause associated with DISEASE DISEASE	1
GENE for cause associated with DISEASE	1
GENE for cause DISEASE report with DISEASE DISEASE	1
GENE for cause DISEASE	1
GENE family proteins shown revealed in gastric line DISEASE	1
GENE families related upregulated validated modulated induced CHEMICAL	1
GENE families related upregulated expression of genes related DISEASE	1
GENE factor express found contribute to DISEASE	1
GENE factor encoded by gene -associated DISEASE	1
GENE factor GENE	1
GENE facilitate revealed formed with GENE	1
GENE expression.-landrier of reduction signaling response CHEMICAL	1
GENE expression upregulated in tissues -embedded CHEMICAL	1
GENE expression through signaling recognition included cells GENE	1
GENE expression served CHEMICAL	1
GENE expression revealed increased with GENE	1
GENE expression reduced revealed increased expression GENE	1
GENE expression reduced conclude signaling response CHEMICAL	1
GENE expression reduced conclude increased expression GENE	1
GENE expression of silencing had altered were infected observed release GENE GENE	1
GENE expression of reductions observed is crossed mutations DISEASE	1
GENE expression of downregulation in resulted revealed downregulation of GENE	1
GENE expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE GENE	1
GENE expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE	1
GENE expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
GENE expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE	1
GENE expression of downregulation in resulted revealed downregulation GENE GENE	1
GENE expression of GENE including downregulation of GENE	1
GENE expression observed revealed increased expression GENE	1
GENE expression observed observed fed CHEMICAL	1
GENE expression observed fed diet CHEMICAL	1
GENE expression lost in DISEASE	1
GENE expression levels CHEMICAL	1
GENE expression level in DISEASE	1
GENE expression leads to induction GENE	1
GENE expression induces via mechanism -independent GENE	1
GENE expression induces demonstrated observed GENE GENE GENE GENE	1
GENE expression induces demonstrated observed GENE GENE GENE	1
GENE expression induces demonstrated observed GENE GENE	1
GENE expression induces demonstrated observed GENE	1
GENE expression induced indicated revealed in gastric line DISEASE	1
GENE expression increases susceptibility to CHEMICAL	1
GENE expression increases occur DISEASE	1
GENE expression increases -induced DISEASE	1
GENE expression increased revealed observed observed fed CHEMICAL	1
GENE expression increased revealed observed fed diet CHEMICAL	1
GENE expression increased CHEMICAL	1
GENE expression in layer of rats DISEASE	1
GENE expression in CHEMICAL	1
GENE expression favour than GENE	1
GENE expression examined observed fed CHEMICAL	1
GENE expression examined involved CHEMICAL CHEMICAL	1
GENE expression evaluated in cases of DISEASE	1
GENE expression enhanced were suppressed showed ko GENE	1
GENE expression enhanced were suppressed in ko GENE	1
GENE expression enhanced suppressed DISEASE	1
GENE expression downregulated in GENE	1
GENE expression decreased reduced GENE	1
GENE expression decreased pretreated with GENE	1
GENE expression correlated associated contribute to invasion DISEASE	1
GENE expression correlated GENE	1
GENE expression associated with regulation of GENE	1
GENE expression activated cells DISEASE	1
GENE expression GENE increased with GENE	1
GENE expression GENE GENE elevation features DISEASE	1
GENE expressing transgenic received triggers CHEMICAL	1
GENE expressing to killing by CHEMICAL	1
GENE expressing cells driven by GENE	1
GENE expressing cells -depolarised CHEMICAL	1
GENE expressing activity GENE	1
GENE expressed reveal associated with DISEASE	1
GENE expressed remains show in article neutrophil functions including adhesion production of CHEMICAL	1
GENE expressed related with DISEASE DISEASE	1
GENE expressed related with DISEASE	1
GENE expressed involved in metabolism of pneumotoxicants with effects DISEASE	1
GENE expressed formed initiated DISEASE	1
GENE express show exhibited expressed levels of GENE GENE GENE	1
GENE express show exhibited expressed levels of GENE GENE	1
GENE express show exhibited expressed levels of GENE	1
GENE exhibited observed upregulated in DISEASE	1
GENE exhibited activated genes in DISEASE	1
GENE excluded repress targets including GENE GENE	1
GENE excluded repress targets including GENE	1
GENE excluded by GENE GENE	1
GENE excluded by GENE	1
GENE exacerbated exhibited that encoding GENE	1
GENE exacerbated exhibited DISEASE	1
GENE enzyme catalyzes to CHEMICAL	1
GENE enzyme catalyzes oxidation of CHEMICAL	1
GENE enrichment of site -binding GENE	1
GENE enhanced expression GENE	1
GENE engages deployed GENE	1
GENE encoding that exhibited DISEASE	1
GENE encoding polymorphisms influenced DISEASE	1
GENE encoding is DISEASE	1
GENE encoding identified have ratio degrees of DISEASE DISEASE	1
GENE encoding identified have ratio degrees of DISEASE	1
GENE encoding identified causes DISEASE	1
GENE encoding gene makes contribution to susceptibility to DISEASE DISEASE	1
GENE encoding gene makes contribution to susceptibility to DISEASE	1
GENE encoding cause DISEASE	1
GENE elimination decreased increased content protein GENE	1
GENE elimination decreased increased affected GENE GENE GENE	1
GENE elimination decreased increased affected GENE GENE	1
GENE elimination decreased increased affected GENE	1
GENE elevation features DISEASE -induced CHEMICAL	1
GENE elevation features DISEASE	1
GENE elevated reduces DISEASE suppresses responses DISEASE	1
GENE dynamics in role of GENE	1
GENE dorsalizes cleaved by GENE	1
GENE domain in patients with DISEASE	1
GENE displays reveal associated with DISEASE	1
GENE displays behavior with CHEMICAL	1
GENE displaying specificity -binding CHEMICAL	1
GENE discovered regulated reduced production GENE GENE	1
GENE discovered regulated reduced production GENE	1
GENE discovered regulated by stimulation with GENE GENE	1
GENE discovered regulated by stimulation with GENE	1
GENE deposition in area was dependent on signaling GENE	1
GENE depletion caused trafficking GENE	1
GENE depletion caused localization with GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE	1
GENE depletion associated observed identified list p included genes known involved in DISEASE like GENE	1
GENE deletion inactivates block GENE	1
GENE deletion employ was was conducted objectives DISEASE	1
GENE deletion caused rescued senescence gene GENE	1
GENE deletion caused accumulation of GENE	1
GENE deletion by triggered senescence gene GENE	1
GENE deletion affects response in DISEASE	1
GENE deletion affects response DISEASE	1
GENE degradation induces increase sensitivity DISEASE	1
GENE degradation induces dose of CHEMICAL	1
GENE deficiency results suggested methods profound DISEASE DISEASE DISEASE relapsing DISEASE	1
GENE deficiency results suggested methods profound DISEASE DISEASE DISEASE	1
GENE deficiency results suggested methods profound DISEASE DISEASE	1
GENE deficiency results background DISEASE	1
GENE deficiency reduced activity production GENE	1
GENE deficiency lymphocytes to DISEASE	1
GENE deficiency had activation GENE	1
GENE deficiency had activation -mediated GENE	1
GENE deficiency cooperates increasing rendering cells independent of GENE	1
GENE deficiency cooperates increasing expression GENE	1
GENE defects are occur with mutations GENE	1
GENE defect with patients amongst is suggests records in patient with DISEASE	1
GENE decreased had showed glomeruli DISEASE	1
GENE decreased downregulated pathway GENE GENE	1
GENE decreased downregulated pathway GENE	1
GENE cre/+ females GENE	1
GENE coupling regulation GENE	1
GENE correlates show GENE	1
GENE correlated indicated overexpressed in cells DISEASE	1
GENE correlated indicated overexpressed had patients DISEASE	1
GENE correlated associated contribute to invasion DISEASE	1
GENE correlated GENE	1
GENE cornea in upregulated regulators of signaling GENE	1
GENE cornea in upregulated elevated were showed embryos GENE	1
GENE cornea in upregulated elevated levels GENE GENE	1
GENE cornea in upregulated elevated levels GENE	1
GENE contribute to susceptibility in DISEASE	1
GENE contribute to susceptibility DISEASE	1
GENE contribute to DISEASE	1
GENE contains site phosphorylation GENE	1
GENE contains contains site make candidates for studies in patients DISEASE	1
GENE contains block of part is associated with risk of DISEASE	1
GENE consists associated with DISEASE DISEASE	1
GENE consists associated with DISEASE	1
GENE confers protection against DISEASE DISEASE	1
GENE confers have generated increased displayed reduced sensitivity GENE	1
GENE confers have CHEMICAL	1
GENE concurrent with dephosphorylation of GENE	1
GENE concurrent found GENE	1
GENE concentrations decrease increase compromises used manage -associated CHEMICAL	1
GENE concentrations decrease increase compromises reversed DISEASE -associated CHEMICAL	1
GENE concentrations decrease associated is therapy with GENE CHEMICAL	1
GENE concentrations decrease as result of DISEASE -induced CHEMICAL	1
GENE concentrations decrease as result of DISEASE	1
GENE combination of CHEMICAL upregulates CHEMICAL	1
GENE combination of CHEMICAL	1
GENE codon found increased detected DISEASE	1
GENE channel shown signaling restored GENE increased levels that of GENE	1
GENE channel shown signaling restored GENE increased levels GENE GENE	1
GENE channel shown signaling restored GENE increased levels GENE	1
GENE channel shown regulate entry CHEMICAL	1
GENE channel shown GENE mice DISEASE	1
GENE channel -selective CHEMICAL	1
GENE changes responsible for resistance to CHEMICAL	1
GENE changes detected detected resistance to CHEMICAL CHEMICAL	1
GENE changes detected detected resistance to CHEMICAL	1
GENE changes detected coincided sensitivity to CHEMICAL	1
GENE chain of region in mutations carry suggest caused DISEASE	1
GENE chain of region in mutations carry risk of DISEASE	1
GENE cells with properties driven by GENE	1
GENE cells suppressed GENE	1
GENE cells produced identified expressed GENE GENE	1
GENE cells produced GENE	1
GENE cells play inhibit growth DISEASE	1
GENE cells increased raised levels of GENE	1
GENE cells increased produced GENE GENE GENE	1
GENE cells increased produced GENE GENE	1
GENE cells increased produced GENE	1
GENE cells increased included cells expressing levels of GENE	1
GENE cells increased included cells GENE GENE GENE	1
GENE cells increased included cells GENE GENE	1
GENE cells increased included cells GENE	1
GENE cells increased included GENE	1
GENE cells increased expression of GENE GENE	1
GENE cells increased expression of GENE	1
GENE cells increased GENE	1
GENE cells included cells expressing levels of GENE	1
GENE cells included cells GENE GENE GENE	1
GENE cells included cells GENE GENE	1
GENE cells included cells GENE	1
GENE cells included GENE	1
GENE cells in were regulated GENE	1
GENE cells exhibited expressed levels of GENE GENE GENE	1
GENE cells exhibited expressed levels of GENE GENE	1
GENE cells exhibited expressed levels of GENE	1
GENE cells GENE production during DISEASE	1
GENE cells GENE GENE GENE	1
GENE cells GENE GENE	1
GENE cells GENE	1
GENE causes elucidated DISEASE	1
GENE catalyzes synthesis CHEMICAL	1
GENE catalyzes production of CHEMICAL	1
GENE catalyzes polymorphism to DISEASE	1
GENE catalyzes breakdown of CHEMICAL	1
GENE catalyzes breakdown including CHEMICAL	1
GENE catalyses reported genes DISEASE	1
GENE catalyses conversion to CHEMICAL	1
GENE catalyses conversion of CHEMICAL	1
GENE c genotypes of contribution found ab GENE	1
GENE c genotypes in patients with DISEASE	1
GENE by upregulated via GENE	1
GENE by signaling in cells DISEASE	1
GENE by produced CHEMICAL	1
GENE by modulation of GENE	1
GENE by modulated secretion mrna GENE	1
GENE by modulated pathways GENE	1
GENE by induction transmitted by activating GENE	1
GENE by effects increased occur changes DISEASE	1
GENE by driven cells in influx CHEMICAL	1
GENE by caused DISEASE is DISEASE	1
GENE by attenuated coli CHEMICAL CHEMICAL	1
GENE by attenuated coli CHEMICAL	1
GENE by accompanied levels in DISEASE	1
GENE bound GENE phosphorylation by GENE	1
GENE bound GENE phosphorylation GENE	1
GENE bound GENE induced decreased volumes mortality of mice DISEASE	1
GENE blocker CHEMICAL	1
GENE blockade perturbs show investigated demonstrate reduced GENE GENE	1
GENE blockade perturbs show investigated demonstrate reduced GENE	1
GENE blockade perturbs resulting in GENE GENE density GENE	1
GENE blockade perturbs resulting in GENE GENE	1
GENE blockade perturbs resulting in GENE	1
GENE block ability of CHEMICAL	1
GENE binds to GENE	1
GENE binds reduced activity production GENE	1
GENE bind induces GENE	1
GENE bep2d in stimulated CHEMICAL	1
GENE be target for DISEASE	1
GENE be suggested revealed decreased demonstrated by secretion expression of GENE GENE GENE	1
GENE be suggested revealed decreased demonstrated by secretion expression of GENE GENE	1
GENE be suggested revealed decreased demonstrated by secretion expression of GENE	1
GENE be indicating regulating GENE	1
GENE be explanation for DISEASE	1
GENE be attenuates after DISEASE	1
GENE be attenuates DISEASE	1
GENE background is transporter of CHEMICAL	1
GENE background is association with autoantibodies GENE	1
GENE axis contributed through enhancing monopoiesis -associated GENE	1
GENE axis GENE	1
GENE autosomal phenotype DISEASE had comprising depletion DISEASE	1
GENE autoantibodies with association in DISEASE	1
GENE attenuates -induced DISEASE	1
GENE at variation remains impact of therapy CHEMICAL	1
GENE associations between variability DISEASE	1
GENE associated with predisposition recurrence of DISEASE	1
GENE associated with functions DISEASE	1
GENE associated with fasting CHEMICAL GENE	1
GENE associated with GENE	1
GENE associated associated with predisposition recurrence of DISEASE	1
GENE associated associated linked linked to predisposition DISEASE	1
GENE assessed in trimester along with CHEMICAL	1
GENE assessed fasting CHEMICAL GENE	1
GENE assessed fasting CHEMICAL	1
GENE as modulators of GENE	1
GENE as genes of activation seems balance response to activation GENE	1
GENE as genes of activation seems balance response by limiting activation of GENE	1
GENE around polymorphisms reported associated with response to therapy GENE	1
GENE around polymorphisms reported affect efficacy of therapy in DISEASE	1
GENE around polymorphisms reported affect efficacy of therapy CHEMICAL GENE	1
GENE around polymorphisms reported affect efficacy of therapy CHEMICAL	1
GENE are shown shown actions DISEASE	1
GENE are known shown response coli CHEMICAL CHEMICAL	1
GENE are known shown response coli CHEMICAL	1
GENE are involved CHEMICAL	1
GENE are causes DISEASE	1
GENE are assumed predispose factors as DISEASE	1
GENE are aims reduces DISEASE	1
GENE antibodies with subjects DISEASE	1
GENE antagonists of microinjections CHEMICAL CHEMICAL	1
GENE antagonists of microinjections CHEMICAL	1
GENE antagonists CHEMICAL CHEMICAL	1
GENE antagonists CHEMICAL	1
GENE antagonist with pretreatment found mice attenuated DISEASE	1
GENE antagonist with pretreatment found blocked CHEMICAL	1
GENE antagonist GENE	1
GENE antagonist CHEMICAL CHEMICAL	1
GENE animals GENE infected were in GENE GENE	1
GENE amplification deletion GENE	1
GENE altered were infected GENE	1
GENE alterations identified lacked mutated gene GENE	1
GENE alleles promote DISEASE	1
GENE alleles lack site GENE	1
GENE alleles DISEASE	1
GENE allele of loss associated with DISEASE	1
GENE allele of characterization causes prolonged DISEASE with CHEMICAL	1
GENE allele of characterization causes prolonged DISEASE	1
GENE allele of characterization causes characterized DISEASE	1
GENE allele associated with DISEASE	1
GENE agonists with stimulation upon -treated showed through activation of GENE GENE	1
GENE agonists with stimulation upon -treated showed through activation of GENE	1
GENE agonists to response via production of GENE	1
GENE agonist reduced suggest induces DISEASE	1
GENE agonist reduced increased expression of GENE proteins GENE GENE	1
GENE agonist reduced increased expression of GENE proteins GENE	1
GENE agonist of microl challenged DISEASE	1
GENE agonist of CHEMICAL	1
GENE agonist CHEMICAL increased phosphorylation GENE	1
GENE agonist CHEMICAL increased phosphorylation -stimulated GENE	1
GENE agonist CHEMICAL DISEASE	1
GENE after methylating for DISEASE	1
GENE affects methods determined by reaction in patients including patients DISEASE	1
GENE affecting through promoted apoptosis cell DISEASE	1
GENE activity using repletion GENE	1
GENE activity required are DISEASE	1
GENE activity required -induced DISEASE	1
GENE activity reduces DISEASE	1
GENE activity raising in raised flux CHEMICAL	1
GENE activity of studies revealed had DISEASE	1
GENE activity of increase decrease of GENE	1
GENE activity measured by monitoring oxidation of CHEMICAL	1
GENE activity increased treated decreased in cortex of CHEMICAL	1
GENE activity increased treated concentration activity GENE	1
GENE activity increased treated concentration CHEMICAL	1
GENE activity increased compared with CHEMICAL	1
GENE activity evoked by CHEMICAL	1
GENE activity decreased treated concentration activity GENE	1
GENE activity decreased achieved revealed had DISEASE	1
GENE activity blocked rises preventing DISEASE	1
GENE activity blocked rises level GENE	1
GENE activity CHEMICAL	1
GENE activities of inhibition through DISEASE suppresses responses DISEASE	1
GENE activation to response balance seems activation of genes as GENE GENE	1
GENE activation to response balance seems activation of genes as GENE	1
GENE activation suppressed showed were involved in metabolism metabolism GENE GENE GENE	1
GENE activation suppressed showed were involved in metabolism metabolism GENE GENE	1
GENE activation suppressed showed were involved in metabolism metabolism GENE	1
GENE activation suppressed showed were involved in metabolism GENE GENE	1
GENE activation suppressed showed were involved in metabolism GENE	1
GENE activation suppressed showed were involved in metabolism CHEMICAL	1
GENE activation suppressed showed were GENE genes genes GENE GENE GENE	1
GENE activation suppressed showed were GENE genes genes GENE GENE	1
GENE activation suppressed showed were GENE genes genes GENE	1
GENE activation suppressed showed were GENE genes GENE GENE GENE GENE	1
GENE activation suppressed showed were GENE genes GENE GENE GENE	1
GENE activation suppressed showed were GENE genes GENE GENE	1
GENE activation suppressed showed were GENE genes GENE	1
GENE activation suppressed showed were GENE genes -induced GENE	1
GENE activation release loss of evidence resulted in DISEASE	1
GENE activation reduced GENE	1
GENE activation is sufficient for upregulation of GENE	1
GENE activation in systems including GENE GENE GENE GENE	1
GENE activation in systems including GENE GENE GENE	1
GENE activation in systems including GENE GENE	1
GENE activation in systems including GENE	1
GENE activation in reduction with associated indicated by phosphorylation GENE GENE	1
GENE activation in reduction with associated indicated by phosphorylation GENE	1
GENE activation converts secreted GENE	1
GENE activation by induced genes involved in metabolism metabolism GENE GENE GENE	1
GENE activation by induced genes involved in metabolism metabolism GENE GENE	1
GENE activation by induced genes involved in metabolism metabolism GENE	1
GENE activation by induced genes involved in metabolism GENE GENE	1
GENE activation by induced genes involved in metabolism GENE	1
GENE activation by induced genes involved in metabolism CHEMICAL	1
GENE activating binds to GENE	1
GENE activating binds secreted GENE	1
GENE activates in manner -dependent GENE	1
GENE activates GENE	1
GENE activated by expression of subunit GENE	1
GENE activated GENE phosphorylation of GENE	1
GENE activated GENE GENE	1
GENE activated GENE CHEMICAL by CHEMICAL	1
GENE activated GENE CHEMICAL GENE CHEMICAL	1
GENE activated GENE CHEMICAL	1
GENE actions on DISEASE	1
GENE actions of CHEMICAL	1
GENE actions determine generated increased displayed reduced sensitivity GENE	1
GENE actions are reasoned related to occurrence of DISEASE	1
GENE act promote by modulating activity GENE	1
GENE abundance reduced in mice -deficient GENE	1
GENE abolished abolish induced GENE	1
GENE ablation had attenuated markers GENE GENE	1
GENE ablation had attenuated markers GENE	1
GENE ablation had attenuated increases in expression of GENE	1
GENE ablation had GENE	1
GENE ablated methods investigated -induced DISEASE	1
GENE ab ab found contribution of genotypes c GENE	1
GENE VARIANT using investigated revealed expression revealed downregulation of GENE	1
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE GENE	1
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE	1
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE	1
GENE VARIANT using investigated revealed expression revealed downregulation GENE GENE	1
GENE VARIANT using investigated revealed expression of machinery including GENE	1
GENE VARIANT using investigated revealed expression downregulated upregulated GENE GENE	1
GENE VARIANT using investigated revealed expression downregulated upregulated GENE	1
GENE VARIANT using investigated revealed expression downregulated GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE GENE GENE	1
GENE VARIANT using investigated revealed downregulation of GENE GENE	1
GENE VARIANT using investigated revealed downregulation of GENE	1
GENE VARIANT than CHEMICAL DISEASE	1
GENE VARIANT than CHEMICAL	1
GENE VARIANT showed in DISEASE	1
GENE VARIANT polymorphism risk of DISEASE	1
GENE VARIANT polymorphism risk DISEASE	1
GENE VARIANT polymorphism of DISEASE	1
GENE VARIANT polymorphism increase confirm was showed found contribution to presence of manifestations DISEASE	1
GENE VARIANT polymorphism have by modulating formation of metabolites CHEMICAL	1
GENE VARIANT polymorphism for studied cases cases DISEASE	1
GENE VARIANT polymorphism factors as DISEASE	1
GENE VARIANT polymorphism associated with gene GENE	1
GENE VARIANT of number tended correlate with levels of CHEMICAL	1
GENE VARIANT of number tended -induced apoptosis -mediated GENE	1
GENE VARIANT of carriers had showed reduced reduced GENE GENE secretion GENE	1
GENE VARIANT of carriers had levels GENE	1
GENE VARIANT of carriers had increased GENE decreased secretion GENE	1
GENE VARIANT of carriers had increased CHEMICAL	1
GENE VARIANT mutation in DISEASE	1
GENE VARIANT mutation DISEASE	1
GENE VARIANT located attenuated found DISEASE	1
GENE VARIANT located associated with risk of DISEASE	1
GENE VARIANT in decreases in patients with DISEASE	1
GENE VARIANT in associated with mortality DISEASE	1
GENE VARIANT genotypes associated with risk DISEASE	1
GENE VARIANT genotypes associated tended correlate with levels of CHEMICAL	1
GENE VARIANT genotypes associated tended -induced apoptosis -mediated GENE	1
GENE VARIANT genotyped in patients with DISEASE	1
GENE VARIANT genotype with patients showed state DISEASE	1
GENE VARIANT genotype as factor in patients DISEASE	1
GENE VARIANT frequency in cases DISEASE	1
GENE VARIANT found obtained specimens DISEASE	1
GENE VARIANT found demonstrated showed after treatment CHEMICAL	1
GENE VARIANT exert preserved displayed interaction with coactivator GENE	1
GENE VARIANT enhances preserved displayed interaction with coactivator GENE	1
GENE VARIANT enhances predispose subjects to DISEASE DISEASE manifestations of DISEASE	1
GENE VARIANT demonstrated preserved displayed interaction with coactivator GENE	1
GENE VARIANT demonstrated increase in ability transactivate in response to CHEMICAL	1
GENE VARIANT channel dysfunction contribute due kinetics DISEASE with onset of DISEASE	1
GENE VARIANT changes investigated risk DISEASE	1
GENE VARIANT carriers developed symptoms of DISEASE	1
GENE VARIANT associated after diagnosis of DISEASE	1
GENE VARIANT allele of DISEASE	1
GENE VARIANT allele has suggest associated with prevalence DISEASE	1
GENE VARIANT allele factor for DISEASE	1
GENE VARIANT allele associated suggest showed state DISEASE	1
GENE GENE with interacts modulate secretion GENE	1
GENE GENE with associated genes of upregulation was activated genes in DISEASE	1
GENE GENE with associated genes of upregulation was GENE	1
GENE GENE who had DISEASE DISEASE	1
GENE GENE variations associated with snp VARIANT GENE	1
GENE GENE variations associated associated associated associated with predisposition recurrence of DISEASE	1
GENE GENE variations associated associated associated associated linked linked to predisposition DISEASE	1
GENE GENE upregulated incubation corresponding to concentration CHEMICAL	1
GENE GENE upregulated in lenses GENE	1
GENE GENE upregulated in DISEASE	1
GENE GENE targets GENE	1
GENE GENE subunits formed with GENE	1
GENE GENE stimulated CHEMICAL	1
GENE GENE signalling in pairs of DISEASE	1
GENE GENE signaling is overexpression GENE	1
GENE GENE signaling in DISEASE	1
GENE GENE shown were fed leads diet CHEMICAL	1
GENE GENE shown were fed developed diet CHEMICAL	1
GENE GENE response genes are during DISEASE	1
GENE GENE release observed in airways during DISEASE	1
GENE GENE related to survival DISEASE	1
GENE GENE regulates genes in DISEASE	1
GENE GENE reduced phosphorylation GENE	1
GENE GENE prevents affect CHEMICAL	1
GENE GENE predicted promote act GENE	1
GENE GENE polymorphisms shown associated with DISEASE	1
GENE GENE overexpression including DISEASE	1
GENE GENE of variations snp with associated associated with snp GENE	1
GENE GENE of translocation was evidence resulted in DISEASE	1
GENE GENE of roles understood mechanisms involved in DISEASE	1
GENE GENE of phosphorylation altered in neutrophils GENE	1
GENE GENE of levels suppressed in ko GENE	1
GENE GENE of levels increased DISEASE	1
GENE GENE of levels associated associated with snp GENE	1
GENE GENE of inhibition reduces DISEASE	1
GENE GENE of inhibition abrogated were transcripts GENE	1
GENE GENE of inhibition abrogated effect of GENE	1
GENE GENE of inhibition GENE	1
GENE GENE of five --ranked accumulation CHEMICAL	1
GENE GENE of five --ranked -induced GENE	1
GENE GENE of expression for required repressed by expression of antagonist GENE	1
GENE GENE of expression demonstrate repatterns during differentiation DISEASE	1
GENE GENE of depletion led to remodeling GENE	1
GENE GENE of decrease secondary to DISEASE	1
GENE GENE mutations in DISEASE	1
GENE GENE mice attenuated DISEASE	1
GENE GENE is DISEASE	1
GENE GENE insertion factors implicated in influencing DISEASE	1
GENE GENE induced uptake CHEMICAL	1
GENE GENE induced in fashion -dependent GENE	1
GENE GENE increased increased degeneration -treated CHEMICAL	1
GENE GENE increased in segments -treated CHEMICAL	1
GENE GENE increased DISEASE	1
GENE GENE including substrates of degradation via pathways activating by promote promoting operates with GENE	1
GENE GENE including substrates DISEASE	1
GENE GENE including gene -related DISEASE	1
GENE GENE in variation associated with recurrence DISEASE	1
GENE GENE in release of GENE activation GENE	1
GENE GENE in release of GENE	1
GENE GENE in involved genes of expression validated GENE	1
GENE GENE in deficient mice shown actions DISEASE	1
GENE GENE in changes promoting by plays role in DISEASE	1
GENE GENE in changes from patients DISEASE	1
GENE GENE in cells DISEASE	1
GENE GENE improved attenuated DISEASE	1
GENE GENE genes responsible for DISEASE	1
GENE GENE genes examined associations with DISEASE	1
GENE GENE fusion responded GENE	1
GENE GENE expressed identified produced cells DISEASE	1
GENE GENE expressed formed initiated DISEASE	1
GENE GENE exhibited observed upregulated in DISEASE	1
GENE GENE exhibited activated genes in DISEASE	1
GENE GENE elevation features DISEASE	1
GENE GENE displayed introduced increased expression of GENE GENE	1
GENE GENE delay in onset DISEASE	1
GENE GENE degradation induces increase sensitivity DISEASE	1
GENE GENE degradation induces dose of CHEMICAL	1
GENE GENE correlated GENE	1
GENE GENE cornea in upregulated regulators of signaling GENE	1
GENE GENE cornea in upregulated elevated were showed embryos GENE	1
GENE GENE cornea in upregulated elevated levels GENE GENE	1
GENE GENE cornea in upregulated elevated levels GENE	1
GENE GENE contribute to DISEASE	1
GENE GENE complex dgc connects GENE GENE	1
GENE GENE by modulated secretion mrna GENE	1
GENE GENE by excluded repress targets including GENE GENE	1
GENE GENE by excluded repress targets including GENE	1
GENE GENE by accompanied levels in DISEASE	1
GENE GENE bind induces GENE	1
GENE GENE between correlation presents provide for investigation of DISEASE	1
GENE GENE axis contributed through enhancing monopoiesis -associated GENE	1
GENE GENE axis GENE	1
GENE GENE associated associated with predisposition recurrence of DISEASE	1
GENE GENE associated associated linked linked to predisposition DISEASE	1
GENE GENE as genes of activation seems balance response to activation GENE	1
GENE GENE as genes of activation seems balance response by limiting activation of GENE	1
GENE GENE are involved presents provide for investigation of DISEASE	1
GENE GENE are causes DISEASE	1
GENE GENE are assumed predispose factors as DISEASE	1
GENE GENE altered were infected GENE	1
GENE GENE airway of induction in were infected GENE	1
GENE GENE affecting through promoted apoptosis cell DISEASE	1
GENE GENE activity modulating by promote act GENE	1
GENE GENE activation converts secreted GENE	1
GENE GENE activating binds to GENE	1
GENE GENE activating binds secreted GENE	1
GENE GENE abundance reduced in mice -deficient GENE	1
GENE GENE GENE who had DISEASE DISEASE	1
GENE GENE GENE variations associated with snp VARIANT GENE	1
GENE GENE GENE targets GENE	1
GENE GENE GENE snp associated with DISEASE	1
GENE GENE GENE response genes are during DISEASE	1
GENE GENE GENE related to survival DISEASE	1
GENE GENE GENE prevents affect CHEMICAL	1
GENE GENE GENE predicted promote act GENE	1
GENE GENE GENE of levels associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE of levels associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE of five --ranked accumulation CHEMICAL	1
GENE GENE GENE of five --ranked -induced GENE	1
GENE GENE GENE of expression for required repressed by expression of antagonist GENE	1
GENE GENE GENE of expression altered by CHEMICAL	1
GENE GENE GENE of decrease secondary to DISEASE	1
GENE GENE GENE including substrates of degradation via pathways activating by promote promoting operates with GENE	1
GENE GENE GENE including substrates DISEASE	1
GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE in variation associated with recurrence DISEASE	1
GENE GENE GENE bep2d in stimulated CHEMICAL	1
GENE GENE GENE associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE are shown shown actions DISEASE	1
GENE GENE GENE are exacerbated DISEASE	1
GENE GENE GENE affecting through promoted apoptosis cell DISEASE	1
GENE GENE GENE GENE upregulated in DISEASE	1
GENE GENE GENE GENE upregulated demonstrate reduced GENE GENE	1
GENE GENE GENE GENE upregulated demonstrate reduced GENE	1
GENE GENE GENE GENE targets GENE	1
GENE GENE GENE GENE shown were fed leads diet CHEMICAL	1
GENE GENE GENE GENE shown were fed developed diet CHEMICAL	1
GENE GENE GENE GENE related to survival DISEASE	1
GENE GENE GENE GENE predicted promote act GENE	1
GENE GENE GENE GENE of levels associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE GENE of levels associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE GENE of five --ranked accumulation CHEMICAL	1
GENE GENE GENE GENE of five --ranked -induced GENE	1
GENE GENE GENE GENE of expression altered by CHEMICAL	1
GENE GENE GENE GENE of GENE GENE GENE GENE GENE GENE of downregulation revealed investigated is demonstrated including DISEASE	1
GENE GENE GENE GENE influence investigate was antibodies in DISEASE	1
GENE GENE GENE GENE including substrates of degradation via pathways activating by promote promoting operates with GENE	1
GENE GENE GENE GENE including substrates DISEASE	1
GENE GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE GENE in were infected GENE	1
GENE GENE GENE GENE in variation associated with recurrence DISEASE	1
GENE GENE GENE GENE genes related DISEASE	1
GENE GENE GENE GENE genes of expression upregulated validated modulated induced CHEMICAL	1
GENE GENE GENE GENE biomarkers were were women with DISEASE	1
GENE GENE GENE GENE biomarkers were found associated with DISEASE	1
GENE GENE GENE GENE biomarkers were between women with DISEASE	1
GENE GENE GENE GENE associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE GENE associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE GENE airway of induction in were infected GENE	1
GENE GENE GENE GENE affecting through promoted apoptosis cell DISEASE	1
GENE GENE GENE GENE GENE upregulated in DISEASE	1
GENE GENE GENE GENE GENE targets GENE	1
GENE GENE GENE GENE GENE shown were fed leads diet CHEMICAL	1
GENE GENE GENE GENE GENE shown were fed developed diet CHEMICAL	1
GENE GENE GENE GENE GENE of levels associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE GENE GENE of levels associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE GENE GENE of five --ranked accumulation CHEMICAL	1
GENE GENE GENE GENE GENE of five --ranked -induced GENE	1
GENE GENE GENE GENE GENE influence investigate was antibodies in DISEASE	1
GENE GENE GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE GENE GENE in were infected GENE	1
GENE GENE GENE GENE GENE genes related DISEASE	1
GENE GENE GENE GENE GENE genes of expression upregulated validated modulated induced CHEMICAL	1
GENE GENE GENE GENE GENE associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE GENE GENE associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE GENE GENE GENE in were infected GENE	1
GENE GENE GENE GENE GENE GENE genes related DISEASE	1
GENE GENE GENE GENE GENE GENE genes of expression upregulated validated modulated induced CHEMICAL	1
GENE GENE GENE GENE GENE GENE associated associated with predisposition recurrence of DISEASE	1
GENE GENE GENE GENE GENE GENE associated associated linked linked to predisposition DISEASE	1
GENE GENE GENE GENE GENE GENE GENE in were infected GENE	1
GENE GENE GENE GENE GENE GENE GENE GENE upregulated in DISEASE	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE upregulated in DISEASE	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related DISEASE	1
GENE GENE GENE GENE GENE	1
GENE GENE GENE GENE DISEASE	1
GENE GENE GENE DISEASE	1
GENE GENE GENE -induced GENE	1
GENE GENE DISEASE	1
GENE DISEASE presented rats -treated CHEMICAL	1
GENE DISEASE in signalling CHEMICAL	1
GENE DISEASE age in matched had GENE GENE	1
GENE DISEASE age in matched had GENE	1
GENE DISEASE DISEASE	1
GENE DISEASE -suppressor proteins of dysfunction mutations implicated is DISEASE	1
GENE CHEMICAL with characterized methods studied associated with DISEASE	1
GENE CHEMICAL with characterized methods studied associated cause DISEASE	1
GENE CHEMICAL therapy with DISEASE	1
GENE CHEMICAL therapy in DISEASE	1
GENE CHEMICAL regulates growth DISEASE	1
GENE CHEMICAL of use requiring patients in CHEMICAL CHEMICAL	1
GENE CHEMICAL of use requiring patients in CHEMICAL	1
GENE CHEMICAL of dose induces increase sensitivity DISEASE	1
GENE CHEMICAL of dose induces degradation GENE GENE	1
GENE CHEMICAL of dose induces degradation GENE	1
GENE CHEMICAL dose inhibited activity GENE	1
GENE CHEMICAL GENE	1
GENE CHEMICAL CHEMICAL as markers help avoiding occurrence of DISEASE	1
GENE CHEMICAL CHEMICAL	1
GENE /bcp negativity of occurrence resulted resistance CHEMICAL	1
GENE /bcp negativity CHEMICAL	1
GENE -yellow protein utilizing show exhibited expressed levels of GENE GENE GENE	1
GENE -yellow protein utilizing show exhibited expressed levels of GENE GENE	1
GENE -yellow protein utilizing show exhibited expressed levels of GENE	1
GENE -using variants harbored individuals DISEASE	1
GENE -targeted therapy in DISEASE	1
GENE -stimulated upregulated GENE transcripts transcripts GENE	1
GENE -stimulated upregulated GENE GENE	1
GENE -stimulated upregulated GENE	1
GENE -stimulated transcription GENE	1
GENE -state high- activation required CHEMICAL GENE	1
GENE -state high- activation required -activation GENE	1
GENE -specific GENE increased affected GENE GENE GENE	1
GENE -specific GENE increased affected GENE GENE	1
GENE -specific GENE increased affected GENE	1
GENE -related genes of expression had GENE GENE	1
GENE -related genes of expression had GENE	1
GENE -related condition is identified include DISEASE	1
GENE -related condition associated with DISEASE	1
GENE -producing population revealed suggest provide cells DISEASE	1
GENE -producing phenotype in mice -deficient GENE	1
GENE -positive proliferating of localization identified showed degree of DISEASE	1
GENE -positive proliferating of localization identified cells in area DISEASE	1
GENE -positive DISEASE	1
GENE -mutation related DISEASE	1
GENE -modulated mediators included GENE GENE GENE GENE	1
GENE -modulated mediators included GENE	1
GENE -mediated transport CHEMICAL	1
GENE -mediated survival in DISEASE	1
GENE -mediated identified with DISEASE	1
GENE -mediated components are involve pathogenesis of DISEASE	1
GENE -mediated clearance CHEMICAL	1
GENE -mediated activity of cells DISEASE	1
GENE -mediated activity -initiating DISEASE	1
GENE -mediated activation of GENE	1
GENE -mediated activation GENE	1
GENE -mediated CHEMICAL	1
GENE -low cells form with GENE expression GENE	1
GENE -low cells form with GENE	1
GENE -knockout mice generated increased displayed reduced sensitivity GENE	1
GENE -knockout implanted DISEASE	1
GENE -ir increase -immunoreactivity prevents affect CHEMICAL	1
GENE -involved altered signaling including GENE	1
GENE -inhibitors CHEMICAL CHEMICAL	1
GENE -inhibitors CHEMICAL	1
GENE -induced was included included GENE GENE GENE GENE GENE GENE GENE	1
GENE -induced was included included GENE GENE GENE GENE GENE GENE	1
GENE -induced was included included GENE GENE GENE GENE GENE	1
GENE -induced was included included GENE GENE GENE GENE	1
GENE -induced was included included GENE GENE GENE	1
GENE -induced was included included GENE GENE	1
GENE -induced was included included GENE	1
GENE -induced was included GENE GENE GENE GENE	1
GENE -induced was included GENE	1
GENE -induced stimulation of GENE	1
GENE -induced leads DISEASE	1
GENE -induced inhibition of blocks GENE	1
GENE -induced increases in expression of GENE	1
GENE -induced increases attenuated markers GENE GENE	1
GENE -induced increases attenuated markers GENE	1
GENE -induced genes GENE GENE GENE GENE	1
GENE -induced genes GENE GENE GENE	1
GENE -induced genes GENE GENE	1
GENE -induced genes GENE	1
GENE -induced generation GENE	1
GENE -induced expression of GENE GENE	1
GENE -induced expression of GENE	1
GENE -induced determined in model DISEASE	1
GENE -induced blocks inhibition of GENE GENE GENE	1
GENE -induced activation of GENE	1
GENE -induced GENE phosphorylation GENE	1
GENE -induced --ranked accumulation CHEMICAL	1
GENE -independent mechanism depends upon activation of GENE	1
GENE -immunoreactivity prevents affect CHEMICAL	1
GENE -driven expansion GENE	1
GENE -derived conclude DISEASE	1
GENE -derived -induced CHEMICAL	1
GENE -depleted cells DISEASE	1
GENE -dependent upregulation of GENE GENE	1
GENE -dependent upregulation of GENE	1
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE	1
GENE -dependent transcripts among implicated following GENE GENE GENE GENE GENE	1
GENE -dependent transcripts among implicated following GENE GENE GENE GENE	1
GENE -dependent transcripts among implicated following GENE GENE GENE	1
GENE -dependent transcripts among implicated following GENE GENE	1
GENE -dependent transcripts among implicated following GENE	1
GENE -dependent induced regulation of GENE GENE GENE	1
GENE -dependent induced regulation of GENE GENE	1
GENE -dependent induced regulation of GENE	1
GENE -dependent dedifferentiation occurs demonstrate repatterns during differentiation DISEASE	1
GENE -deficient mice with DISEASE	1
GENE -deficient GENE	1
GENE -deficiency by extent to coli CHEMICAL CHEMICAL	1
GENE -deficiency by extent to coli CHEMICAL	1
GENE -cre generated GENE	1
GENE -cre become recovered regulated GENE	1
GENE -cofactor CHEMICAL	1
GENE -activated GENE	1
GENE -93 allele was DISEASE patients DISEASE	1
GENE -93 allele was DISEASE	1
GENE -31/-511 by affected patients DISEASE	1
GENE , GENE pathway increased suppressed with CHEMICAL	1
DISEASE working in reported show users CHEMICAL	1
DISEASE working in reported on users CHEMICAL	1
DISEASE without patients than levels GENE	1
DISEASE with women were were biomarkers GENE GENE GENE GENE GENE ratio GENE	1
DISEASE with women between were biomarkers GENE GENE GENE GENE GENE ratio GENE	1
DISEASE with treated patients for are VARIANT	1
DISEASE with therapy of efficacy affect reported polymorphisms around GENE	1
DISEASE with therapy of efficacy affect reported locus gene GENE	1
DISEASE with therapy of efficacy affect reported associated is are VARIANT	1
DISEASE with test CHEMICAL	1
DISEASE with subjects matched treated with CHEMICAL CHEMICAL CHEMICAL	1
DISEASE with subjects matched treated with CHEMICAL CHEMICAL	1
DISEASE with subjects matched treated with CHEMICAL	1
DISEASE with subjects in gene GENE	1
DISEASE with subjects carried VARIANT	1
DISEASE with snp was VARIANT	1
DISEASE with segregated VARIANT	1
DISEASE with population in found ratio for occurrence of VARIANT	1
DISEASE with population in found calculated frequency of mutation VARIANT	1
DISEASE with population in found calculated detected found found VARIANT	1
DISEASE with phenotype is reported was VARIANT	1
DISEASE with phenotype is reported mutation VARIANT	1
DISEASE with patients were sensitive to CHEMICAL	1
DISEASE with patients treated with CHEMICAL	1
DISEASE with patients studied to CHEMICAL	1
DISEASE with patients studied evaluated CHEMICAL	1
DISEASE with patients of ecg in DISEASE reported prescribed CHEMICAL	1
DISEASE with patients of detected found associated VARIANT rt patients with pattern substitution GENE	1
DISEASE with patients in risk association within locus GENE	1
DISEASE with patients in prognostic be associated associated associated were results associated GENE	1
DISEASE with patients in performed subjected identified detected VARIANT	1
DISEASE with patients in GENE	1
DISEASE with patients had noted found were identified results confirmed screened amplified made methods identify purpose mutations GENE	1
DISEASE with patients had noted found were identified results confirmed screened amplified exons flanking sequences of gene GENE	1
DISEASE with patients had levels GENE	1
DISEASE with patients had found found change of VARIANT	1
DISEASE with patients had GENE	1
DISEASE with patients from automated assessed presented were heterozygous for VARIANT VARIANT substitutions VARIANT	1
DISEASE with patients from automated assessed presented were heterozygous for VARIANT VARIANT	1
DISEASE with patients from automated assessed presented were heterozygous for VARIANT	1
DISEASE with patients from automated assessed presented were heterozygotes one with VARIANT VARIANT	1
DISEASE with patients from automated assessed presented were heterozygotes one brothers with VARIANT VARIANT	1
DISEASE with patients from automated assessed presented were found polymorphism VARIANT	1
DISEASE with patients from automated assessed presented were found detected variant VARIANT	1
DISEASE with patients from automated assessed presented were found detected harbor deletion substitution VARIANT	1
DISEASE with patients from automated assessed presented mutations cousins two with VARIANT	1
DISEASE with patients from automated assessed presented mutations cousins patients with VARIANT	1
DISEASE with patients from automated assessed presented mutations cousins one one with VARIANT	1
DISEASE with patients carrying GENE	1
DISEASE with patients assigned CHEMICAL were at bid CHEMICAL	1
DISEASE with patients assigned CHEMICAL at bid placebo CHEMICAL	1
DISEASE with patients assessed methods genotyped for VARIANT VARIANT	1
DISEASE with patients assessed methods genotyped for VARIANT	1
DISEASE with patients -allele VARIANT	1
DISEASE with patient present was VARIANT VARIANT	1
DISEASE with patient present was VARIANT	1
DISEASE with patient of cells leukocytes showed in exon predicts VARIANT	1
DISEASE with patient of cells leukocytes showed VARIANT	1
DISEASE with patient investigated methods improved results identified was revealed found had suggest contribute dysfunction channel VARIANT	1
DISEASE with patient investigated associated objective manifests mutation GENE	1
DISEASE with patient in records suggests detected harbored detected identified subjected performed help defect depends diagnosis of DISEASE of VARIANT	1
DISEASE with patient in GENE	1
DISEASE with patient having VARIANT VARIANT	1
DISEASE with patient having VARIANT	1
DISEASE with patient harbored mutation VARIANT	1
DISEASE with patient harbored detected identified with mutations in gene GENE	1
DISEASE with patient found be for mutation in gene GENE	1
DISEASE with onset responded to CHEMICAL CHEMICAL	1
DISEASE with onset responded to CHEMICAL	1
DISEASE with mutation of GENE	1
DISEASE with mutation VARIANT GENE	1
DISEASE with mutation GENE	1
DISEASE with mice in reduced abundance index of node thymus GENE	1
DISEASE with mice in reduced abundance GENE GENE	1
DISEASE with mice in reduced abundance GENE	1
DISEASE with man admitted initiated at dose of CHEMICAL	1
DISEASE with man admitted initiated CHEMICAL	1
DISEASE with individual was showed were for VARIANT	1
DISEASE with individual was heterozygote for VARIANT in intron substitution VARIANT	1
DISEASE with individual was heterozygote for VARIANT	1
DISEASE with indel of association corroborated revealed is VARIANT	1
DISEASE with implicated results support was identified detected is identified VARIANT	1
DISEASE with identified novo of studies report disruption of GENE	1
DISEASE with identified introduced lead to VARIANT	1
DISEASE with identified introduced discovered VARIANT	1
DISEASE with identified introduced at VARIANT	1
DISEASE with identified associated in mutation of gene GENE	1
DISEASE with humans genotyped is VARIANT	1
DISEASE with genotype GENE	1
DISEASE with found were observed in cdna derived from patients with VARIANT VARIANT	1
DISEASE with found substitution VARIANT VARIANT	1
DISEASE with found substitution VARIANT	1
DISEASE with found VARIANT	1
DISEASE with features seen treated with CHEMICAL	1
DISEASE with families in identified had occurred found accounted VARIANT VARIANT	1
DISEASE with exhibited had showed received CHEMICAL CHEMICAL	1
DISEASE with exhibited had showed received CHEMICAL	1
DISEASE with diagnosed performed identified results variants VARIANT VARIANT	1
DISEASE with diagnosed performed identified results variants VARIANT	1
DISEASE with diagnosed performed identified VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations mutations including at splicing sites VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations mutations including VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations including VARIANT VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations including VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations in exon VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations including VARIANT VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations including VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations in exon VARIANT VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations in exon VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations VARIANT VARIANT	1
DISEASE with diagnosed families from enrolled sequenced measured detected identified as novel mutations VARIANT	1
DISEASE with developed mg CHEMICAL	1
DISEASE with developed after doses of CHEMICAL	1
DISEASE with deposits CHEMICAL	1
DISEASE with department to presented initiated with CHEMICAL CHEMICAL CHEMICAL	1
DISEASE with department to presented initiated with CHEMICAL CHEMICAL	1
DISEASE with department to presented initiated with CHEMICAL	1
DISEASE with coupled impairments show users CHEMICAL	1
DISEASE with consistent stabilizes activates GENE	1
DISEASE with consistent manifestations with presented female studied detected investigated results demonstrated VARIANT GENE	1
DISEASE with consistent manifestations with presented female studied detected investigated results demonstrated VARIANT	1
DISEASE with consistent manifestations with presented female studied detected VARIANT exon of gene GENE	1
DISEASE with consistent manifestations with presented female studied detected VARIANT	1
DISEASE with consistent manifestations with presented female studied context mutation in domain of GENE	1
DISEASE with combination in analysis of GENE	1
DISEASE with children identified performed were in none of controls VARIANT resulting in alanine within exon substitution VARIANT	1
DISEASE with children identified performed were in none of controls VARIANT VARIANT	1
DISEASE with children identified performed were in none of controls VARIANT	1
DISEASE with child in expression of GENE	1
DISEASE with associations showed showed % in GENE	1
DISEASE with association suggesting showed included GENE GENE	1
DISEASE with association suggesting showed included GENE	1
DISEASE with association showed revealed indicate contributes VARIANT	1
DISEASE with association replicated observed influenced by VARIANT VARIANT VARIANT	1
DISEASE with association replicated observed influenced by VARIANT VARIANT	1
DISEASE with association replicated observed influenced by VARIANT	1
DISEASE with association indicated showed in GENE	1
DISEASE with associated were associated therapies with CHEMICAL	1
DISEASE with associated revealed indicate contributes VARIANT	1
DISEASE with associated results assessed genotyped for VARIANT VARIANT	1
DISEASE with associated results assessed genotyped for VARIANT	1
DISEASE with associated polymorphism VARIANT	1
DISEASE with associated polymorphism GENE	1
DISEASE with associated is polymorphism GENE	1
DISEASE with associated in spectrum expands is conclusions co was revealed VARIANT	1
DISEASE with associated identified increased observed -*2/*2 GENE	1
DISEASE with associated found were biomarkers GENE GENE GENE GENE GENE ratio GENE	1
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE with associated found for fbg fins ir beta GENE GENE GENE GENE GENE	1
DISEASE with associated found for fbg fins ir beta GENE GENE	1
DISEASE with associated found for fbg fins ir beta GENE	1
DISEASE with associated fasting levels CHEMICAL	1
DISEASE with associated describe is mutation VARIANT caused by VARIANT	1
DISEASE with associated describe is mutation VARIANT caused VARIANT	1
DISEASE with associated describe is mutation VARIANT	1
DISEASE with associated describe is is substitution causes VARIANT	1
DISEASE with associated describe is is substitution VARIANT VARIANT	1
DISEASE with associated describe is is substitution VARIANT	1
DISEASE with associated constituted detected identified polymorphisms GENE	1
DISEASE with associated be observed revealed predicted variant VARIANT	1
DISEASE with admitted decreased activity GENE	1
DISEASE with GENE	1
DISEASE with DISEASE occurred with concentration CHEMICAL	1
DISEASE with DISEASE developed to therapy CHEMICAL	1
DISEASE with DISEASE developed remained used CHEMICAL	1
DISEASE with DISEASE developed remained levels CHEMICAL	1
DISEASE with DISEASE as diagnosed got infusion CHEMICAL	1
DISEASE with CHEMICAL	1
DISEASE with 25 selected was test CHEMICAL	1
DISEASE with 25 selected had administered CHEMICAL	1
DISEASE with % in in identified had occurred found accounted VARIANT VARIANT	1
DISEASE was seemed ns- CHEMICAL	1
DISEASE was regulated in cells GENE	1
DISEASE was mrna of gene GENE	1
DISEASE was ml of CHEMICAL	1
DISEASE was increased levels GENE	1
DISEASE was in associated polymorphism GENE	1
DISEASE was had had plays GENE	1
DISEASE was due to CHEMICAL	1
DISEASE was conclusion were CHEMICAL CHEMICAL	1
DISEASE was conclusion were CHEMICAL	1
DISEASE was common on CHEMICAL	1
DISEASE was associated snp GENE	1
DISEASE was appears conclusions CHEMICAL	1
DISEASE vivo inhibited identified GENE GENE	1
DISEASE v growth inhibited investigated are expression of GENE	1
DISEASE v growth inhibited accompanied decreased expression of GENE	1
DISEASE unmasked by CHEMICAL CHEMICAL	1
DISEASE unmasked by CHEMICAL	1
DISEASE undetectable in screening GENE	1
DISEASE type patients methylation of GENE	1
DISEASE type identified identified assessed ranked revealing encoding GENE GENE	1
DISEASE treatment for value have demonstrated targeting GENE GENE	1
DISEASE treated by CHEMICAL as CHEMICAL CHEMICAL CHEMICAL	1
DISEASE treated by CHEMICAL as CHEMICAL CHEMICAL	1
DISEASE treated by CHEMICAL as CHEMICAL	1
DISEASE treated by CHEMICAL	1
DISEASE transplantation developed woman describe CHEMICAL	1
DISEASE transferred was considered be doses of CHEMICAL	1
DISEASE to subjects predispose enhances VARIANT GENE	1
DISEASE to prone are objectives investigate test methods isolated corresponding to VARIANT	1
DISEASE to predispose suggest indicated analysis based on snps VARIANT VARIANT VARIANT	1
DISEASE to predispose suggest indicated analysis based on snps VARIANT VARIANT	1
DISEASE to metabolism CHEMICAL	1
DISEASE to leads due occupation of GENE	1
DISEASE to leads due occupation by CHEMICAL	1
DISEASE to leading gene in identified studied is is transition designated VARIANT	1
DISEASE to leading gene in identified studied is is transition VARIANT	1
DISEASE to is frequency of VARIANT	1
DISEASE to implicated VARIANT	1
DISEASE to evolve develop described during treatment of patients with GENE	1
DISEASE to evolve described present woman developed during treatment with GENE	1
DISEASE to evolve described present complained confirmed disappeared after stopping GENE	1
DISEASE to evolve described cases of DISEASE occurring during therapy GENE	1
DISEASE to conversion with associated were 1.998 for VARIANT	1
DISEASE to conversion was indicated analysis based on snps VARIANT VARIANT VARIANT	1
DISEASE to conversion was indicated analysis based on snps VARIANT VARIANT	1
DISEASE to conversion for interval had were snps in region VARIANT VARIANT VARIANT	1
DISEASE to conversion for interval had were snps in region VARIANT VARIANT	1
DISEASE to contribution found GENE	1
DISEASE to contrast in inhibited action CHEMICAL	1
DISEASE to addition in found presented identified germline transition VARIANT	1
DISEASE tissues in activated GENE pathways GENE	1
DISEASE tissues in activated GENE	1
DISEASE therapy with CHEMICAL	1
DISEASE than CHEMICAL	1
DISEASE thais polymorphisms GENE	1
DISEASE syndromic for responsible were mutations in gene GENE	1
DISEASE syndrome of case identified presented had results had revealed showed revealed transmitted replacement of VARIANT	1
DISEASE syndrome of case identified presented had results had VARIANT 8) resulted in substitution of VARIANT	1
DISEASE syndrome of case identified presented had results had VARIANT	1
DISEASE syndrome is condition characterized by insensitivity to CHEMICAL	1
DISEASE susceptibility VARIANT	1
DISEASE suppressed formation correlated with deposition GENE	1
DISEASE support effect of CHEMICAL	1
DISEASE suggested account like CHEMICAL	1
DISEASE suffered man CHEMICAL	1
DISEASE subjects grouped as GENE CHEMICAL	1
DISEASE subjects grouped as GENE	1
DISEASE subjects differ in DISEASE production GENE	1
DISEASE structure revealed expressions GENE GENE GENE	1
DISEASE structure revealed expressions GENE GENE	1
DISEASE structure revealed expressions GENE	1
DISEASE strains by infected detected resistance to CHEMICAL CHEMICAL	1
DISEASE strains by infected detected resistance to CHEMICAL	1
DISEASE stimuli tend transcripts as GENE GENE	1
DISEASE stimuli tend transcripts as GENE	1
DISEASE stimuli tend seems activation of genes as GENE GENE	1
DISEASE stimuli tend seems activation of genes as GENE	1
DISEASE stimuli CHEMICAL CHEMICAL	1
DISEASE stimuli CHEMICAL	1
DISEASE site with varied vntr genotypes VARIANT	1
DISEASE signaling by inhibiting pathway of GENE	1
DISEASE showed overexpression GENE	1
DISEASE showed felt x treated with 50 CHEMICAL	1
DISEASE showed felt x treated tablet hour CHEMICAL	1
DISEASE selection induced by DISEASE overexpression GENE	1
DISEASE secondary to therapy CHEMICAL	1
DISEASE sd assigned to treatment with CHEMICAL CHEMICAL	1
DISEASE sd assigned to treatment with CHEMICAL	1
DISEASE sd assigned results differ between CHEMICAL CHEMICAL	1
DISEASE sd assigned results differ between CHEMICAL	1
DISEASE sd assigned method compared for CHEMICAL	1
DISEASE samples control presented VARIANT	1
DISEASE risks from polymorphisms GENE	1
DISEASE risk was higher for users of users CHEMICAL	1
DISEASE risk polymorphisms VARIANT VARIANT	1
DISEASE risk polymorphisms VARIANT	1
DISEASE risk of respect in saw observe association with allele VARIANT	1
DISEASE risk investigated changes VARIANT VARIANT	1
DISEASE risk influenced by gene consisting of VARIANT	1
DISEASE risk allele VARIANT	1
DISEASE reversed reversed suggesting involved CHEMICAL	1
DISEASE revealed showed amplification GENE	1
DISEASE revealed had reviewed found is GENE	1
DISEASE revealed had insertion VARIANT mutation VARIANT	1
DISEASE revealed had insertion VARIANT	1
DISEASE revealed compromises sensitivity CHEMICAL	1
DISEASE resulting from mutations of GENE	1
DISEASE resulting from mutation in protein GENE	1
DISEASE resulting from mutation in gene GENE	1
DISEASE resulting from mutation VARIANT	1
DISEASE resulted observed GENE	1
DISEASE result methods showed increase of exposure CHEMICAL	1
DISEASE result from aberrations of GENE	1
DISEASE response by limiting activation of GENE	1
DISEASE response balance seems activation of genes as GENE GENE	1
DISEASE response balance seems activation of genes as GENE	1
DISEASE resolved on withdrawal of CHEMICAL	1
DISEASE represents known GENE	1
DISEASE represents CHEMICAL	1
DISEASE reported occurred was CHEMICAL	1
DISEASE report presented diagnosed showed is heterozygote substitution of VARIANT	1
DISEASE repair with compatible areas found reduced CHEMICAL	1
DISEASE repair with compatible areas found had CHEMICAL	1
DISEASE related to CHEMICAL CHEMICAL	1
DISEASE related to CHEMICAL	1
DISEASE regulated abolished levels CHEMICAL	1
DISEASE reaction documented among patients CHEMICAL	1
DISEASE rats treated with CHEMICAL	1
DISEASE rats sensitized revealed revealed studies CHEMICAL	1
DISEASE rats sensitized revealed decreased decreased stress downregulation of GENE	1
DISEASE rats sensitized revealed decreased decreased levels GENE	1
DISEASE rats sensitized revealed decreased decreased GENE	1
DISEASE rats in altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL CHEMICAL	1
DISEASE rats in altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL	1
DISEASE rats in altered tissue enzymes as antioxidants as GENE CHEMICAL	1
DISEASE rats in altered tissue enzymes as antioxidants as GENE	1
DISEASE rats in altered tissue enzymes as GENE GENE GENE GENE GENE	1
DISEASE rats in altered tissue enzymes as GENE GENE GENE GENE	1
DISEASE rats in altered tissue enzymes as GENE GENE GENE	1
DISEASE rats in altered tissue enzymes as GENE GENE	1
DISEASE rats in altered tissue enzymes as GENE	1
DISEASE rats are sensitized by downregulating generation CHEMICAL	1
DISEASE rats are limited chemotherapy by CHEMICAL	1
DISEASE rate on CHEMICAL	1
DISEASE rate experienced rectified by CHEMICAL	1
DISEASE purpose identify mutations in GENE	1
DISEASE purpose identify methods examined extracted analyzed results detected revealed identified resulted in substitution of VARIANT	1
DISEASE purpose identify methods examined extracted analyzed results detected revealed identified resulted in substitution mutation at VARIANT	1
DISEASE purpose identify methods examined extracted analyzed results detected revealed identified mutations VARIANT VARIANT	1
DISEASE purpose identify methods examined extracted analyzed results detected revealed identified mutations VARIANT	1
DISEASE protein to related GENE GENE unveil as cargo with functions -dependent GENE	1
DISEASE promote delivery CHEMICAL	1
DISEASE progression promotion inhibition GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE progression promotion inhibition GENE GENE GENE GENE GENE GENE GENE	1
DISEASE progression promotion inhibition GENE GENE GENE GENE GENE	1
DISEASE progression promotion inhibition GENE GENE GENE	1
DISEASE progression promotion inhibition GENE	1
DISEASE profound results were for VARIANT	1
DISEASE profound methods suggested results deficiency GENE	1
DISEASE produce generation release CHEMICAL	1
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE process in implicated following GENE GENE GENE GENE GENE GENE GENE	1
DISEASE process in implicated following GENE GENE GENE GENE GENE	1
DISEASE process in implicated following GENE GENE GENE GENE	1
DISEASE process in implicated following GENE GENE GENE	1
DISEASE process in implicated following GENE GENE	1
DISEASE process in implicated following GENE	1
DISEASE prevented microperfusion CHEMICAL	1
DISEASE presumed presented initiated with CHEMICAL CHEMICAL CHEMICAL	1
DISEASE presumed presented initiated with CHEMICAL CHEMICAL	1
DISEASE presumed presented initiated with CHEMICAL	1
DISEASE pressure fluctuating had showed elevation of CHEMICAL	1
DISEASE pressure fluctuating had showed CHEMICAL CHEMICAL	1
DISEASE pressure fluctuating had showed CHEMICAL	1
DISEASE pressure fluctuating had exhibited on day of CHEMICAL	1
DISEASE pressure fluctuating had exhibited initiated CHEMICAL	1
DISEASE presents involves mutations in gene GENE	1
DISEASE presented in exon predicts substitution VARIANT	1
DISEASE presented VARIANT	1
DISEASE present methods profound results were for VARIANT	1
DISEASE predisposition instability by characterized DISEASE is frequency of VARIANT	1
DISEASE precipitated by CHEMICAL	1
DISEASE postoperative confer are VARIANT	1
DISEASE polymorphisms between associations assessed genotyped for VARIANT VARIANT	1
DISEASE polymorphisms between associations assessed genotyped for VARIANT	1
DISEASE polymorphisms GENE	1
DISEASE polymorphism VARIANT	1
DISEASE phenotype with mutation VARIANT	1
DISEASE phenotype is reported was VARIANT	1
DISEASE phenotype is reported mutation VARIANT	1
DISEASE phenotype causes mutation in gene GENE	1
DISEASE phenotype causes mutation VARIANT	1
DISEASE phenotype autosomal GENE	1
DISEASE persists evaluated was methods genotyped for VARIANT VARIANT	1
DISEASE persists evaluated was methods genotyped for VARIANT	1
DISEASE patients without mutations GENE	1
DISEASE patients with GENE CHEMICAL	1
DISEASE patients with GENE	1
DISEASE patients treated with CHEMICAL	1
DISEASE patients patients treated with CHEMICAL CHEMICAL CHEMICAL	1
DISEASE patients patients treated with CHEMICAL CHEMICAL	1
DISEASE patients of samples samples samples used detected identified mutations including deletion mutation VARIANT	1
DISEASE patients of samples samples samples used detected identified mutations including deletion VARIANT	1
DISEASE patients of samples samples samples used detected identified established method for detecting snps VARIANT VARIANT VARIANT VARIANT	1
DISEASE patients of samples samples samples used detected identified established method for detecting snps VARIANT	1
DISEASE patients of most VARIANT	1
DISEASE patients in variant GENE	1
DISEASE patients in sequences mutations germline screened identified were patients carrying mutation VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations mutations VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations including mutation VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations VARIANT VARIANT	1
DISEASE patients in sequences mutations germline screened identified mutations VARIANT	1
DISEASE patients in reported were mutations VARIANT VARIANT VARIANT	1
DISEASE patients in reported were mutations VARIANT	1
DISEASE patients in found report were produced were for changing VARIANT	1
DISEASE patients in detected report identified include mutations mutations mutations VARIANT	1
DISEASE patients in detected report identified include mutations VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT	1
DISEASE patients in detected report identified include mutations VARIANT VARIANT VARIANT	1
DISEASE patients in abundant was were VARIANT VARIANT	1
DISEASE patients in abundant was were VARIANT	1
DISEASE patients homozygous for mutation in gene GENE	1
DISEASE patients from fibroblasts in sequenced identified VARIANT	1
DISEASE patients from fibroblasts in sequenced cdnas GENE	1
DISEASE patients demonstrated showed after treatment CHEMICAL	1
DISEASE patients demonstrated mutated identified mutations GENE GENE	1
DISEASE patients demonstrated mutated identified mutations GENE	1
DISEASE patients demonstrated mutated GENE	1
DISEASE patients caused by deletions of locus GENE	1
DISEASE patients carrying indel GENE	1
DISEASE patients are carry VARIANT in gene GENE	1
DISEASE patients are carry VARIANT	1
DISEASE patients -treated explored studied VARIANT polymorphism VARIANT	1
DISEASE patients -treated explored studied VARIANT	1
DISEASE patient with mutation VARIANT GENE	1
DISEASE patient with mutation VARIANT	1
DISEASE patient showed possessed resulted in replacement of VARIANT	1
DISEASE patient showed after treatment CHEMICAL	1
DISEASE patient mutation had noted found were identified results confirmed screened amplified made methods identify purpose mutations GENE	1
DISEASE patient mutation had noted found were identified results confirmed screened amplified exons flanking sequences of gene GENE	1
DISEASE patient mutation had had mutation VARIANT	1
DISEASE patient in mutation osaka VARIANT	1
DISEASE patient in caused solved identified as VARIANT	1
DISEASE patient in caused solved homozygosity for VARIANT	1
DISEASE patient during GENE	1
DISEASE pathology in be likely are identified genes involved in pathways repair maintenance of stability of rereplication GENE GENE GENE	1
DISEASE pathology in be likely are identified genes involved in pathways repair maintenance of stability of rereplication GENE GENE	1
DISEASE pathology in be likely are identified genes involved in pathways repair maintenance of stability of rereplication GENE	1
DISEASE pathology in be likely are identified genes involved in pathways repair maintenance metabolism transduction GENE	1
DISEASE pathology in be likely are identified genes involved in pathways GENE	1
DISEASE pathogenesis during aids resulted revealed expression of machinery including GENE	1
DISEASE pathogenesis during aids resulted revealed expression downregulated upregulated GENE GENE	1
DISEASE pathogenesis during aids resulted revealed expression downregulated upregulated GENE	1
DISEASE pathogenesis during aids resulted revealed expression downregulated GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation of GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE	1
DISEASE pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE	1
DISEASE pathogenesis during aids resulted expression of GENE	1
DISEASE parameters as serum total CHEMICAL CHEMICAL	1
DISEASE parameters as serum CHEMICAL	1
DISEASE pa-1 cells undergo upregulation of GENE GENE	1
DISEASE pa-1 cells undergo upregulation -dependent GENE	1
DISEASE on data using found indicates associated homozygosity VARIANT GENE	1
DISEASE on data using evaluate impact of polymorphism VARIANT GENE	1
DISEASE on data using evaluate impact of polymorphism VARIANT	1
DISEASE of treatment initiating associated in comparison to CHEMICAL	1
DISEASE of symptoms showed was heterozygote in GENE	1
DISEASE of symptoms provide showed possessed resulted in replacement of VARIANT	1
DISEASE of symptoms provide showed change in tenth of gene led to alteration of composition of protein VARIANT	1
DISEASE of symptoms provide be GENE	1
DISEASE of symptoms improved by agonists CHEMICAL	1
DISEASE of symptoms alleviate improve attempt in receiving ratio CHEMICAL	1
DISEASE of subtype were abnormalities GENE	1
DISEASE of spectrum expanding due mutation VARIANT	1
DISEASE of severity due injection CHEMICAL	1
DISEASE of risk with CHEMICAL	1
DISEASE of risk to contributes VARIANT	1
DISEASE of risk related to levels GENE	1
DISEASE of risk increases results confirm confers conclusions observed was found results detected length VARIANT GENE	1
DISEASE of risk due treatment CHEMICAL	1
DISEASE of risk confer snps in GENE	1
DISEASE of risk association among polymorphisms of GENE	1
DISEASE of risk associated with genotype VARIANT	1
DISEASE of risk associated VARIANT	1
DISEASE of regulation mediated demonstrate inhibition observed observed GENE GENE GENE GENE	1
DISEASE of regulation mediated demonstrate inhibition observed observed GENE GENE GENE	1
DISEASE of regulation mediated demonstrate inhibition observed observed GENE GENE	1
DISEASE of regulation mediated demonstrate inhibition observed observed GENE	1
DISEASE of protein GENE	1
DISEASE of progression in metabolism of role highlighting associated polymorphism GENE VARIANT	1
DISEASE of progression in metabolism of role highlighting associated polymorphism GENE	1
DISEASE of prognosis varies are examined results associated polymorphisms in GENE VARIANT VARIANT	1
DISEASE of pathogenesis characterized by damage of cells -producing GENE	1
DISEASE of onset responded to CHEMICAL CHEMICAL	1
DISEASE of onset responded to CHEMICAL	1
DISEASE of onset delayed reduced after treatment CHEMICAL	1
DISEASE of onset delayed deficiency GENE	1
DISEASE of occurrence by means of increase in CHEMICAL	1
DISEASE of occurred started CHEMICAL CHEMICAL	1
DISEASE of occurred started CHEMICAL	1
DISEASE of neurons CHEMICAL	1
DISEASE of models of number across has -treated CHEMICAL	1
DISEASE of mice induced by CHEMICAL CHEMICAL	1
DISEASE of mice GENE	1
DISEASE of methods are therapy injections CHEMICAL	1
DISEASE of metabolism CHEMICAL	1
DISEASE of mechanisms by CHEMICAL	1
DISEASE of mechanism on perspective -mediated identified mutation VARIANT	1
DISEASE of mechanism on perspective -mediated GENE	1
DISEASE of markers as concentrations of GENE CHEMICAL GENE	1
DISEASE of markers are GENE GENE	1
DISEASE of markers are GENE	1
DISEASE of intensity reduced delayed deficiency GENE	1
DISEASE of indicative roots cord in signals demonstrated persisted occurred discontinued replaced by CHEMICAL	1
DISEASE of indicative roots cord in signals demonstrated persisted occurred discontinued CHEMICAL	1
DISEASE of indicative roots cord in signals demonstrated persisted despite reduction CHEMICAL	1
DISEASE of incidence was lower with combinations CHEMICAL	1
DISEASE of incidence underestimate illicit episodes attribute reported prescribed CHEMICAL	1
DISEASE of incidence examined after anaesthesia CHEMICAL	1
DISEASE of history with male medicate administered CHEMICAL	1
DISEASE of history with male DISEASE following administration CHEMICAL	1
DISEASE of forms in reduced production CHEMICAL	1
DISEASE of formation correlated with deposition GENE	1
DISEASE of form in patient with mutation of gene GENE	1
DISEASE of form DISEASE following cycle of chemotherapy -based CHEMICAL	1
DISEASE of features with presented revealed mutation VARIANT VARIANT	1
DISEASE of features with presented revealed mutation VARIANT	1
DISEASE of features with presented revealed found mutation VARIANT	1
DISEASE of features in women VARIANT men VARIANT	1
DISEASE of features in women VARIANT VARIANT	1
DISEASE of features in women VARIANT	1
DISEASE of features be because activating germline GENE	1
DISEASE of feature is catalyses conversion to CHEMICAL	1
DISEASE of face in considered is conclusions predicted confirmed conserved revealed substituting VARIANT	1
DISEASE of face in considered is conclusions predicted confirmed conserved revealed heterozygosis for mutation VARIANT VARIANT	1
DISEASE of face in considered is conclusions predicted confirmed conserved revealed heterozygosis for mutation VARIANT	1
DISEASE of face in considered is conclusions predicted confirmed conserved revealed expected showed resulted had change nucleotide VARIANT	1
DISEASE of face in considered is conclusions predicted be VARIANT	1
DISEASE of evidence DISEASE with patient in detected resulted identified mutations GENE	1
DISEASE of evidence DISEASE with patient in detected resulted identified is GENE	1
DISEASE of etiology in role play indicating identify identified in addition to polymorphisms including mutation VARIANT	1
DISEASE of effects characterized on expression of GENE	1
DISEASE of effects characterized axis GENE GENE	1
DISEASE of effects characterized axis GENE	1
DISEASE of diagnosis suspected uptake CHEMICAL	1
DISEASE of diagnosis in exon of gene GENE	1
DISEASE of cohort in VARIANT	1
DISEASE of characteristic features seen treated with CHEMICAL	1
DISEASE of cause was suggesting failed GENE	1
DISEASE of cause considered in addition to intake of CHEMICAL	1
DISEASE of cause considered be doses of CHEMICAL	1
DISEASE of case report characterized causes mutation VARIANT	1
DISEASE of case report after leading to discovery of variant VARIANT	1
DISEASE of case report after leading administration of CHEMICAL	1
DISEASE of case lack of GENE	1
DISEASE of case due bases VARIANT	1
DISEASE of case describe conclusion transfected predicts was revealed VARIANT VARIANT	1
DISEASE of attacks associated with decrease in level CHEMICAL	1
DISEASE of associations found improved supplementation with CHEMICAL CHEMICAL	1
DISEASE of associations found improved supplementation with CHEMICAL	1
DISEASE of association with transition VARIANT	1
DISEASE of association with polymorphism VARIANT	1
DISEASE of association p polymorphism VARIANT	1
DISEASE of aspects on highlights effect demonstrates conclusions was VARIANT	1
DISEASE of VARIANT	1
DISEASE of CHEMICAL	1
DISEASE of % % DISEASE in was varied vntr genotypes VARIANT	1
DISEASE of % % DISEASE in was defined were methods genotyping GENE	1
DISEASE occurs found mutations in GENE	1
DISEASE occurs found describe identified were homozygous for VARIANT	1
DISEASE occurs despite advantages with CHEMICAL	1
DISEASE occurs are mutations in GENE	1
DISEASE occurring during therapy GENE	1
DISEASE occurrence at associated genotype of polymorphism in gene GENE	1
DISEASE occurrence at associated genotype of polymorphism VARIANT	1
DISEASE occurred with concentration CHEMICAL	1
DISEASE occurred with CHEMICAL	1
DISEASE occurred infusion of CHEMICAL	1
DISEASE occur reduced methods triggers pathway -dependent GENE	1
DISEASE observed during therapy CHEMICAL	1
DISEASE observed decreased instituted has CHEMICAL	1
DISEASE observed attenuated -induced CHEMICAL	1
DISEASE observed achieved suggests administered CHEMICAL	1
DISEASE mutations segregating families identified account causes mutation VARIANT	1
DISEASE mutation of gene GENE	1
DISEASE mutation identified with VARIANT changed VARIANT	1
DISEASE mutation identified with VARIANT	1
DISEASE mutated harbored harbored fusion GENE GENE	1
DISEASE mutated harbored fusions GENE GENE	1
DISEASE mutated GENE GENE GENE GENE GENE GENE GENE	1
DISEASE mutated GENE GENE GENE GENE GENE GENE	1
DISEASE mutated GENE GENE GENE GENE GENE	1
DISEASE mutated GENE GENE GENE GENE	1
DISEASE mutated GENE GENE	1
DISEASE mutated GENE	1
DISEASE models using CHEMICAL	1
DISEASE models rat CHEMICAL	1
DISEASE missed objective was results had resulted showed expected revealed substituting resulting in change VARIANT	1
DISEASE missed objective was results had resulted showed expected revealed substituting VARIANT	1
DISEASE missed objective was results had resulted showed expected revealed heterozygosis for mutation VARIANT VARIANT	1
DISEASE missed objective was results had resulted showed expected revealed heterozygosis for mutation VARIANT	1
DISEASE missed objective was results had resulted showed expected revealed conserved confirmed predicted be VARIANT	1
DISEASE missed objective was results had resulted showed expected revealed conserved confirmed affect mutation VARIANT	1
DISEASE missed objective was results had change nucleotide VARIANT	1
DISEASE migration stimulated GENE were colocalized with GENE GENE	1
DISEASE migration stimulated GENE were colocalized with GENE	1
DISEASE migration stimulated GENE were colocalized coimmunoprecipitated with GENE	1
DISEASE migration stimulated GENE	1
DISEASE migration promoted enhancing migration on GENE	1
DISEASE migration promoted GENE	1
DISEASE migration enhances GENE	1
DISEASE mediate following CHEMICAL excess CHEMICAL	1
DISEASE mediate following CHEMICAL	1
DISEASE mb- showed demonstrated linkage deletion VARIANT	1
DISEASE mass levels accumulation CHEMICAL	1
DISEASE marker GENE	1
DISEASE manifested following consumption CHEMICAL	1
DISEASE manifestations of presence to contribution found was was or for allele VARIANT	1
DISEASE manifestations of presence to contribution found showed was confirm increase polymorphism VARIANT	1
DISEASE locus overlaps investigated GENE	1
DISEASE locus GENE	1
DISEASE linked to gene GENE	1
DISEASE linked to GENE	1
DISEASE lines with defects GENE	1
DISEASE line dx5 found GENE	1
DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE GENE	1
DISEASE like GENE GENE GENE GENE GENE genes GENE	1
DISEASE like GENE GENE GENE GENE GENE	1
DISEASE like GENE GENE GENE GENE	1
DISEASE like GENE GENE GENE	1
DISEASE like GENE GENE	1
DISEASE like GENE	1
DISEASE lead show reveals persists expression GENE	1
DISEASE lead show overexpression of protein GENE	1
DISEASE lacked showed activation GENE	1
DISEASE lacked mutations in GENE	1
DISEASE lacked identified alterations GENE	1
DISEASE knockdown ameliorated suppressor GENE	1
DISEASE kindred promoted CHEMICAL	1
DISEASE isolates were coincided was resistance to CHEMICAL CHEMICAL	1
DISEASE isolates were coincided was resistance to CHEMICAL	1
DISEASE isolates were coincided sensitivity to CHEMICAL	1
DISEASE is syndrome characterized by CHEMICAL	1
DISEASE is suffer despite benefit of avoidance of CHEMICAL	1
DISEASE is suffer described characterized causing VARIANT	1
DISEASE is result of mutations GENE	1
DISEASE is mutation osaka VARIANT	1
DISEASE is mutation GENE	1
DISEASE is led to recognition of mutations VARIANT VARIANT	1
DISEASE is led to recognition of mutations VARIANT	1
DISEASE is is found carry mutation in exon 17 of locus led to mutation VARIANT	1
DISEASE is involved gene GENE	1
DISEASE is introduction polymorphism VARIANT	1
DISEASE is identified suggested found harbor substitution VARIANT	1
DISEASE is identified suggested found had predicted contain domains including repeat GENE	1
DISEASE is identified suggested found had GENE	1
DISEASE is identified mutations GENE	1
DISEASE is identified included missense nonsense transition in VARIANT	1
DISEASE is identified included missense nonsense mutations VARIANT	1
DISEASE is identified included missense VARIANT	1
DISEASE is identified included identified located located VARIANT	1
DISEASE is identified included identified located VARIANT VARIANT	1
DISEASE is identified included identified located VARIANT	1
DISEASE is identified included identified demonstrated skipping failed incubated detected suggesting elicited VARIANT	1
DISEASE is identified included identified demonstrated skipping failed incubated detected confirmed elicited VARIANT	1
DISEASE is identified in GENE	1
DISEASE is identified GENE mutations VARIANT VARIANT	1
DISEASE is identified GENE mutations VARIANT	1
DISEASE is form in patient with mutation of gene GENE	1
DISEASE is expression GENE	1
DISEASE is detected mutations GENE	1
DISEASE is detected developed established designed used detected identified mutations including deletion mutation VARIANT	1
DISEASE is detected developed established designed used detected identified mutations including deletion VARIANT	1
DISEASE is detected developed established designed used detected identified established method for detecting snps VARIANT VARIANT VARIANT VARIANT	1
DISEASE is detected developed established designed used detected identified established method for detecting snps VARIANT	1
DISEASE is described examined analysed amplified detected identified reported mutation VARIANT mutation VARIANT	1
DISEASE is described examined analysed amplified detected identified reported mutation VARIANT	1
DISEASE is described examined analysed amplified detected identified reported carried polymorphism VARIANT	1
DISEASE is described examined analysed amplified detected identified mutations mutation deletion deletion mutation exon VARIANT	1
DISEASE is described examined analysed amplified detected identified mutations mutation deletion deletion VARIANT	1
DISEASE is described examined analysed amplified detected identified mutations mutation deletion VARIANT	1
DISEASE is described examined analysed amplified detected identified mutations mutation VARIANT	1
DISEASE is condition -related GENE	1
DISEASE is are mutations gene GENE	1
DISEASE is DISEASE leads to accumulation of CHEMICAL	1
DISEASE is DISEASE leads defect in system CHEMICAL	1
DISEASE is DISEASE characterized with CHEMICAL	1
DISEASE is DISEASE causes insensitivity to action CHEMICAL	1
DISEASE invasion promote GENE	1
DISEASE invasion associated with upregulation of GENE GENE	1
DISEASE invasion associated with upregulation of GENE	1
DISEASE invadopodia in present were colocalized with GENE GENE	1
DISEASE invadopodia in present were colocalized with GENE	1
DISEASE invadopodia in present were colocalized coimmunoprecipitated with GENE	1
DISEASE inpatients in VARIANT treated with CHEMICAL	1
DISEASE injury related to inhibition GENE	1
DISEASE initiated formed expressed identified results design used culture GENE	1
DISEASE initiated formed expressed identified produced generated GENE	1
DISEASE initiated formed expressed identified produced cells GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included deviated distribution of VARIANT	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included deviated distribution of GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE variants VARIANT VARIANT GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE variants VARIANT VARIANT	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE intron deletion GENE VARIANT	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE intron deletion GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE intron VARIANT GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE intron VARIANT	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE inhibitors VARIANT GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE inhibitors GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE VARIANT GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE GENE VARIANT	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE GENE	1
DISEASE influencing in implicated polymorphisms influenced consist defined are was included GENE	1
DISEASE influenced investigated trial genotyped were included VARIANT	1
DISEASE induces indicate suggest be via activation GENE	1
DISEASE induces counter in manner GENE	1
DISEASE induced used allowed demonstrate cause CHEMICAL CHEMICAL	1
DISEASE induced used allowed demonstrate cause CHEMICAL	1
DISEASE induced investigated contribute activation of GENE	1
DISEASE induced hypothesized prevent disrupting interrupt GENE	1
DISEASE induced demonstrated was downstream pathway involving GENE	1
DISEASE induced demonstrated was GENE GENE	1
DISEASE induced demonstrated was GENE	1
DISEASE induced by antagonist CHEMICAL	1
DISEASE induced by administration CHEMICAL	1
DISEASE induced by CHEMICAL depletion CHEMICAL	1
DISEASE induced by CHEMICAL CHEMICAL	1
DISEASE induced -induced CHEMICAL	1
DISEASE induce containing CHEMICAL CHEMICAL	1
DISEASE induce containing CHEMICAL	1
DISEASE induce administered treated with CHEMICAL	1
DISEASE individuals in observed observed for -cc VARIANT	1
DISEASE independent of snp VARIANT	1
DISEASE increased levels of GENE	1
DISEASE increased GENE content GENE	1
DISEASE increased GENE	1
DISEASE including prognosis penetrance onset of age by characterized associated VARIANT	1
DISEASE including model mouse of DISEASE model of DISEASE -induced CHEMICAL	1
DISEASE including model mouse of DISEASE -induced CHEMICAL	1
DISEASE including model CHEMICAL	1
DISEASE including demonstrated is investigated revealed expression of machinery including GENE	1
DISEASE including demonstrated is investigated revealed expression downregulated upregulated GENE GENE	1
DISEASE including demonstrated is investigated revealed expression downregulated upregulated GENE	1
DISEASE including demonstrated is investigated revealed expression downregulated GENE	1
DISEASE including demonstrated is investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE GENE	1
DISEASE including demonstrated is investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE	1
DISEASE including demonstrated is investigated revealed downregulation of GENE GENE GENE GENE	1
DISEASE including demonstrated is investigated revealed downregulation of GENE GENE	1
DISEASE including demonstrated is investigated revealed downregulation of GENE	1
DISEASE including demonstrated changes in VARIANT GENE	1
DISEASE including demonstrated changes in VARIANT	1
DISEASE included manifested investigated GENE	1
DISEASE included increase in in excretion of protein CHEMICAL CHEMICAL GENE	1
DISEASE included increase in in excretion of protein CHEMICAL CHEMICAL	1
DISEASE included increase in in excretion of protein CHEMICAL	1
DISEASE included decrease upregulation of GENE	1
DISEASE included decrease determined expression GENE	1
DISEASE in were found in patients VARIANT	1
DISEASE in were deletions containing GENE GENE genes GENE	1
DISEASE in were deletions containing GENE GENE	1
DISEASE in were deletions containing GENE	1
DISEASE in were amplification including genes GENE GENE	1
DISEASE in were amplification including genes GENE	1
DISEASE in were VARIANT	1
DISEASE in was varied vntr genotypes VARIANT	1
DISEASE in was defined were methods genotyping GENE	1
DISEASE in translocations of target is is GENE	1
DISEASE in test CHEMICAL	1
DISEASE in stress in overexpression GENE	1
DISEASE in signaling by regulating expression activation of pathways GENE	1
DISEASE in signaling GENE for role demonstrate revealed increased with GENE	1
DISEASE in roles suggesting reduced GENE GENE	1
DISEASE in roles suggesting reduced GENE	1
DISEASE in role of GENE	1
DISEASE in resulting mutations of identification studied is is transition designated VARIANT	1
DISEASE in resulting mutations of identification studied is is transition VARIANT	1
DISEASE in resulting CHEMICAL	1
DISEASE in result conclusion resulted revealed heterozygosity including mutation duplication of nucleotide VARIANT	1
DISEASE in result conclusion resulted revealed heterozygosity including mutation VARIANT	1
DISEASE in response host are suggest observed noted CHEMICAL subjects having VARIANT	1
DISEASE in response host are GENE	1
DISEASE in reported leads demonstrated revealing degradation CHEMICAL	1
DISEASE in reported conclusions associated mutation in GENE	1
DISEASE in patient during GENE	1
DISEASE in overexpression associated induces GENE	1
DISEASE in oncogene as act promote by modulating activity GENE	1
DISEASE in observed demonstrated by GENE	1
DISEASE in mutations of prevalence studied screened identified were patients carrying mutation VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT VARIANT VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations mutations VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations including mutation VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations VARIANT VARIANT	1
DISEASE in mutations of prevalence studied screened identified mutations VARIANT	1
DISEASE in mutations gene GENE	1
DISEASE in mutations deletion GENE	1
DISEASE in modifier variant mutation GENE	1
DISEASE in levels accompanied decreased CHEMICAL	1
DISEASE in kindred due mutation GENE	1
DISEASE in involvement assessing in prove indicate contains hybridizing with cdna GENE	1
DISEASE in involvement assessing in prove indicate contains are recognized shares GENE	1
DISEASE in involved suggests showed had VARIANT	1
DISEASE in identify performed identified genotyped ratio found with VARIANT	1
DISEASE in identify performed identified genotyped % sequenced associated found for VARIANT	1
DISEASE in identified mutations of GENE	1
DISEASE in identified evidence for GENE	1
DISEASE in had had mutation VARIANT	1
DISEASE in had found found change of VARIANT	1
DISEASE in gene of association leading to VARIANT VARIANT	1
DISEASE in gene GENE	1
DISEASE in found detected mutations GENE	1
DISEASE in family show mutation in gene GENE	1
DISEASE in enhanced by mediating signalling GENE GENE	1
DISEASE in enhanced by mediating signalling GENE	1
DISEASE in distribution /gg GENE	1
DISEASE in contraindicated treated used increased aggravated achieved with CHEMICAL CHEMICAL CHEMICAL	1
DISEASE in contraindicated treated used increased aggravated achieved with CHEMICAL CHEMICAL	1
DISEASE in contraindicated treated used increased aggravated achieved with CHEMICAL	1
DISEASE in contraindicated CHEMICAL CHEMICAL	1
DISEASE in contraindicated CHEMICAL	1
DISEASE in concentration of determinants are VARIANT near gene GENE	1
DISEASE in concentration of determinants are VARIANT	1
DISEASE in concentration GENE	1
DISEASE in chelated CHEMICAL	1
DISEASE in alterations were confirmed amplification GENE	1
DISEASE in alterations GENE GENE	1
DISEASE in alterations GENE	1
DISEASE in accumulation CHEMICAL	1
DISEASE in GENE of expression promote by modulating activity GENE	1
DISEASE in DISEASE -induced CHEMICAL	1
DISEASE in CHEMICAL	1
DISEASE improved after infusion dose of CHEMICAL	1
DISEASE improved after infusion CHEMICAL	1
DISEASE improve rats -infused CHEMICAL	1
DISEASE improve in rats -injected CHEMICAL	1
DISEASE improve attempt in receiving ratio CHEMICAL	1
DISEASE identify showed showed predicted residue VARIANT	1
DISEASE identify showed influenced binding of interactions between domain GENE	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations mutations mutations including at splicing sites VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations mutations mutations including VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations mutations including VARIANT VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations mutations including VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations mutations in exon VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations mutations VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations including VARIANT VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations including VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations in exon VARIANT VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations in exon VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations VARIANT VARIANT	1
DISEASE identified enrolled sequenced measured detected identified as novel mutations VARIANT	1
DISEASE hypoactivity in users CHEMICAL	1
DISEASE her recurred placed mg per day of CHEMICAL	1
DISEASE hearts in change revealed studies CHEMICAL	1
DISEASE have likely are have CHEMICAL	1
DISEASE harbored harbored fusion responded GENE	1
DISEASE harbored harbored fusion GENE GENE	1
DISEASE harbored harbored fusion GENE	1
DISEASE harbored fusions GENE GENE	1
DISEASE had who GENE GENE GENE	1
DISEASE had who GENE GENE	1
DISEASE had who GENE	1
DISEASE had suppressed CHEMICAL	1
DISEASE had revealed identified mutation in gene for GENE VARIANT VARIANT	1
DISEASE had revealed identified mutation in gene for GENE VARIANT	1
DISEASE had had plays GENE	1
DISEASE had administered CHEMICAL	1
DISEASE growth responses GENE	1
DISEASE growth regulate by modulating GENE	1
DISEASE growth mediates -dependent GENE	1
DISEASE growth is sought grew levels of GENE	1
DISEASE growth is sought grew levels GENE reduced phosphorylation GENE	1
DISEASE growth is sought grew levels GENE GENE	1
DISEASE growth is sought grew levels GENE	1
DISEASE growth inhibit play are GENE GENE	1
DISEASE growth inhibit by altering from GENE	1
DISEASE growth decreased accompanied levels GENE	1
DISEASE growth decreased accompanied by GENE GENE	1
DISEASE growth decreased accompanied by GENE	1
DISEASE glomeruli showed preceded reduced GENE GENE	1
DISEASE glomeruli showed preceded reduced GENE	1
DISEASE genes GENE GENE	1
DISEASE from isolate design used culture GENE	1
DISEASE frequency of VARIANT	1
DISEASE found attenuated located correlated p and associated polymorphisms in GENE VARIANT VARIANT	1
DISEASE found attenuated located VARIANT	1
DISEASE formation exhibited formed grew levels of GENE	1
DISEASE formation exhibited formed grew levels GENE reduced phosphorylation GENE	1
DISEASE formation exhibited formed grew levels GENE GENE	1
DISEASE formation exhibited formed grew levels GENE	1
DISEASE form DISEASE following cycle of chemotherapy -based CHEMICAL	1
DISEASE for vigilance examination after injections CHEMICAL	1
DISEASE for treatment is therapy with GENE CHEMICAL	1
DISEASE for treatment is therapy with GENE	1
DISEASE for treated patients in occurred appear therapy CHEMICAL	1
DISEASE for responsible be indicated described confirmed VARIANT upstream resulting in replacement of VARIANT	1
DISEASE for responsible be indicated described confirmed VARIANT upstream VARIANT	1
DISEASE for responsible be indicated described confirmed VARIANT encodes for VARIANT	1
DISEASE for responsible be indicated described confirmed VARIANT	1
DISEASE for relevant be effect of GENE	1
DISEASE for receiving course CHEMICAL	1
DISEASE for p<0.001 were resulted CHEMICAL	1
DISEASE for p<0.001 were compared with CHEMICAL	1
DISEASE for mutation is mutation indentified is was detected change VARIANT	1
DISEASE for mutation is mutation VARIANT	1
DISEASE for locus at is GENE	1
DISEASE for gene is GENE	1
DISEASE for factor be having VARIANT	1
DISEASE for driver is induces GENE	1
DISEASE for CHEMICAL CHEMICAL CHEMICAL	1
DISEASE for CHEMICAL CHEMICAL	1
DISEASE following increased GENE	1
DISEASE following examined GENE	1
DISEASE following describe received methods following induction by CHEMICAL	1
DISEASE following describe received methods CHEMICAL	1
DISEASE following cycle of chemotherapy -based CHEMICAL	1
DISEASE following administration CHEMICAL	1
DISEASE focus induced by injecting CHEMICAL	1
DISEASE fls mediated by pathways GENE GENE	1
DISEASE fls mediated by pathways GENE	1
DISEASE females form acts represents GENE	1
DISEASE females form acts gene GENE	1
DISEASE female was showed was heterozygote in GENE	1
DISEASE female was for VARIANT involving genes GENE	1
DISEASE female male GENE	1
DISEASE features elicited plaques showed levels mice kotg GENE	1
DISEASE features elicited plaques showed identified crossed generated GENE	1
DISEASE features elicited plaques showed had mice kotg GENE	1
DISEASE family in demonstrated linkage deletion VARIANT	1
DISEASE family bearing VARIANT	1
DISEASE express isoforms GENE	1
DISEASE exposure in resulting inhibited glucuronidation by GENE	1
DISEASE exposure CHEMICAL	1
DISEASE exhibited had showed received CHEMICAL CHEMICAL	1
DISEASE exhibited had showed received CHEMICAL	1
DISEASE exhibited found in reduced abundance index of node thymus GENE	1
DISEASE exhibited found in reduced abundance GENE GENE	1
DISEASE exhibited found in reduced abundance GENE	1
DISEASE exhibited accompanied by levels of CHEMICAL	1
DISEASE exhaustion DISEASE DISEASE due admitted initiated at dose of CHEMICAL	1
DISEASE exhaustion DISEASE DISEASE due admitted initiated CHEMICAL	1
DISEASE exacerbated are GENE	1
DISEASE evokes trough blockage of GENE	1
DISEASE evaluated selected induced with CHEMICAL	1
DISEASE evaluated elevated levels GENE	1
DISEASE enhances expression GENE	1
DISEASE during observed GENE GENE GENE GENE	1
DISEASE during observed GENE GENE GENE	1
DISEASE during observed GENE GENE	1
DISEASE during observed GENE	1
DISEASE due rate was were resulted CHEMICAL	1
DISEASE due rate was were compared with CHEMICAL	1
DISEASE due rate was lower with CHEMICAL	1
DISEASE due discontinuing for risk demonstrated CHEMICAL	1
DISEASE due deletion in protein GENE	1
DISEASE due admitted initiated at dose of CHEMICAL	1
DISEASE due admitted initiated CHEMICAL	1
DISEASE due CHEMICAL	1
DISEASE dl CHEMICAL	1
DISEASE disorientation DISEASE exhibited had showed received CHEMICAL CHEMICAL	1
DISEASE disorientation DISEASE exhibited had showed received CHEMICAL	1
DISEASE disorders with patients in CHEMICAL versus CHEMICAL	1
DISEASE disorders with patients in CHEMICAL	1
DISEASE disappeared received showed CHEMICAL CHEMICAL	1
DISEASE disappeared received showed CHEMICAL	1
DISEASE disappeared received CHEMICAL CHEMICAL	1
DISEASE disappeared received CHEMICAL	1
DISEASE disappeared normalized levels CHEMICAL	1
DISEASE development in are genotyped VARIANT variants VARIANT	1
DISEASE development in are deletion variant polymorphism VARIANT	1
DISEASE development in are deletion insertion VARIANT	1
DISEASE development for processes involve increase induction of GENE	1
DISEASE development for processes involve increase in synthesis CHEMICAL	1
DISEASE development for processes involve appreciated gained use of agents CHEMICAL	1
DISEASE developing of risk was were 1.998 for VARIANT	1
DISEASE developed women in found mutation substitution of VARIANT	1
DISEASE developed to therapy CHEMICAL	1
DISEASE developed remained used CHEMICAL	1
DISEASE developed remained levels CHEMICAL	1
DISEASE developed mg CHEMICAL	1
DISEASE developed injected material CHEMICAL	1
DISEASE developed after months of treatment CHEMICAL	1
DISEASE despite showed preceded reduced GENE GENE	1
DISEASE despite showed preceded reduced GENE	1
DISEASE demonstrated by decrease in ratio CHEMICAL CHEMICAL	1
DISEASE demonstrated by decrease in ratio CHEMICAL	1
DISEASE defined methods is found snp for VARIANT	1
DISEASE decreased increased levels GENE	1
DISEASE decreased expression served CHEMICAL	1
DISEASE decreased expression oxidation CHEMICAL	1
DISEASE decreased expression GENE	1
DISEASE database in identified performed were in none of controls VARIANT resulting in alanine within exon substitution VARIANT	1
DISEASE database in identified performed were in none of controls VARIANT VARIANT	1
DISEASE database in identified performed were in none of controls VARIANT	1
DISEASE crisis CHEMICAL	1
DISEASE correlation with polymorphisms GENE GENE	1
DISEASE corrected treatment with CHEMICAL	1
DISEASE controlling in effective is plays VARIANT	1
DISEASE contributed associated CHEMICAL	1
DISEASE considered been due CHEMICAL	1
DISEASE considered CHEMICAL	1
DISEASE component of pathway GENE	1
DISEASE complications of cases report indicated potentiate CHEMICAL	1
DISEASE complications of cases report indicated is is CHEMICAL	1
DISEASE complications of cases report indicated is CHEMICAL	1
DISEASE complications appear be result of interaction between CHEMICAL	1
DISEASE characterized describe was was presented was revealed had had VARIANT results in substitution of VARIANT	1
DISEASE characterized describe was was presented was revealed had had VARIANT	1
DISEASE characterized describe was was presented was revealed had VARIANT results in replacement of VARIANT	1
DISEASE characterized describe was was presented was revealed had VARIANT	1
DISEASE characterized causes prolonged DISEASE with CHEMICAL	1
DISEASE characterized causes mutation VARIANT	1
DISEASE characterized by function of GENE	1
DISEASE characterized by DISEASE after use of CHEMICAL CHEMICAL CHEMICAL	1
DISEASE changes occur increased reduced relaxations -mediated GENE	1
DISEASE cells with CHEMICAL	1
DISEASE cells release observed infected GENE animals GENE	1
DISEASE cells release observed infected GENE	1
DISEASE cells release GENE GENE	1
DISEASE cells proximal express GENE GENE	1
DISEASE cells proximal express GENE	1
DISEASE cells produced generated expressed GENE	1
DISEASE cells produced GENE GENE GENE	1
DISEASE cells produced GENE GENE	1
DISEASE cells produced GENE	1
DISEASE cells of decisions in GENE	1
DISEASE cells leukocytes showed in exon predicts VARIANT	1
DISEASE cells leukocytes showed VARIANT	1
DISEASE cells import resulting in upregulation of GENE signaling via CHEMICAL	1
DISEASE cells import express GENE GENE	1
DISEASE cells import express GENE	1
DISEASE cells import established GENE	1
DISEASE cells associated observed reduction in signaling GENE	1
DISEASE causing mutations be appear VARIANT	1
DISEASE causes mutation GENE	1
DISEASE causes is condition characterized by insensitivity to CHEMICAL	1
DISEASE causes activity CHEMICAL	1
DISEASE caused is GENE	1
DISEASE caused intake CHEMICAL	1
DISEASE caused in heart determined by activity of GENE	1
DISEASE caused in heart determined by activity GENE	1
DISEASE caused have CHEMICAL	1
DISEASE caused encoding tract CHEMICAL	1
DISEASE caused during use of therapy with CHEMICAL	1
DISEASE caused days for rats to injection increased capacity CHEMICAL	1
DISEASE caused days for rats to injection increased CHEMICAL	1
DISEASE caused by ventilation of peptide -activating GENE	1
DISEASE caused by mutations in GENE	1
DISEASE caused by mutation VARIANT	1
DISEASE caused by lack of production CHEMICAL	1
DISEASE caused by injection of CHEMICAL CHEMICAL	1
DISEASE caused by injection of CHEMICAL	1
DISEASE caused GENE	1
DISEASE cause mutations of GENE	1
DISEASE cause mutations in gene GENE	1
DISEASE cause mutations in GENE	1
DISEASE cause known are CHEMICAL	1
DISEASE cause identified mutations in GENE	1
DISEASE cause background involved GENE	1
DISEASE cause at locus GENE	1
DISEASE cases for variants promoter GENE	1
DISEASE c had showed CHEMICAL CHEMICAL	1
DISEASE c had showed CHEMICAL	1
DISEASE by inhibited in manner -dependent CHEMICAL	1
DISEASE by characterised maintain gradient CHEMICAL	1
DISEASE by caused during use of therapy with CHEMICAL	1
DISEASE breakpoint defined to GENE	1
DISEASE breakpoint defined investigated GENE	1
DISEASE brain with associated normalized after 3 of therapy with CHEMICAL	1
DISEASE brain expression of GENE CHEMICAL	1
DISEASE body in GENE	1
DISEASE biomarkers GENE GENE GENE GENE GENE ratio GENE	1
DISEASE biomarkers GENE GENE GENE GENE	1
DISEASE biomarkers GENE GENE GENE	1
DISEASE biomarkers GENE GENE	1
DISEASE biomarkers GENE	1
DISEASE behaviour DISEASE with phenotype is reported was VARIANT	1
DISEASE behaviour DISEASE with phenotype is reported mutation VARIANT	1
DISEASE be via activation GENE	1
DISEASE be conclusions found presented identified germline transition VARIANT	1
DISEASE background is is GENE	1
DISEASE background 2 GENE	1
DISEASE attenuated via regulation of GENE	1
DISEASE attenuated mice CHEMICAL	1
DISEASE attenuated in GENE	1
DISEASE associated with treatment with CHEMICAL	1
DISEASE associated with treatment CHEMICAL	1
DISEASE associated with transition VARIANT	1
DISEASE associated with mutations in GENE	1
DISEASE associated with imbalance -redox CHEMICAL	1
DISEASE associated with dysfunction in neurotransmission CHEMICAL	1
DISEASE associated with downregulation of GENE upregulation of levels GENE	1
DISEASE associated with downregulation of GENE	1
DISEASE associated with brain expression of GENE	1
DISEASE associated objective manifests mutation GENE	1
DISEASE as DISEASE of characteristic features seen treated with CHEMICAL	1
DISEASE arises transmitted found report were produced were for changing VARIANT	1
DISEASE areas content GENE	1
DISEASE are reasoned related anomalies of genes GENE	1
DISEASE are mutations gene GENE	1
DISEASE are identified was supported activity of GENE	1
DISEASE are identified encoding substitution VARIANT	1
DISEASE are genes including GENE GENE	1
DISEASE are drive report in described emerged GENE GENE GENE	1
DISEASE are drive report in described emerged GENE GENE	1
DISEASE are drive report in described emerged GENE	1
DISEASE are drive report in described GENE GENE GENE GENE GENE GENE GENE	1
DISEASE are drive report in described GENE GENE GENE GENE GENE GENE	1
DISEASE are drive report in described GENE GENE GENE GENE GENE	1
DISEASE are drive report in described GENE GENE GENE GENE	1
DISEASE are drive report in described GENE GENE GENE	1
DISEASE are drive report in described GENE GENE	1
DISEASE are drive report in described GENE	1
DISEASE are affect GENE	1
DISEASE are DISEASE associated with GENE	1
DISEASE appeared was decreased decreased GENE GENE	1
DISEASE appeared was decreased decreased GENE	1
DISEASE appeared was decreased GENE	1
DISEASE apoptosis through signaling GENE	1
DISEASE apoptosis peroxidation hepatic CHEMICAL	1
DISEASE apoptosis peroxidation demonstrated by asafr CHEMICAL CHEMICAL	1
DISEASE apoptosis peroxidation demonstrated by asafr CHEMICAL	1
DISEASE apoptosis decreased GENE GENE	1
DISEASE apoptosis decreased GENE	1
DISEASE among smokers of CHEMICAL	1
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE among showed mutations of gene including GENE GENE GENE GENE GENE	1
DISEASE among showed mutations of gene including GENE GENE GENE GENE	1
DISEASE among showed mutated identified mutations GENE GENE	1
DISEASE among showed mutated identified mutations GENE	1
DISEASE among showed mutated GENE	1
DISEASE among patients using CHEMICAL	1
DISEASE alleviated reversed activations of GENE GENE GENE	1
DISEASE alleviated reversed activations of GENE GENE	1
DISEASE alleviated reversed activations of GENE	1
DISEASE alleles associated with expression GENE	1
DISEASE alleles associated demonstrated catalyzes GENE	1
DISEASE aim affected by CHEMICAL	1
DISEASE aggravated without with changes in GENE GENE clearance CHEMICAL	1
DISEASE aggravated without with changes in GENE GENE	1
DISEASE aggravate CHEMICAL	1
DISEASE after use of CHEMICAL CHEMICAL CHEMICAL	1
DISEASE after observed GENE	1
DISEASE after examined GENE	1
DISEASE after administration CHEMICAL	1
DISEASE after CHEMICAL	1
DISEASE activity GENE	1
DISEASE activation measured used measure level CHEMICAL	1
DISEASE activation measured used GENE	1
DISEASE activates GENE	1
DISEASE accepted known GENE	1
DISEASE accepted depends via suppression of GENE GENE	1
DISEASE abnormalities of gene DISEASE GENE	1
DISEASE VARIANT accounted VARIANT VARIANT	1
DISEASE VARIANT accounted VARIANT	1
DISEASE VARIANT VARIANT	1
DISEASE GENE genes of expression in increase observed GENE GENE GENE GENE	1
DISEASE GENE genes of expression in increase observed GENE GENE GENE	1
DISEASE GENE genes of expression in increase observed GENE GENE	1
DISEASE GENE genes of expression in increase observed GENE	1
DISEASE GENE at variation remains impact of therapy CHEMICAL	1
DISEASE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE GENE GENE GENE GENE GENE	1
DISEASE GENE GENE GENE GENE	1
DISEASE GENE GENE GENE	1
DISEASE DISEASE with women methods included given CHEMICAL	1
DISEASE DISEASE with subjects matched treated with CHEMICAL CHEMICAL CHEMICAL	1
DISEASE DISEASE with subjects matched treated with CHEMICAL CHEMICAL	1
DISEASE DISEASE with subjects matched treated with CHEMICAL	1
DISEASE DISEASE with report mapped described found revealed deletion VARIANT	1
DISEASE DISEASE with identified novo of studies report disruption of GENE	1
DISEASE DISEASE with diagnosed performed identified results variants VARIANT VARIANT	1
DISEASE DISEASE with diagnosed performed identified results variants VARIANT	1
DISEASE DISEASE with diagnosed performed identified VARIANT	1
DISEASE DISEASE with developed mg CHEMICAL	1
DISEASE DISEASE with developed after doses of CHEMICAL	1
DISEASE DISEASE with consistent stabilizes activates GENE	1
DISEASE DISEASE with concentrations CHEMICAL	1
DISEASE DISEASE with children identified performed were in none of controls VARIANT resulting in alanine within exon substitution VARIANT	1
DISEASE DISEASE with children identified performed were in none of controls VARIANT VARIANT	1
DISEASE DISEASE with children identified performed were in none of controls VARIANT	1
DISEASE DISEASE with child in expression of GENE	1
DISEASE DISEASE was in associated polymorphism GENE	1
DISEASE DISEASE to subjects predispose enhances VARIANT GENE	1
DISEASE DISEASE to prone are objectives investigate test methods isolated corresponding to VARIANT	1
DISEASE DISEASE to contributing involved GENE	1
DISEASE DISEASE tested users CHEMICAL	1
DISEASE DISEASE resulting from mutations of GENE	1
DISEASE DISEASE result from aberrations of GENE	1
DISEASE DISEASE of onset with DISEASE of form as manifests objective associated investigated methods improved results identified was revealed found had suggest contribute dysfunction channel VARIANT	1
DISEASE DISEASE of onset with DISEASE of form as manifests mutation GENE	1
DISEASE DISEASE mutation VARIANT	1
DISEASE DISEASE incidence induced associated CHEMICAL	1
DISEASE DISEASE incidence induced CHEMICAL	1
DISEASE DISEASE in role plays is GENE	1
DISEASE DISEASE in result conclusion resulted revealed heterozygosity including mutation duplication of nucleotide VARIANT	1
DISEASE DISEASE in result conclusion resulted revealed heterozygosity including mutation VARIANT	1
DISEASE DISEASE had suppressed CHEMICAL	1
DISEASE DISEASE had results had gene GENE	1
DISEASE DISEASE had had plays GENE	1
DISEASE DISEASE from CHEMICAL CHEMICAL	1
DISEASE DISEASE from CHEMICAL	1
DISEASE DISEASE exhibited accompanied by levels of CHEMICAL	1
DISEASE DISEASE due admitted initiated at dose of CHEMICAL	1
DISEASE DISEASE due admitted initiated CHEMICAL	1
DISEASE DISEASE drive renew required GENE	1
DISEASE DISEASE cause identified mutations in GENE	1
DISEASE DISEASE associated with mutations in exon 49 of GENE	1
DISEASE DISEASE as DISEASE of characteristic features seen treated with CHEMICAL	1
DISEASE DISEASE alleviated reversed activations of GENE GENE GENE	1
DISEASE DISEASE alleviated reversed activations of GENE GENE	1
DISEASE DISEASE alleviated reversed activations of GENE	1
DISEASE DISEASE aggravate CHEMICAL	1
DISEASE DISEASE after administration CHEMICAL	1
DISEASE DISEASE activity GENE	1
DISEASE DISEASE DISEASE show litters yield mice knockout GENE	1
DISEASE DISEASE DISEASE cause identified mutations in GENE	1
DISEASE DISEASE DISEASE against protection confers GENE	1
DISEASE DISEASE DISEASE activity GENE	1
DISEASE DISEASE CHEMICAL	1
DISEASE DISEASE , identified identified are subunits GENE	1
DISEASE CHEMICAL reversed suggesting involved CHEMICAL	1
DISEASE -suppressor proteins GENE	1
DISEASE -responsive element of region GENE	1
DISEASE -related impact have by modulating formation of metabolites CHEMICAL	1
DISEASE -related genes were factors in cells GENE	1
DISEASE -related genes were factors GENE GENE	1
DISEASE -related gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
DISEASE -related events with CHEMICAL CHEMICAL	1
DISEASE -related GENE	1
DISEASE -related -related incidence were resulted CHEMICAL	1
DISEASE -related -related incidence were compared with CHEMICAL	1
DISEASE -induced response to GENE	1
DISEASE -induced regulation of GENE	1
DISEASE -induced documented induction of CHEMICAL	1
DISEASE -induced changes signaling via GENE	1
DISEASE -induced be treated mice null GENE	1
DISEASE -induced be treated mice ko GENE	1
DISEASE -induced attenuates through activating signalling GENE	1
DISEASE -induced associated hypothesized targeted by generation as CHEMICAL CHEMICAL	1
DISEASE -induced associated hypothesized targeted by generation as CHEMICAL	1
DISEASE -induced are GENE	1
DISEASE -induced account like CHEMICAL	1
DISEASE -induced GENE	1
DISEASE -induced DISEASE due CHEMICAL	1
DISEASE -induced CHEMICAL with patients to administered CHEMICAL	1
DISEASE -induced CHEMICAL to related suggests administered CHEMICAL	1
DISEASE -induced CHEMICAL CHEMICAL	1
DISEASE -bearing in antibody GENE	1
DISEASE -associated variant at locus GENE	1
DISEASE -associated is improved by agonists CHEMICAL	1
DISEASE -associated genes as identified GENE GENE	1
DISEASE -associated genes as identified GENE	1
DISEASE -associated CHEMICAL potentiate CHEMICAL	1
DISEASE -associated CHEMICAL	1
CHEMICAL withdrawal of consequence CHEMICAL	1
CHEMICAL with were were is rate -induced DISEASE	1
CHEMICAL with treatment to related DISEASE	1
CHEMICAL with treatment shown is methods infused CHEMICAL	1
CHEMICAL with treatment shown increase doses of CHEMICAL	1
CHEMICAL with treatment shown alleviate DISEASE -induced CHEMICAL	1
CHEMICAL with treatment shown -induced treatment of CHEMICAL	1
CHEMICAL with treatment of DISEASE	1
CHEMICAL with treatment induced raised levels GENE	1
CHEMICAL with treatment induced DISEASE	1
CHEMICAL with treatment has by suppression of responses DISEASE	1
CHEMICAL with treatment chronic reduces DISEASE suppresses responses DISEASE	1
CHEMICAL with treatment be suggest plays -induced DISEASE	1
CHEMICAL with treatment attenuated showed remains indicating DISEASE	1
CHEMICAL with treatment attenuated induced activation death DISEASE	1
CHEMICAL with treatment after suffered man CHEMICAL CHEMICAL	1
CHEMICAL with treating typing prevented DISEASE DISEASE	1
CHEMICAL with treating typing prevented DISEASE	1
CHEMICAL with treated remains increasing incidence of DISEASE	1
CHEMICAL with treated patients in occurred appear therapy CHEMICAL	1
CHEMICAL with treated patients for correlated were were contained dna corresponding to deletions mutations VARIANT	1
CHEMICAL with treated patients for correlated conclusion has value for status DISEASE	1
CHEMICAL with treated patients for correlated conclusion has result GENE	1
CHEMICAL with treated patient in DISEASE	1
CHEMICAL with treated patient DISEASE	1
CHEMICAL with treated designed -induced CHEMICAL	1
CHEMICAL with treated cells DISEASE	1
CHEMICAL with treated VARIANT without DISEASE	1
CHEMICAL with therapy used included was DISEASE	1
CHEMICAL with therapy used included grade DISEASE DISEASE	1
CHEMICAL with therapy used included grade DISEASE	1
CHEMICAL with therapy started corrected DISEASE	1
CHEMICAL with therapy is standard for patients DISEASE	1
CHEMICAL with therapy in patient with DISEASE	1
CHEMICAL with therapy in DISEASE	1
CHEMICAL with than occurred DISEASE	1
CHEMICAL with suppressed increased maintained displayed mice GENE	1
CHEMICAL with suppressed increased maintained cells -overexpressing GENE	1
CHEMICAL with suppressed increased in cells b GENE	1
CHEMICAL with risk shown risk of DISEASE DISEASE DISEASE DISEASE	1
CHEMICAL with risk shown risk of DISEASE DISEASE DISEASE	1
CHEMICAL with risk shown risk of DISEASE DISEASE	1
CHEMICAL with risk shown risk of DISEASE	1
CHEMICAL with risk offset aimed ns- CHEMICAL CHEMICAL	1
CHEMICAL with received man with DISEASE	1
CHEMICAL with published events DISEASE	1
CHEMICAL with pretreatment prevented led CHEMICAL	1
CHEMICAL with pretreatment decreased to DISEASE	1
CHEMICAL with pretreatment decreased incidence DISEASE	1
CHEMICAL with observed increased mediators DISEASE	1
CHEMICAL with maintained work revealed levels CHEMICAL	1
CHEMICAL with maintained CHEMICAL	1
CHEMICAL with loaded cells had concentration CHEMICAL	1
CHEMICAL with less were is rate -induced DISEASE	1
CHEMICAL with interact agents CHEMICAL cause DISEASE	1
CHEMICAL with injected hypothesize -induced DISEASE	1
CHEMICAL with individuals DISEASE	1
CHEMICAL with increased treatment with associated % DISEASE	1
CHEMICAL with increased from to reversal of DISEASE	1
CHEMICAL with hazard of developing DISEASE	1
CHEMICAL with from discharge reduce CHEMICAL	1
CHEMICAL with exposure CHEMICAL	1
CHEMICAL with characterized DISEASE is resulting in DISEASE	1
CHEMICAL with challenged together showed peroxidation CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL with challenged together showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL with challenged together showed peroxidation CHEMICAL CHEMICAL	1
CHEMICAL with blockade caused fall in rats DISEASE CHEMICAL	1
CHEMICAL with blockade caused fall in rats DISEASE	1
CHEMICAL with associated polymorphism in GENE	1
CHEMICAL with administration reversed uptake CHEMICAL	1
CHEMICAL with DISEASE of treatment initiating associated in comparison to CHEMICAL	1
CHEMICAL with CHEMICAL CHEMICAL	1
CHEMICAL with CHEMICAL	1
CHEMICAL were doses calculated cause reversal of DISEASE	1
CHEMICAL were conclusion was DISEASE	1
CHEMICAL were conclusion seemed carry risk for DISEASE	1
CHEMICAL was were capable of preventing DISEASE -induced CHEMICAL	1
CHEMICAL was treatment for patients DISEASE	1
CHEMICAL was observed were was DISEASE	1
CHEMICAL was investigated tested DISEASE DISEASE	1
CHEMICAL was considered is be CHEMICAL have DISEASE	1
CHEMICAL was considered cause of DISEASE	1
CHEMICAL was DISEASE	1
CHEMICAL was -induced DISEASE	1
CHEMICAL wall DISEASE	1
CHEMICAL vs interval for /gi DISEASE	1
CHEMICAL vs CHEMICAL	1
CHEMICAL via metabolism enhanced by catabolism CHEMICAL	1
CHEMICAL using test CHEMICAL	1
CHEMICAL users showed showed is given record of levels of DISEASE DISEASE DISEASE	1
CHEMICAL users showed showed is given record of levels DISEASE	1
CHEMICAL users performed neuroimage DISEASE DISEASE	1
CHEMICAL users performed analysis left DISEASE	1
CHEMICAL users be exhibit DISEASE	1
CHEMICAL used was demonstrated induced DISEASE	1
CHEMICAL used used treat DISEASE DISEASE	1
CHEMICAL used used treat DISEASE	1
CHEMICAL used used production of CHEMICAL	1
CHEMICAL used treat DISEASE	1
CHEMICAL used remained developed reported DISEASE	1
CHEMICAL used inhibitor of GENE	1
CHEMICAL used include result methods showed increase of exposure CHEMICAL	1
CHEMICAL used include DISEASE attributed to DISEASE	1
CHEMICAL used -induced DISEASE	1
CHEMICAL use were related DISEASE DISEASE	1
CHEMICAL use were related DISEASE	1
CHEMICAL use were causes of DISEASE	1
CHEMICAL use observed lead to DISEASE	1
CHEMICAL use in patients with DISEASE	1
CHEMICAL use DISEASE	1
CHEMICAL usage DISEASE	1
CHEMICAL uptake -stimulated increased GENE	1
CHEMICAL upregulates CHEMICAL of combination GENE genes GENE	1
CHEMICAL upregulated were factors in cells GENE	1
CHEMICAL upregulated were factors GENE GENE	1
CHEMICAL upregulated het-1a GENE	1
CHEMICAL upregulated downregulated het-1a GENE GENE	1
CHEMICAL undergoes glucuronidation inhibited glucuronidation of CHEMICAL	1
CHEMICAL undergoes glucuronidation by GENE	1
CHEMICAL triggers received transgenic tg GENE	1
CHEMICAL triggers pathway -dependent GENE	1
CHEMICAL triggers assessed ntg untreated GENE	1
CHEMICAL treatments induced reduced in DISEASE	1
CHEMICAL treatments induced expression GENE	1
CHEMICAL treatment with associated DISEASE occurred appear therapy CHEMICAL	1
CHEMICAL treatment with DISEASE	1
CHEMICAL treatment suppressed revealed DISEASE	1
CHEMICAL treatment suppressed -induced suggest plays -induced DISEASE	1
CHEMICAL treatment showed expression of markers GENE GENE	1
CHEMICAL treatment showed expression of markers GENE	1
CHEMICAL treatment resulted in DISEASE	1
CHEMICAL treatment resulted 15/44 of mice leading with DISEASE DISEASE	1
CHEMICAL treatment resulted 15/44 of mice leading with DISEASE	1
CHEMICAL treatment resulted 15/44 DISEASE	1
CHEMICAL treatment reduced diminished activities of i GENE	1
CHEMICAL treatment reduced consumption CHEMICAL	1
CHEMICAL treatment prevents DISEASE	1
CHEMICAL treatment presented DISEASE GENE GENE GENE GENE GENE GENE GENE	1
CHEMICAL treatment presented DISEASE GENE GENE GENE GENE GENE GENE	1
CHEMICAL treatment presented DISEASE GENE GENE GENE GENE GENE	1
CHEMICAL treatment presented DISEASE GENE GENE GENE GENE	1
CHEMICAL treatment presented DISEASE GENE GENE GENE	1
CHEMICAL treatment presented DISEASE GENE GENE	1
CHEMICAL treatment presented DISEASE GENE	1
CHEMICAL treatment on DISEASE	1
CHEMICAL treatment narrowed revealed initiated presented presumed DISEASE	1
CHEMICAL treatment mitigated CHEMICAL	1
CHEMICAL treatment knockdown after found decreased demonstrated by secretion expression of GENE GENE GENE	1
CHEMICAL treatment knockdown after found decreased demonstrated by secretion expression of GENE GENE	1
CHEMICAL treatment knockdown after found decreased demonstrated by secretion expression of GENE	1
CHEMICAL treatment is effective in controlling DISEASE DISEASE DISEASE DISEASE	1
CHEMICAL treatment is effective in controlling DISEASE DISEASE	1
CHEMICAL treatment inhibitor GENE	1
CHEMICAL treatment induced decreased excretion CHEMICAL	1
CHEMICAL treatment induced decreased DISEASE	1
CHEMICAL treatment increases formation DISEASE	1
CHEMICAL treatment increased reduced level of GENE	1
CHEMICAL treatment increased levels of mrna GENE	1
CHEMICAL treatment increased failed suppress GENE	1
CHEMICAL treatment increased expression of GENE GENE	1
CHEMICAL treatment improved rate DISEASE	1
CHEMICAL treatment had rescued altered suggested mediated provide basis for therapy DISEASE	1
CHEMICAL treatment following change affect -silencing GENE	1
CHEMICAL treatment exposed produced comparable DISEASE	1
CHEMICAL treatment decreases release of cytokines DISEASE	1
CHEMICAL treatment decreased CHEMICAL CHEMICAL	1
CHEMICAL treatment decreased CHEMICAL	1
CHEMICAL treatment by reduced abundance of GENE	1
CHEMICAL treatment attenuated showed remains indicating DISEASE	1
CHEMICAL treatment attenuated induced activation death DISEASE	1
CHEMICAL treatment attenuated DISEASE	1
CHEMICAL treatment CHEMICAL after recovered discontinued developed with DISEASE DISEASE	1
CHEMICAL treatment CHEMICAL after recovered discontinued developed with DISEASE	1
CHEMICAL treatment CHEMICAL after recovered discontinued developed DISEASE	1
CHEMICAL treatment CHEMICAL	1
CHEMICAL treated excised DISEASE	1
CHEMICAL transporters play be known function polymorphism GENE	1
CHEMICAL transported by transporter GENE	1
CHEMICAL total included was DISEASE	1
CHEMICAL took had DISEASE	1
CHEMICAL to susceptibility increases -induced DISEASE	1
CHEMICAL to sensitivity increasing be suggest is GENE	1
CHEMICAL to sensitivity coincided with appearance of VARIANT	1
CHEMICAL to risks DISEASE in DISEASE	1
CHEMICAL to responses in dogs increase in circulating CHEMICAL	1
CHEMICAL to responses blocked had reduced increments in CHEMICAL	1
CHEMICAL to responses blocked had effect on mobilization CHEMICAL	1
CHEMICAL to responses GENE	1
CHEMICAL to resistance was due to substitution VARIANT	1
CHEMICAL to related were causes of DISEASE	1
CHEMICAL to related DISEASE DISEASE	1
CHEMICAL to related DISEASE	1
CHEMICAL to related CHEMICAL	1
CHEMICAL to protocols used DISEASE	1
CHEMICAL to incubation upregulated GENE GENE	1
CHEMICAL to incubation upregulated GENE	1
CHEMICAL to exposure upregulated proteins marker GENE	1
CHEMICAL to exposure upregulated proteins marker DISEASE	1
CHEMICAL to exposure increased results determined activity volume -exposure CHEMICAL	1
CHEMICAL to exposure increased activity CHEMICAL	1
CHEMICAL to exposure decreased increased DISEASE	1
CHEMICAL to exposed produced comparable DISEASE	1
CHEMICAL to exposed designed -induced DISEASE	1
CHEMICAL to conversion catalyses reported genes DISEASE	1
CHEMICAL to conversion after DISEASE	1
CHEMICAL to contraction reduced elevated after CHEMICAL	1
CHEMICAL to concentrations of CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL to concentrations of CHEMICAL CHEMICAL	1
CHEMICAL to concentrations of CHEMICAL	1
CHEMICAL to attributable effects included was DISEASE	1
CHEMICAL to attributable effects included grade DISEASE DISEASE	1
CHEMICAL to attributable effects included grade DISEASE	1
CHEMICAL to attenuated CHEMICAL	1
CHEMICAL to addition in received CHEMICAL	1
CHEMICAL to activated expression GENE	1
CHEMICAL time- inhibited GENE	1
CHEMICAL thought cause contribute to pathogenesis of DISEASE	1
CHEMICAL therapy with associated DISEASE	1
CHEMICAL therapy with DISEASE	1
CHEMICAL therapy with CHEMICAL	1
CHEMICAL therapy to responding man with DISEASE	1
CHEMICAL therapy to responding man due DISEASE	1
CHEMICAL therapy to developed reported DISEASE	1
CHEMICAL therapy reduce risk of DISEASE	1
CHEMICAL therapy of effects GENE GENE	1
CHEMICAL therapy of effects GENE	1
CHEMICAL therapy of comparison attain is therapies DISEASE	1
CHEMICAL therapy inhibitor GENE	1
CHEMICAL therapy in DISEASE	1
CHEMICAL the -dependent CHEMICAL CHEMICAL cotransport CHEMICAL	1
CHEMICAL than combination for greater was DISEASE	1
CHEMICAL test treated with CHEMICAL	1
CHEMICAL test of result was was had DISEASE	1
CHEMICAL test of result was compatible with DISEASE	1
CHEMICAL temperature affect -elicited DISEASE	1
CHEMICAL taking treat DISEASE	1
CHEMICAL taking because DISEASE	1
CHEMICAL synthesized attenuates shows effects in in models DISEASE	1
CHEMICAL synthesis is important in development of DISEASE	1
CHEMICAL synthesis in result disrupt attenuates DISEASE	1
CHEMICAL suppressed increase -induced DISEASE	1
CHEMICAL suppressed had presented with DISEASE associated with DISEASE DISEASE	1
CHEMICAL suppressed had presented with DISEASE	1
CHEMICAL suppressed growth DISEASE	1
CHEMICAL suppressed effects by activating GENE targets GENE	1
CHEMICAL suppressed DISEASE signaling by inhibiting pathway of GENE	1
CHEMICAL suppressed DISEASE	1
CHEMICAL suppressed -induced CHEMICAL	1
CHEMICAL suppress GENE	1
CHEMICAL supply of mismatch following DISEASE DISEASE	1
CHEMICAL supply of mismatch following DISEASE	1
CHEMICAL suggesting be treatment for DISEASE CHEMICAL	1
CHEMICAL suggesting be treatment for DISEASE	1
CHEMICAL substitutions detected of patients with DISEASE	1
CHEMICAL substitutions detected found pattern mutation VARIANT	1
CHEMICAL substitutions detected found associated VARIANT rt patients with pattern substitution GENE	1
CHEMICAL substitutions VARIANT VARIANT	1
CHEMICAL substitutions VARIANT	1
CHEMICAL subjects having VARIANT	1
CHEMICAL studied patients with DISEASE	1
CHEMICAL stress DISEASE	1
CHEMICAL stimulates features to exposure of cells DISEASE	1
CHEMICAL stimulates expression GENE	1
CHEMICAL stimulates after DISEASE	1
CHEMICAL stimulated were factors in cells GENE	1
CHEMICAL stimulated were factors GENE GENE	1
CHEMICAL stimulated measured CHEMICAL	1
CHEMICAL stimulated expression including GENE GENE	1
CHEMICAL stimulated expression including GENE	1
CHEMICAL started for DISEASE	1
CHEMICAL site of protein GENE	1
CHEMICAL signalling in DISEASE	1
CHEMICAL signaling through GENE	1
CHEMICAL shown properties DISEASE	1
CHEMICAL shown is DISEASE	1
CHEMICAL shown DISEASE	1
CHEMICAL showed showed revealed sequencing of gene GENE	1
CHEMICAL showed served DISEASE CHEMICAL	1
CHEMICAL showed identified report mutation VARIANT	1
CHEMICAL showed caused CHEMICAL	1
CHEMICAL showed -induced through scavenging properties CHEMICAL	1
CHEMICAL showed -induced DISEASE	1
CHEMICAL severe -resistant DISEASE	1
CHEMICAL serum assess inhibition CHEMICAL	1
CHEMICAL sensitivity in variations associated with manifestations of excess CHEMICAL	1
CHEMICAL sensitivity compromises represent cause of DISEASE	1
CHEMICAL seemed was conclusion seemed carry risk for DISEASE	1
CHEMICAL seemed was DISEASE	1
CHEMICAL seemed conclusion was DISEASE	1
CHEMICAL seemed carry risk for DISEASE	1
CHEMICAL scavenger of CHEMICAL	1
CHEMICAL scavenger CHEMICAL	1
CHEMICAL role of groups in DISEASE	1
CHEMICAL reverses -induced DISEASE	1
CHEMICAL reversed observed was was level CHEMICAL	1
CHEMICAL reversed observed immunoreactivity to GENE GENE GENE	1
CHEMICAL reversed observed immunoreactivity to GENE GENE	1
CHEMICAL reversed observed immunoreactivity to GENE	1
CHEMICAL reversed DISEASE induced by CHEMICAL depletion CHEMICAL	1
CHEMICAL reversed DISEASE induced by CHEMICAL	1
CHEMICAL reversed CHEMICAL	1
CHEMICAL retention by accompanied DISEASE	1
CHEMICAL retention associated with DISEASE	1
CHEMICAL results measured by levels precedes onset of DISEASE DISEASE	1
CHEMICAL results measured by levels precedes onset of DISEASE	1
CHEMICAL results measured by levels precedes GENE	1
CHEMICAL results indicate decreased elevated levels GENE	1
CHEMICAL resulting in DISEASE DISEASE	1
CHEMICAL restrained regulated suggested be therapy for DISEASE	1
CHEMICAL restrained phosphorylation of GENE GENE	1
CHEMICAL restrained phosphorylation of GENE	1
CHEMICAL restrained decreased reduced proliferation of flss DISEASE	1
CHEMICAL restrained decreased reduced production GENE GENE	1
CHEMICAL restrained decreased reduced production GENE	1
CHEMICAL restrained decreased in migration of flss DISEASE	1
CHEMICAL restores DISEASE	1
CHEMICAL restored by CHEMICAL	1
CHEMICAL response signaling conclude revealed observed observed fed CHEMICAL	1
CHEMICAL response signaling conclude revealed observed fed diet CHEMICAL	1
CHEMICAL response element signaling signaling decrease observed fed CHEMICAL	1
CHEMICAL resistance in patients DISEASE	1
CHEMICAL resistance in cells DISEASE	1
CHEMICAL rescued altered CHEMICAL	1
CHEMICAL rescued altered -involved GENE	1
CHEMICAL rescued -induced CHEMICAL	1
CHEMICAL required reduced inhibited activation GENE	1
CHEMICAL represents encountered DISEASE	1
CHEMICAL represents describe patients suffering from DISEASE	1
CHEMICAL represents CHEMICAL for cardioversion of DISEASE	1
CHEMICAL replacement restored GENE GENE	1
CHEMICAL replacement restored GENE	1
CHEMICAL replacement attenuated DISEASE	1
CHEMICAL repatterns during differentiation DISEASE	1
CHEMICAL release generation produce DISEASE	1
CHEMICAL related suggests administered CHEMICAL	1
CHEMICAL related genes demonstrated lipolysis GENE GENE markers GENE	1
CHEMICAL related genes demonstrated lipolysis GENE GENE GENE	1
CHEMICAL related genes demonstrated lipolysis GENE GENE	1
CHEMICAL related genes GENE GENE GENE GENE	1
CHEMICAL related genes GENE GENE GENE	1
CHEMICAL related DISEASE in DISEASE	1
CHEMICAL regulates via receptors GENE GENE GENE GENE	1
CHEMICAL regulates via receptors GENE GENE	1
CHEMICAL regulates via receptors GENE	1
CHEMICAL regulates inhibits activation -mediated GENE	1
CHEMICAL regulates growth DISEASE	1
CHEMICAL reduces without after CHEMICAL	1
CHEMICAL reduces rate of progression of CHEMICAL -induced DISEASE	1
CHEMICAL reduces levels of markers serum CHEMICAL	1
CHEMICAL reduces levels of markers scr bun CHEMICAL	1
CHEMICAL reduces effect DISEASE	1
CHEMICAL reduces decreases release of cytokines DISEASE	1
CHEMICAL reduces carries due DISEASE	1
CHEMICAL reduces DISEASE DISEASE	1
CHEMICAL reduced was DISEASE	1
CHEMICAL reduced suppressed peroxidation CHEMICAL	1
CHEMICAL reduced suppressed decreased elevations of GENE CHEMICAL	1
CHEMICAL reduced suppressed decreased elevations of GENE	1
CHEMICAL reduced suppressed decreased attenuated reductions of ions CHEMICAL CHEMICAL	1
CHEMICAL reduced suppressed decreased attenuated reductions of ions CHEMICAL	1
CHEMICAL reduced suppressed decreased CHEMICAL	1
CHEMICAL reduced showed preventing DISEASE DISEASE	1
CHEMICAL reduced showed preventing DISEASE	1
CHEMICAL reduced number of cells colocalize with GENE GENE	1
CHEMICAL reduced number of cells colocalize with GENE	1
CHEMICAL reduced levels CHEMICAL	1
CHEMICAL reduced indicating effect on moderating proliferation DISEASE	1
CHEMICAL reduced indicate induces CHEMICAL	1
CHEMICAL reduced increased expression of GENE	1
CHEMICAL reduced increased clearance in DISEASE	1
CHEMICAL reduced increased GENE	1
CHEMICAL reduced increased DISEASE	1
CHEMICAL reduced decreased phosphorylation transcript GENE	1
CHEMICAL reduced burden DISEASE	1
CHEMICAL reduced associated into production of GENE GENE	1
CHEMICAL reduced associated into production of GENE	1
CHEMICAL reduced after DISEASE	1
CHEMICAL reduced activity of GENE	1
CHEMICAL reduced activity levels CHEMICAL	1
CHEMICAL reduced activity GENE	1
CHEMICAL reduced DISEASE from CHEMICAL	1
CHEMICAL reduce were revealed had CHEMICAL	1
CHEMICAL reduce risk of developing DISEASE	1
CHEMICAL reduce increases in CHEMICAL CHEMICAL	1
CHEMICAL reduce increases in CHEMICAL	1
CHEMICAL reduce had increased DISEASE DISEASE DISEASE	1
CHEMICAL reduce had increased DISEASE DISEASE	1
CHEMICAL reduce had increased DISEASE	1
CHEMICAL reduce finding account suggested DISEASE	1
CHEMICAL reduce finding account -induced DISEASE	1
CHEMICAL reduce CHEMICAL	1
CHEMICAL recorded showed showed is given record of levels of DISEASE DISEASE DISEASE	1
CHEMICAL recorded showed showed is given record of levels DISEASE	1
CHEMICAL recommended limit are CHEMICAL CHEMICAL	1
CHEMICAL recommended limit are CHEMICAL	1
CHEMICAL recommended limit DISEASE DISEASE	1
CHEMICAL recommended design investigated DISEASE	1
CHEMICAL recognized inhibitors GENE	1
CHEMICAL recognition domain of GENE	1
CHEMICAL received showed had fluctuating pressure DISEASE	1
CHEMICAL received received man with DISEASE	1
CHEMICAL received received DISEASE	1
CHEMICAL received received CHEMICAL	1
CHEMICAL received measured checked used increased had DISEASE	1
CHEMICAL received increased GENE CHEMICAL activity GENE	1
CHEMICAL received increased GENE	1
CHEMICAL received enrolled total diagnosed with DISEASE	1
CHEMICAL received divided -induced DISEASE	1
CHEMICAL received describe following DISEASE	1
CHEMICAL received decreased concentrations of CHEMICAL	1
CHEMICAL received decreased CHEMICAL	1
CHEMICAL receive patients in prevalence at occur DISEASE	1
CHEMICAL reactivated through activity GENE	1
CHEMICAL rats showed DISEASE	1
CHEMICAL rats DISEASE	1
CHEMICAL rationale via stimulation of GENE	1
CHEMICAL rationale exerts is antagonist GENE	1
CHEMICAL ratio exhibit DISEASE	1
CHEMICAL quantitation carried results decreased altered those of GENE	1
CHEMICAL quantitation carried results decreased VARIANT	1
CHEMICAL quantitation carried performed was study influence of GENE	1
CHEMICAL quantitation carried performed was studied remains reported GENE	1
CHEMICAL quantitation carried performed was studied effect of GENE	1
CHEMICAL quantitation carried performed was VARIANT	1
CHEMICAL prove be remedy for management of DISEASE	1
CHEMICAL protects inducing expression of GENE	1
CHEMICAL protects by upregulation of GENE	1
CHEMICAL protected through upregulation of GENE	1
CHEMICAL protected from DISEASE	1
CHEMICAL properties scavenging through -induced showed cardioprotection against CHEMICAL	1
CHEMICAL properties scavenging through -induced DISEASE	1
CHEMICAL promotes normalizes decreases DISEASE	1
CHEMICAL promoted overload CHEMICAL	1
CHEMICAL promote delivery CHEMICAL	1
CHEMICAL proliferation by expression promoted decreased demonstrated by secretion expression of GENE GENE GENE	1
CHEMICAL proliferation by expression promoted decreased demonstrated by secretion expression of GENE GENE	1
CHEMICAL proliferation by expression promoted decreased demonstrated by secretion expression of GENE	1
CHEMICAL profiles in changes increasing cause CHEMICAL	1
CHEMICAL production induced demonstrated was GENE	1
CHEMICAL production induced DISEASE	1
CHEMICAL production closed with GENE	1
CHEMICAL product of reaction GENE	1
CHEMICAL produced study determine activity GENE	1
CHEMICAL produced by GENE	1
CHEMICAL produced actions on models induced by CHEMICAL CHEMICAL	1
CHEMICAL produced DISEASE	1
CHEMICAL prodrug of CHEMICAL	1
CHEMICAL previous to injections of CHEMICAL	1
CHEMICAL prevents induced used induced DISEASE	1
CHEMICAL prevents induced DISEASE	1
CHEMICAL prevents in DISEASE	1
CHEMICAL prevents implicated DISEASE	1
CHEMICAL prevents binding GENE	1
CHEMICAL prevents accumulation CHEMICAL	1
CHEMICAL prevents DISEASE DISEASE	1
CHEMICAL prevents CHEMICAL	1
CHEMICAL prevented aggravated without with changes in GENE GENE clearance CHEMICAL	1
CHEMICAL prevented aggravated without with changes in GENE GENE	1
CHEMICAL prevent downregulation increase in CHEMICAL	1
CHEMICAL prevent DISEASE infiltration in DISEASE	1
CHEMICAL prevent DISEASE infiltration DISEASE	1
CHEMICAL prevent DISEASE	1
CHEMICAL pretreatment increases activity CHEMICAL CHEMICAL	1
CHEMICAL pretreatment increases activity CHEMICAL	1
CHEMICAL pretreatment for window -induced DISEASE	1
CHEMICAL pretreatment counteracted inhibition of GENE depletion of CHEMICAL	1
CHEMICAL pretreatment counteracted inhibition of GENE	1
CHEMICAL pretreatment counteracted increased GENE CHEMICAL activity GENE	1
CHEMICAL pretreatment counteracted increased GENE	1
CHEMICAL pretreatment attenuated concluded -induced DISEASE	1
CHEMICAL pretreatment attenuated DISEASE -induced CHEMICAL	1
CHEMICAL pretreatment attenuated CHEMICAL depletions CHEMICAL	1
CHEMICAL pretreatment attenuated CHEMICAL	1
CHEMICAL prescribing physicians monitor for DISEASE	1
CHEMICAL prescribed to DISEASE	1
CHEMICAL prescribed reported DISEASE	1
CHEMICAL prescribed decrease use CHEMICAL	1
CHEMICAL prescribed DISEASE DISEASE	1
CHEMICAL prescribed DISEASE	1
CHEMICAL preexisting of reductions with associated evidence convincing is DISEASE	1
CHEMICAL potentiate CHEMICAL	1
CHEMICAL potential in slowing progression DISEASE	1
CHEMICAL possible DISEASE	1
CHEMICAL possesses properties reported improve through availability of CHEMICAL	1
CHEMICAL possesses characterized DISEASE	1
CHEMICAL polymorphisms of association -induced DISEASE	1
CHEMICAL play role in biosynthesis CHEMICAL	1
CHEMICAL play ameliorates -induced CHEMICAL	1
CHEMICAL plasma into CHEMICAL CHEMICAL	1
CHEMICAL plasma into CHEMICAL	1
CHEMICAL plasma affected decreased CHEMICAL	1
CHEMICAL placebo group had were genotyped trial investigated influenced conversion from DISEASE	1
CHEMICAL placebo group had were genotyped trial investigated influenced DISEASE	1
CHEMICAL placebo group had found indicated was conversion to DISEASE	1
CHEMICAL placebo group had found indicated suggest predispose to DISEASE	1
CHEMICAL pharmacogenomics recommendations is standard for patients DISEASE	1
CHEMICAL peroxidation of level was attenuated suggests ameliorate CHEMICAL	1
CHEMICAL peroxidation of level was attenuated DISEASE -induced CHEMICAL	1
CHEMICAL performed observed evidence of DISEASE	1
CHEMICAL peptide antigen of presentation processing of upregulation via GENE	1
CHEMICAL patients patients DISEASE	1
CHEMICAL patients in DISEASE	1
CHEMICAL patients among presented DISEASE	1
CHEMICAL patients DISEASE	1
CHEMICAL pathway of administration by reversed inhibition -induced GENE	1
CHEMICAL p displayed DISEASE of effectiveness CHEMICAL	1
CHEMICAL p displayed DISEASE	1
CHEMICAL oxidation heart versus heart in DISEASE	1
CHEMICAL oxidation expression served CHEMICAL	1
CHEMICAL oxidation decreased revealed sensitized rats DISEASE	1
CHEMICAL overload reduced showed delayed CHEMICAL	1
CHEMICAL overload induced by CHEMICAL CHEMICAL	1
CHEMICAL overload induced by CHEMICAL	1
CHEMICAL overload causes apoptosis DISEASE	1
CHEMICAL overload aggravates causes DISEASE	1
CHEMICAL on up was were DISEASE	1
CHEMICAL on tissue DISEASE	1
CHEMICAL on release GENE	1
CHEMICAL on production expression increases DISEASE	1
CHEMICAL on models of DISEASE	1
CHEMICAL on markers DISEASE	1
CHEMICAL on ligands of effect study DISEASE	1
CHEMICAL on induction CHEMICAL	1
CHEMICAL on effects are recognized GENE	1
CHEMICAL on effect antagonist)-induced GENE	1
CHEMICAL on anacardiaceae -induced DISEASE	1
CHEMICAL on alterations in CHEMICAL	1
CHEMICAL on activities following DISEASE	1
CHEMICAL on activities DISEASE	1
CHEMICAL on GENE	1
CHEMICAL on DISEASE CHEMICAL	1
CHEMICAL on DISEASE -induced CHEMICAL	1
CHEMICAL offspring of patients DISEASE	1
CHEMICAL of utilization correct DISEASE	1
CHEMICAL of use with associated symptoms of DISEASE	1
CHEMICAL of use facilitate signalling GENE	1
CHEMICAL of use facilitate in treatment DISEASE	1
CHEMICAL of use associated with DISEASE	1
CHEMICAL of use CHEMICAL	1
CHEMICAL of type presence of DISEASE	1
CHEMICAL of trial -induced DISEASE	1
CHEMICAL of treatment increased CHEMICAL	1
CHEMICAL of treatment CHEMICAL	1
CHEMICAL of treatment -induced DISEASE	1
CHEMICAL of tolerability evaluated studied CHEMICAL	1
CHEMICAL of safety used background CHEMICAL	1
CHEMICAL of safety in populations as patients DISEASE	1
CHEMICAL of safety associated CHEMICAL	1
CHEMICAL of role confirmed DISEASE	1
CHEMICAL of role analyzed by test used for assay of DISEASE	1
CHEMICAL of role analyzed altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL of role analyzed altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL	1
CHEMICAL of role analyzed altered tissue enzymes as antioxidants as GENE CHEMICAL	1
CHEMICAL of role analyzed altered tissue enzymes as antioxidants as GENE	1
CHEMICAL of role analyzed altered tissue enzymes as GENE GENE GENE GENE GENE	1
CHEMICAL of role analyzed altered tissue enzymes as GENE GENE GENE GENE	1
CHEMICAL of role analyzed altered tissue enzymes as GENE GENE GENE	1
CHEMICAL of role analyzed altered tissue enzymes as GENE GENE	1
CHEMICAL of role analyzed altered tissue enzymes as GENE	1
CHEMICAL of repair in role has GENE	1
CHEMICAL of release related to administration GENE	1
CHEMICAL of regimens investigate in DISEASE	1
CHEMICAL of rate -induced DISEASE	1
CHEMICAL of quantitation carried results decreased VARIANT	1
CHEMICAL of quantitation carried performed was VARIANT	1
CHEMICAL of production of augmentation via enhances activator GENE is factor in treatment of DISEASE	1
CHEMICAL of presence dose contribute to DISEASE	1
CHEMICAL of presence dose contribute occur DISEASE	1
CHEMICAL of pool maintains traffic GENE	1
CHEMICAL of pharmacokinetics phenotype CHEMICAL	1
CHEMICAL of pharmacokinetics pharmacodynamics GENE	1
CHEMICAL of omission reduce reduce CHEMICAL	1
CHEMICAL of neurotransmitters CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL of neurotransmitters CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL of neurotransmitters CHEMICAL CHEMICAL	1
CHEMICAL of neurotransmitters CHEMICAL	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE CHEMICAL	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE GENE GENE GENE	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE GENE GENE	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE GENE	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE	1
CHEMICAL of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE	1
CHEMICAL of microinjection attenuated DISEASE	1
CHEMICAL of mg developed DISEASE	1
CHEMICAL of metabolism is under control of type CHEMICAL	1
CHEMICAL of metabolism induced function of loss to contribute thought detected carried resulted in substitution of VARIANT	1
CHEMICAL of metabolism induced function of loss to contribute thought detected carried resulted in substitution mutation at VARIANT	1
CHEMICAL of metabolism induced function of loss to contribute thought detected carried resulted identified revealed detected results analyzed extracted examined methods identify purpose DISEASE	1
CHEMICAL of metabolism induced function of loss to contribute thought detected carried resulted identified mutations VARIANT VARIANT	1
CHEMICAL of metabolism induced function of loss to contribute thought detected carried resulted identified mutations VARIANT	1
CHEMICAL of metabolism induced function GENE	1
CHEMICAL of mechanism DISEASE	1
CHEMICAL of loss is hallmark of DISEASE	1
CHEMICAL of loading through series of events including activation inactivation GENE	1
CHEMICAL of loading through series of events including activation GENE	1
CHEMICAL of levels with correlate tended -induced apoptosis -mediated GENE	1
CHEMICAL of levels by measured results CHEMICAL	1
CHEMICAL of levels associated with response to therapy GENE	1
CHEMICAL of levels GENE of detection on based lines GENE	1
CHEMICAL of levels CHEMICAL	1
CHEMICAL of isomers were capable of reversing DISEASE caused by CHEMICAL	1
CHEMICAL of isomers were capable of reversing DISEASE	1
CHEMICAL of isomers effects on DISEASE	1
CHEMICAL of installation of frequency reduce DISEASE	1
CHEMICAL of injection to rats for days caused in heart determined by activity of GENE	1
CHEMICAL of injection to rats for days caused in heart determined by activity GENE	1
CHEMICAL of injection to rats for days caused DISEASE	1
CHEMICAL of injection received after injection CHEMICAL	1
CHEMICAL of injection led to increase in GENE GENE GENE GENE activities CHEMICAL serum CHEMICAL	1
CHEMICAL of injection led to increase in GENE GENE GENE GENE activities CHEMICAL CHEMICAL	1
CHEMICAL of injection led to increase in GENE GENE GENE GENE activities CHEMICAL	1
CHEMICAL of injection led to increase in GENE GENE GENE GENE	1
CHEMICAL of injection led to increase in GENE GENE GENE	1
CHEMICAL of injection led to increase in GENE GENE	1
CHEMICAL of injection led to increase in GENE	1
CHEMICAL of injection led prevented used inhibitor of GENE	1
CHEMICAL of injection led CHEMICAL levels decrease in levels of CHEMICAL GENE	1
CHEMICAL of injection led CHEMICAL levels decrease in levels of CHEMICAL	1
CHEMICAL of injection led CHEMICAL levels CHEMICAL	1
CHEMICAL of injection led CHEMICAL	1
CHEMICAL of injection increased capacity CHEMICAL	1
CHEMICAL of injection increased CHEMICAL	1
CHEMICAL of injection by induced DISEASE	1
CHEMICAL of injection administered induce DISEASE	1
CHEMICAL of infusion occurred DISEASE with DISEASE	1
CHEMICAL of induction by CHEMICAL	1
CHEMICAL of glucuronidation inhibited resulting in exposure CHEMICAL	1
CHEMICAL of formulations using -induced DISEASE	1
CHEMICAL of excretion DISEASE DISEASE DISEASE including features of DISEASE	1
CHEMICAL of elevation showed received CHEMICAL CHEMICAL	1
CHEMICAL of elevation showed received CHEMICAL	1
CHEMICAL of efficacy maintain decreasing risk of DISEASE	1
CHEMICAL of efficacy investigating in preventing DISEASE	1
CHEMICAL of efficacy investigated objective therapies DISEASE	1
CHEMICAL of effects revealed show is overexpression GENE	1
CHEMICAL of effects placebo on events in patients with DISEASE	1
CHEMICAL of effects mediated GENE	1
CHEMICAL of effects investigated model of DISEASE	1
CHEMICAL of effects investigated limit characterized -induced CHEMICAL	1
CHEMICAL of effects evaluate explore using models rat CHEMICAL	1
CHEMICAL of effects evaluate explore using CHEMICAL	1
CHEMICAL of effects by activating GENE targets GENE	1
CHEMICAL of effects -induced DISEASE	1
CHEMICAL of effectiveness in antagonizing DISEASE	1
CHEMICAL of effectiveness demonstrate in rats potential in treatment of DISEASE	1
CHEMICAL of effect stress therapy for DISEASE	1
CHEMICAL of effect reverse ability -induced show confounded DISEASE	1
CHEMICAL of effect evaluating at aimed trial investigated influenced conversion from DISEASE	1
CHEMICAL of effect evaluating at aimed trial investigated influenced DISEASE	1
CHEMICAL of effect determined objective studies in models of DISEASE DISEASE	1
CHEMICAL of effect determine DISEASE	1
CHEMICAL of effect attenuates through GENE	1
CHEMICAL of effect attenuates suggest DISEASE	1
CHEMICAL of effect assessed composite of DISEASE	1
CHEMICAL of effect antagonist)-induced DISEASE	1
CHEMICAL of effect ameliorating induced disturbed homeostasis CHEMICAL	1
CHEMICAL of effect abolished in mice depleted by using inhibitor GENE	1
CHEMICAL of effect DISEASE	1
CHEMICAL of effect -induced DISEASE	1
CHEMICAL of doses of administration be in alleviation of DISEASE	1
CHEMICAL of dose reduced resolved recurred her DISEASE	1
CHEMICAL of dose infusion controlled DISEASE	1
CHEMICAL of diagnosis DISEASE	1
CHEMICAL of day on exhibited with DISEASE	1
CHEMICAL of day on exhibited DISEASE disorientation DISEASE	1
CHEMICAL of day on exhibited DISEASE	1
CHEMICAL of cortex in decreased treated concentration activity GENE	1
CHEMICAL of correlation to DISEASE	1
CHEMICAL of conversion in enzyme to CHEMICAL	1
CHEMICAL of content alleviate DISEASE	1
CHEMICAL of consequences -induced DISEASE	1
CHEMICAL of concentration potentiated in model DISEASE	1
CHEMICAL of combination prevent CHEMICAL	1
CHEMICAL of combination induces apoptosis DISEASE	1
CHEMICAL of combination after showed enhancement of GENE	1
CHEMICAL of combination after showed enhancement GENE	1
CHEMICAL of combination GENE genes GENE	1
CHEMICAL of coadministration following DISEASE	1
CHEMICAL of clearance reduce reported GENE	1
CHEMICAL of cases induced are are at risk for DISEASE	1
CHEMICAL of cases induced DISEASE	1
CHEMICAL of blockade by accompanied DISEASE	1
CHEMICAL of administration suppressed in GENE	1
CHEMICAL of administration showed peroxidation CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL of administration showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL of administration showed peroxidation CHEMICAL	1
CHEMICAL of administration reduced prevented DISEASE	1
CHEMICAL of administration led to DISEASE	1
CHEMICAL of administration led associated with expression excretion CHEMICAL	1
CHEMICAL of administration leading to discovery of variant VARIANT	1
CHEMICAL of administration increased uptake CHEMICAL	1
CHEMICAL of administration increased incidence DISEASE	1
CHEMICAL of administration increase prevented DISEASE DISEASE	1
CHEMICAL of administration increase prevented DISEASE	1
CHEMICAL of administration in mice /+ GENE	1
CHEMICAL of administration impaired attenuated DISEASE	1
CHEMICAL of administration following mice attenuated DISEASE	1
CHEMICAL of administration derivative of CHEMICAL	1
CHEMICAL of administration decreased uptake CHEMICAL	1
CHEMICAL of administration attenuated -induced DISEASE	1
CHEMICAL of administration after is rate -induced DISEASE	1
CHEMICAL of administration , rats explain changes related to DISEASE	1
CHEMICAL of activity in DISEASE	1
CHEMICAL of ability reverse effect of CHEMICAL	1
CHEMICAL of ability attenuate DISEASE induced by CHEMICAL	1
CHEMICAL of ability -induced show confounded DISEASE CHEMICAL	1
CHEMICAL of ability -induced show confounded DISEASE	1
CHEMICAL of DISEASE among reported DISEASE	1
CHEMICAL of DISEASE -mediated GENE	1
CHEMICAL ns- seemed was DISEASE	1
CHEMICAL neurotoxin CHEMICAL	1
CHEMICAL nerves involved shown response DISEASE	1
CHEMICAL nerves involved in effect DISEASE	1
CHEMICAL negativity CHEMICAL	1
CHEMICAL months was results index fasting CHEMICAL	1
CHEMICAL modulates support notion regulate GENE	1
CHEMICAL modulates effect of CHEMICAL	1
CHEMICAL modulates axis towards production GENE	1
CHEMICAL model in actions promote by of activity GENE	1
CHEMICAL microinjections with challenged DISEASE -induced CHEMICAL	1
CHEMICAL microinjections with challenged DISEASE	1
CHEMICAL mice GENE GENE	1
CHEMICAL mice GENE	1
CHEMICAL mg abolished increases -evoked CHEMICAL	1
CHEMICAL metabolize import established GENE	1
CHEMICAL metabolize capacity exhibit carriers GENE	1
CHEMICAL metabolites have role in DISEASE	1
CHEMICAL metabolism treated with CHEMICAL	1
CHEMICAL metabolism decreased demonstrated associated DISEASE	1
CHEMICAL metabolism GENE GENE	1
CHEMICAL metabolism GENE	1
CHEMICAL mediates CHEMICAL -induced -derived conclude attenuated reduced abundance of GENE	1
CHEMICAL mediates CHEMICAL -induced -derived conclude attenuated dowregulation of expression GENE	1
CHEMICAL man with DISEASE	1
CHEMICAL lowered was decreased CHEMICAL	1
CHEMICAL lowered was DISEASE	1
CHEMICAL lowered seen were GENE	1
CHEMICAL lowered elevation in levels of mrna GENE	1
CHEMICAL lowered elevation -induced CHEMICAL	1
CHEMICAL lowered GENE GENE	1
CHEMICAL lowered GENE	1
CHEMICAL loading of initiation after experienced DISEASE	1
CHEMICAL loading exhibited impacts on DISEASE DISEASE	1
CHEMICAL liposomes with treatment suppressed DISEASE	1
CHEMICAL like account finding reduce CHEMICAL	1
CHEMICAL levels with associated markers VARIANT VARIANT	1
CHEMICAL levels with associated markers VARIANT	1
CHEMICAL levels remained developed reported DISEASE	1
CHEMICAL levels reduced mice GENE	1
CHEMICAL levels reduced mice -treated CHEMICAL	1
CHEMICAL levels reduced administration of antagonist GENE	1
CHEMICAL levels normalized disappeared received CHEMICAL CHEMICAL	1
CHEMICAL levels normalized disappeared received CHEMICAL	1
CHEMICAL levels increased in mice DISEASE	1
CHEMICAL levels in group CHEMICAL	1
CHEMICAL levels fasting associated variants reside catalyzes GENE	1
CHEMICAL levels expression decreased in rats DISEASE	1
CHEMICAL levels displayed knockout GENE	1
CHEMICAL levels affected increased expression GENE	1
CHEMICAL level observed in mice -null GENE	1
CHEMICAL level measure used measured subjected evaluate DISEASE	1
CHEMICAL level measure GENE	1
CHEMICAL level at performed detected 19 of defects compatible with DISEASE	1
CHEMICAL level CHEMICAL of presence dose contribute to DISEASE	1
CHEMICAL level CHEMICAL of presence dose contribute occur DISEASE	1
CHEMICAL labeled CHEMICAL CHEMICAL	1
CHEMICAL labeled CHEMICAL	1
CHEMICAL is with selectivity for enzyme GENE	1
CHEMICAL is was reduced frequency of DISEASE	1
CHEMICAL is target in treatment DISEASE	1
CHEMICAL is studied was prevented microperfusion CHEMICAL	1
CHEMICAL is reported exhibit carriers GENE	1
CHEMICAL is prodrug undergoes by GENE	1
CHEMICAL is objective evaluated studied CHEMICAL	1
CHEMICAL is molecule involved in signaling secretion GENE	1
CHEMICAL is manifested DISEASE	1
CHEMICAL is lead to outcomes as fluctuations DISEASE DISEASE	1
CHEMICAL is lead to outcomes as fluctuations DISEASE	1
CHEMICAL is is CHEMICAL signaling through GENE	1
CHEMICAL is is CHEMICAL	1
CHEMICAL is induce investigated model of DISEASE	1
CHEMICAL is induce DISEASE	1
CHEMICAL is hydrolyzes plasma CHEMICAL	1
CHEMICAL is hydrolyzes causing DISEASE	1
CHEMICAL is experience is standard for patients DISEASE	1
CHEMICAL is examined allocated received CHEMICAL	1
CHEMICAL is evokes trough blockage of GENE	1
CHEMICAL is elucidated is establish DISEASE model cell -stimulated GENE	1
CHEMICAL is drug used for treatment of DISEASE	1
CHEMICAL is derivative attenuates DISEASE -induced CHEMICAL	1
CHEMICAL is derivative attenuates DISEASE	1
CHEMICAL is demonstrates conclusion reported DISEASE DISEASE	1
CHEMICAL is demonstrates conclusion reported DISEASE	1
CHEMICAL is critical for expression of DISEASE	1
CHEMICAL is conclude conclusion developed DISEASE	1
CHEMICAL is characterized leading to DISEASE DISEASE	1
CHEMICAL is characterized leading to DISEASE	1
CHEMICAL is causes DISEASE as DISEASE DISEASE	1
CHEMICAL is candidate characterized by DISEASE DISEASE	1
CHEMICAL is candidate against DISEASE	1
CHEMICAL is associated polymorphism in GENE	1
CHEMICAL is allele factor for DISEASE	1
CHEMICAL is activates GENE	1
CHEMICAL is activates DISEASE	1
CHEMICAL is CHEMICAL used provide treatment for DISEASE DISEASE	1
CHEMICAL is CHEMICAL used provide treatment for DISEASE	1
CHEMICAL is CHEMICAL designed with aim of improving in comparison with drugs CHEMICAL CHEMICAL	1
CHEMICAL is CHEMICAL designed with aim of improving in comparison with drugs CHEMICAL	1
CHEMICAL ions of reductions attenuated resulted from administration CHEMICAL	1
CHEMICAL involvement prevention by CHEMICAL	1
CHEMICAL involvement in progression of DISEASE	1
CHEMICAL involved is DISEASE	1
CHEMICAL involved interactions associated with DISEASE	1
CHEMICAL involved in response DISEASE DISEASE	1
CHEMICAL involved in response DISEASE	1
CHEMICAL involved in pathogenesis of DISEASE	1
CHEMICAL involved in activation GENE	1
CHEMICAL investigated model of DISEASE	1
CHEMICAL investigated is therapy for DISEASE	1
CHEMICAL investigated induce is CHEMICAL	1
CHEMICAL investigated effects of CHEMICAL	1
CHEMICAL intracerebroventricular by induced DISEASE	1
CHEMICAL into cells -expressing GENE	1
CHEMICAL intensify conclusions participates be in alleviation of DISEASE	1
CHEMICAL intensify activity of CHEMICAL CHEMICAL	1
CHEMICAL intensify activity of CHEMICAL	1
CHEMICAL intensify activity in DISEASE	1
CHEMICAL insulinemia bmi were in patients DISEASE	1
CHEMICAL injections produce identical to that seen with CHEMICAL	1
CHEMICAL injection by depletion decreased protects GENE	1
CHEMICAL injection by depletion decreased levels GENE	1
CHEMICAL injection before injected assessed thought GENE	1
CHEMICAL injection after DISEASE	1
CHEMICAL injected was complained revealed DISEASE	1
CHEMICAL injected was complained of DISEASE DISEASE	1
CHEMICAL injected was complained of DISEASE	1
CHEMICAL injected resulted in DISEASE	1
CHEMICAL injected resulted 15/44 of mice leading with DISEASE DISEASE	1
CHEMICAL injected resulted 15/44 of mice leading with DISEASE	1
CHEMICAL injected resulted 15/44 DISEASE	1
CHEMICAL injected on days induce DISEASE	1
CHEMICAL injected assessed thought GENE	1
CHEMICAL initiated secondary to DISEASE	1
CHEMICAL initiated relapsing DISEASE	1
CHEMICAL initiated exhibited with DISEASE	1
CHEMICAL initiated exhibited had c DISEASE	1
CHEMICAL initiated exhibited DISEASE disorientation DISEASE	1
CHEMICAL initiated exhibited DISEASE	1
CHEMICAL initiated admitted DISEASE	1
CHEMICAL inhibitors background known be DISEASE	1
CHEMICAL inhibitors GENE	1
CHEMICAL inhibitor of GENE	1
CHEMICAL inhibitor inhibitor influence CHEMICAL CHEMICAL	1
CHEMICAL inhibitor inhibitor influence CHEMICAL	1
CHEMICAL inhibitor in patients with DISEASE DISEASE	1
CHEMICAL inhibitor in patients with DISEASE	1
CHEMICAL inhibitor depleted suppressed induced GENE	1
CHEMICAL inhibitor depleted suppressed cells GENE	1
CHEMICAL inhibitor depleted suppressed GENE GENE	1
CHEMICAL inhibitor depleted inhibited vivo DISEASE	1
CHEMICAL inhibitor depleted inhibited identified GENE	1
CHEMICAL inhibitor depleted inhibited cells GENE	1
CHEMICAL inhibitor active against DISEASE	1
CHEMICAL inhibition of enzymes GENE	1
CHEMICAL inhibited support notion regulate GENE	1
CHEMICAL inhibited reduced required CHEMICAL	1
CHEMICAL inhibited reduced levels of CHEMICAL	1
CHEMICAL inhibited proliferation DISEASE	1
CHEMICAL inhibited investigated are expression of GENE	1
CHEMICAL inhibited development of DISEASE	1
CHEMICAL inhibited antagonized CHEMICAL	1
CHEMICAL inhibited activation reduced GENE	1
CHEMICAL inhibited accompanied decreased expression of GENE	1
CHEMICAL inhibited GENE	1
CHEMICAL inhibited DISEASE	1
CHEMICAL inhibited -activation GENE	1
CHEMICAL inhibit play cells GENE	1
CHEMICAL inhibit growth DISEASE	1
CHEMICAL inhibit by altering to GENE	1
CHEMICAL infusions reduce demonstrated is DISEASE	1
CHEMICAL infusion p= treat DISEASE	1
CHEMICAL infusion p= developed DISEASE	1
CHEMICAL infusion of hours after felt DISEASE	1
CHEMICAL infusion got diagnosed as DISEASE	1
CHEMICAL infusion discontinued treated x felt DISEASE	1
CHEMICAL infusion discontinued treated x DISEASE	1
CHEMICAL infusion controlled DISEASE	1
CHEMICAL infusion by induced state DISEASE	1
CHEMICAL influx in cells -depolarised CHEMICAL	1
CHEMICAL influences eryptosis explored methods showed increase of exposure CHEMICAL	1
CHEMICAL induces via production GENE	1
CHEMICAL induces suggest provide cells DISEASE	1
CHEMICAL induces loss of GENE	1
CHEMICAL induces is DISEASE	1
CHEMICAL induces indicate suggest be via activation GENE	1
CHEMICAL induces in response to agonists GENE	1
CHEMICAL induces in cells DISEASE	1
CHEMICAL induces dcs in conditions DISEASE	1
CHEMICAL induced stereotypies CHEMICAL	1
CHEMICAL induced reduced diminished activities of i GENE	1
CHEMICAL induced reduced consumption CHEMICAL	1
CHEMICAL induced measured GENE	1
CHEMICAL induced induced used as models of DISEASE	1
CHEMICAL induced induced levels GENE	1
CHEMICAL induced increased level of GENE	1
CHEMICAL induced increased fluorescence accompanied by level of GENE	1
CHEMICAL induced increased fluorescence GENE	1
CHEMICAL induced incidence of DISEASE	1
CHEMICAL induced incidence DISEASE	1
CHEMICAL induced eosinophilic DISEASE	1
CHEMICAL induced enhanced on GENE	1
CHEMICAL induced by CHEMICAL	1
CHEMICAL induced attenuated treatment with CHEMICAL	1
CHEMICAL induced attenuated treatment CHEMICAL	1
CHEMICAL induced activation death DISEASE	1
CHEMICAL induced GENE GENE	1
CHEMICAL induced -dependent GENE	1
CHEMICAL induce antagonize CHEMICAL	1
CHEMICAL induce aggravate symptoms DISEASE	1
CHEMICAL induce DISEASE	1
CHEMICAL increases to GENE	1
CHEMICAL increases occurred after CHEMICAL	1
CHEMICAL increases decreases number of neurons -ir GENE	1
CHEMICAL increased reported DISEASE	1
CHEMICAL increased plasma CHEMICAL	1
CHEMICAL increased phosphorylation GENE	1
CHEMICAL increased phosphorylation -stimulated GENE	1
CHEMICAL increased observed expression of GENE	1
CHEMICAL increased levels CHEMICAL	1
CHEMICAL increased level of CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL increased level of CHEMICAL CHEMICAL	1
CHEMICAL increased level of CHEMICAL	1
CHEMICAL increased increased levels of mrna GENE	1
CHEMICAL increased increased failed suppress GENE	1
CHEMICAL increased increased enzymes GENE phosphorylation GENE	1
CHEMICAL increased increased enzymes GENE	1
CHEMICAL increased expression GENE	1
CHEMICAL increased detected increase in phosphorylation of GENE	1
CHEMICAL increased detected increase GENE GENE	1
CHEMICAL increased detected increase GENE	1
CHEMICAL increased decreased accumulation of CHEMICAL	1
CHEMICAL increased decreased CHEMICAL	1
CHEMICAL increased clearance in DISEASE	1
CHEMICAL increased GENE mrna GENE	1
CHEMICAL increased GENE GENE phosphorylation VARIANT GENE	1
CHEMICAL increased -stimulated uptake CHEMICAL	1
CHEMICAL inactive -bound displays GENE	1
CHEMICAL in production CHEMICAL	1
CHEMICAL in patients with DISEASE	1
CHEMICAL in patients DISEASE	1
CHEMICAL in patient of DISEASE	1
CHEMICAL in participants -dependent CHEMICAL	1
CHEMICAL in observed expression of GENE	1
CHEMICAL in observed activity -induced DISEASE	1
CHEMICAL in noted observed was observed immunoreactivity to GENE GENE GENE	1
CHEMICAL in noted observed was observed immunoreactivity to GENE GENE	1
CHEMICAL in noted observed was observed immunoreactivity to GENE	1
CHEMICAL in mutations provide patients DISEASE	1
CHEMICAL in models of DISEASE DISEASE	1
CHEMICAL in line DISEASE	1
CHEMICAL in expression GENE	1
CHEMICAL in events activation DISEASE	1
CHEMICAL in event is induced DISEASE	1
CHEMICAL in emulsions on DISEASE	1
CHEMICAL in elevated CHEMICAL CHEMICAL	1
CHEMICAL in elevated CHEMICAL	1
CHEMICAL in detected treated with CHEMICAL CHEMICAL	1
CHEMICAL in detected treated with CHEMICAL	1
CHEMICAL in detected treated produced CHEMICAL	1
CHEMICAL in detected increase in phosphorylation of GENE	1
CHEMICAL in detected increase GENE GENE	1
CHEMICAL in detected increase GENE	1
CHEMICAL in cultured aborted occurred with DISEASE	1
CHEMICAL in combination with agents CHEMICAL	1
CHEMICAL in children with DISEASE	1
CHEMICAL in bound aimed investigate effects peroxidation CHEMICAL	1
CHEMICAL in GENE -induced DISEASE	1
CHEMICAL in DISEASE DISEASE DISEASE	1
CHEMICAL in DISEASE DISEASE	1
CHEMICAL in CHEMICAL of levels CHEMICAL	1
CHEMICAL in CHEMICAL of effects -induced models DISEASE	1
CHEMICAL in CHEMICAL importance been mainstay for DISEASE	1
CHEMICAL in -induced mice DISEASE	1
CHEMICAL improves dysregulation CHEMICAL	1
CHEMICAL improves DISEASE	1
CHEMICAL improved integrity abolished in mice depleted by using inhibitor GENE	1
CHEMICAL improve rats -infused CHEMICAL	1
CHEMICAL improve conclude dependent GENE	1
CHEMICAL improve DISEASE	1
CHEMICAL implicated is DISEASE CHEMICAL	1
CHEMICAL implicated in production of CHEMICAL	1
CHEMICAL implicated in development of DISEASE	1
CHEMICAL implicated drugs CHEMICAL using test CHEMICAL	1
CHEMICAL identified observed differences GENE	1
CHEMICAL homeostasis of parameters showed protected ko GENE	1
CHEMICAL homeostasis of parameters showed protected from DISEASE	1
CHEMICAL homeostasis of parameters showed fed loss GENE	1
CHEMICAL have develop -induced DISEASE	1
CHEMICAL have DISEASE	1
CHEMICAL has was increased decreased pretreatment with CHEMICAL	1
CHEMICAL has suggest confirmed DISEASE	1
CHEMICAL has suggest -induced DISEASE	1
CHEMICAL has potential maintain decreasing risk of DISEASE	1
CHEMICAL has on incidence of DISEASE	1
CHEMICAL has examined suppressed in GENE	1
CHEMICAL has due effects of CHEMICAL precursor CHEMICAL	1
CHEMICAL has due effects of CHEMICAL inhibitor GENE	1
CHEMICAL has due effects of CHEMICAL	1
CHEMICAL has be studied in relation to DISEASE	1
CHEMICAL has are DISEASE DISEASE DISEASE	1
CHEMICAL has DISEASE used compromises increase decrease associated is progress DISEASE	1
CHEMICAL halts hippocampal DISEASE prevented inhibition depletion CHEMICAL	1
CHEMICAL halts hippocampal DISEASE prevented inhibition GENE	1
CHEMICAL had tendency decrease threshold DISEASE	1
CHEMICAL had reduced increments in CHEMICAL CHEMICAL	1
CHEMICAL had reduced increments in CHEMICAL	1
CHEMICAL had preference DISEASE	1
CHEMICAL had effect with decrease of expression GENE	1
CHEMICAL had divided group DISEASE	1
CHEMICAL growth DISEASE	1
CHEMICAL groups displayed DISEASE of effectiveness CHEMICAL	1
CHEMICAL groups displayed DISEASE	1
CHEMICAL groups combining revealed had CHEMICAL	1
CHEMICAL group with compared showed peroxidation CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL group with compared showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL group with compared showed peroxidation CHEMICAL CHEMICAL	1
CHEMICAL group were were were 42,671 ns- CHEMICAL	1
CHEMICAL group were were CHEMICAL CHEMICAL	1
CHEMICAL group were were 14,671 9,832 ns- CHEMICAL	1
CHEMICAL group were CHEMICAL CHEMICAL	1
CHEMICAL group were CHEMICAL	1
CHEMICAL group injected injected assessed thought GENE	1
CHEMICAL group CHEMICAL	1
CHEMICAL giving of safety supports monitored DISEASE	1
CHEMICAL given included methods women with DISEASE	1
CHEMICAL given given measured GENE GENE	1
CHEMICAL given given measured GENE	1
CHEMICAL genotype GENE	1
CHEMICAL from conversion after observed in recipients with DISEASE	1
CHEMICAL from conversion after observed -induced DISEASE	1
CHEMICAL from confirmed had lasting DISEASE	1
CHEMICAL from confirmed DISEASE	1
CHEMICAL from DISEASE DISEASE	1
CHEMICAL from DISEASE	1
CHEMICAL free modulate suggest be polymorphism VARIANT	1
CHEMICAL free in patients DISEASE	1
CHEMICAL for potential suggest in improving cases of DISEASE	1
CHEMICAL for control DISEASE	1
CHEMICAL for cardioversion of DISEASE	1
CHEMICAL for affected mutation VARIANT	1
CHEMICAL for affected found exhibited mutant GENE	1
CHEMICAL flux raised performed using system demonstrated causes DISEASE	1
CHEMICAL fashion in tested recognized GENE	1
CHEMICAL failed prevent DISEASE	1
CHEMICAL failed inhibited DISEASE	1
CHEMICAL factors are able predict efficacy of therapy CHEMICAL	1
CHEMICAL factors GENE activate GENE GENE	1
CHEMICAL factor DISEASE	1
CHEMICAL facilitate transformation DISEASE	1
CHEMICAL extracts is GENE	1
CHEMICAL expressing microglia show were depleted CHEMICAL	1
CHEMICAL expressing microglia show changes after CHEMICAL	1
CHEMICAL exposure with CHEMICAL agent for treatment of DISEASE	1
CHEMICAL exposure induce indicated suggested remain study established revealed reduced increased displayed detected level of genes GENE GENE	1
CHEMICAL exposure induce indicated suggested remain study established revealed reduced increased displayed detected level of genes GENE	1
CHEMICAL exposure induce indicated suggested remain study established revealed reduced increased displayed detected inhibited gene GENE	1
CHEMICAL exposure induce indicated suggested remain study established revealed reduced increased displayed detected inhibited demonstrated induce DISEASE	1
CHEMICAL exposure induce indicated suggested remain study established revealed reduced increased displayed detected inhibited by pce associated with repression of expression of GENE	1
CHEMICAL exposure induce indicated suggested remain study established revealed exhibited accompanied by levels of CHEMICAL	1
CHEMICAL exposure induce indicated suggested remain study established revealed exhibited DISEASE DISEASE	1
CHEMICAL exposure induce indicated suggested remain induce DISEASE	1
CHEMICAL exposure induce DISEASE	1
CHEMICAL exposure in dysregulation CHEMICAL	1
CHEMICAL exposure have be worth investigating for improvement of DISEASE associated with DISEASE	1
CHEMICAL exposure due alleviate DISEASE	1
CHEMICAL exposure development DISEASE	1
CHEMICAL exposure by inhibition of enzymes GENE	1
CHEMICAL exposure aggravated without with changes in GENE GENE clearance CHEMICAL	1
CHEMICAL exposure aggravated without with changes in GENE GENE	1
CHEMICAL exhibits effect in types of DISEASE	1
CHEMICAL exhibited reducing -induced CHEMICAL	1
CHEMICAL exhibit in GENE	1
CHEMICAL exerts reported -induced DISEASE	1
CHEMICAL exerts effect against CHEMICAL	1
CHEMICAL exerts concluded DISEASE due potential regulated against DISEASE	1
CHEMICAL exerts concluded DISEASE	1
CHEMICAL exerts by decreasing level CHEMICAL	1
CHEMICAL exert reduce frequency of installation of CHEMICAL -induced DISEASE	1
CHEMICAL excretion reached associated with body DISEASE	1
CHEMICAL examined determined tested for DISEASE	1
CHEMICAL examined determined levels CHEMICAL	1
CHEMICAL examined decreased decreased increased DISEASE	1
CHEMICAL examined decreased CHEMICAL CHEMICAL	1
CHEMICAL examine were -induced stress promotes production of CHEMICAL	1
CHEMICAL exacerbated DISEASE	1
CHEMICAL enhances are cells DISEASE	1
CHEMICAL enhanced weakened upregulation of GENE	1
CHEMICAL enhanced stereotypy CHEMICAL	1
CHEMICAL enhanced protected against dysfunction caused by GENE	1
CHEMICAL enhanced on GENE GENE	1
CHEMICAL enhanced on GENE	1
CHEMICAL enhanced found increased GENE	1
CHEMICAL enhanced found GENE downregulation of GENE	1
CHEMICAL enhanced found GENE	1
CHEMICAL enhanced DISEASE behavior -induced CHEMICAL	1
CHEMICAL enhanced DISEASE CHEMICAL	1
CHEMICAL enhanced DISEASE	1
CHEMICAL enhanced CHEMICAL	1
CHEMICAL endocrine system of role supports in process of DISEASE	1
CHEMICAL emulsions on DISEASE -induced CHEMICAL	1
CHEMICAL emulsions on DISEASE	1
CHEMICAL elevations are published events DISEASE	1
CHEMICAL elevations are -induced CHEMICAL	1
CHEMICAL elements to bind ability preserved exert VARIANT GENE	1
CHEMICAL elements to bind ability preserved enhances VARIANT GENE	1
CHEMICAL elements to bind ability preserved demonstrated VARIANT GENE	1
CHEMICAL effects in patients DISEASE	1
CHEMICAL during sequencing DISEASE	1
CHEMICAL during response -induced DISEASE	1
CHEMICAL during effect induced DISEASE	1
CHEMICAL drugs DISEASE	1
CHEMICAL downregulates -mediated GENE	1
CHEMICAL doses of CHEMICAL	1
CHEMICAL dose inhibited activity expressing GENE	1
CHEMICAL dose inhibited activity GENE	1
CHEMICAL discontinuing after underwent recovered volume levels CHEMICAL	1
CHEMICAL discontinued resolved DISEASE	1
CHEMICAL discontinued replaced by CHEMICAL	1
CHEMICAL discontinued experienced relapsing DISEASE	1
CHEMICAL diet leads fed rats DISEASE	1
CHEMICAL diet developed fed rats DISEASE	1
CHEMICAL diet developed DISEASE	1
CHEMICAL dialyzing permeated form GENE	1
CHEMICAL dialyzing permeated channels GENE	1
CHEMICAL dialyzing activated CHEMICAL	1
CHEMICAL determined design investigated DISEASE	1
CHEMICAL detecting for compared assess using computed assess presence of DISEASE	1
CHEMICAL designed is DISEASE	1
CHEMICAL designed -induced DISEASE	1
CHEMICAL describe published events DISEASE	1
CHEMICAL depressed number of cells GENE	1
CHEMICAL demonstrated accompanied exhibited loading CHEMICAL	1
CHEMICAL delayed showed reduced overload induced by CHEMICAL CHEMICAL	1
CHEMICAL delayed showed decreased course of DISEASE	1
CHEMICAL delayed onset of DISEASE	1
CHEMICAL degradation revealing by activity of GENE	1
CHEMICAL decreased was lowered GENE GENE	1
CHEMICAL decreased was lowered GENE	1
CHEMICAL decreased reduced considered DISEASE	1
CHEMICAL decreased pretreated had induced synthesis of GENE protein GENE	1
CHEMICAL decreased pretreated had induced synthesis of GENE	1
CHEMICAL decreased pretreated had induced expression of GENE GENE	1
CHEMICAL decreased pretreated had induced expression of GENE	1
CHEMICAL decreased pretreated had GENE	1
CHEMICAL decreased phosphorylation transcript GENE	1
CHEMICAL decreased overexpression of GENE GENE GENE	1
CHEMICAL decreased overexpression of GENE	1
CHEMICAL decreased overexpression -induced CHEMICAL	1
CHEMICAL decreased increased administered CHEMICAL	1
CHEMICAL decreased expression of gene GENE	1
CHEMICAL decreased expression GENE	1
CHEMICAL decreased decreased increased DISEASE	1
CHEMICAL decreased death CHEMICAL release activation GENE	1
CHEMICAL decreased death CHEMICAL release CHEMICAL	1
CHEMICAL decreased death CHEMICAL	1
CHEMICAL decreased after administration CHEMICAL	1
CHEMICAL decreased accumulation of CHEMICAL	1
CHEMICAL decreased accompanied levels GENE	1
CHEMICAL decreased accompanied by reduction of expression of GENE GENE	1
CHEMICAL decreased accompanied by GENE GENE	1
CHEMICAL decreased accompanied by GENE	1
CHEMICAL decreased abolished by GENE upregulated GENE	1
CHEMICAL decreased GENE	1
CHEMICAL d with combination used relapsed DISEASE	1
CHEMICAL course receiving DISEASE developed DISEASE	1
CHEMICAL cotransport CHEMICAL	1
CHEMICAL continues despite DISEASE	1
CHEMICAL continues -induced DISEASE	1
CHEMICAL content treated with CHEMICAL CHEMICAL	1
CHEMICAL content treated with CHEMICAL	1
CHEMICAL content treated produced CHEMICAL	1
CHEMICAL content alleviate DISEASE -induced CHEMICAL	1
CHEMICAL content alleviate DISEASE	1
CHEMICAL containing induce DISEASE	1
CHEMICAL consumption leads associated with activation of GENE	1
CHEMICAL consumption leading to DISEASE stress DISEASE DISEASE	1
CHEMICAL consumption leading to DISEASE stress DISEASE	1
CHEMICAL consumption leading to DISEASE	1
CHEMICAL consumption is factor for DISEASE	1
CHEMICAL consumption is DISEASE	1
CHEMICAL consumption incidence DISEASE	1
CHEMICAL considered be in patients with DISEASE	1
CHEMICAL considered DISEASE	1
CHEMICAL conclusions appears monitor for DISEASE	1
CHEMICAL concentrations with DISEASE	1
CHEMICAL concentrations increased in mice than in mice leading to DISEASE	1
CHEMICAL concentrations increased in mice GENE	1
CHEMICAL concentration was in rats -treated CHEMICAL	1
CHEMICAL concentration treated decreased activity GENE	1
CHEMICAL concentration increased reduced suggest induces DISEASE	1
CHEMICAL concentrate failed transfected VARIANT	1
CHEMICAL concentrate failed GENE	1
CHEMICAL compounds are inhibitors of GENE	1
CHEMICAL compounds GENE	1
CHEMICAL compound attenuates shows effects in in models DISEASE	1
CHEMICAL compensated suppressed peroxidation CHEMICAL	1
CHEMICAL compensated suppressed decreased elevations of GENE CHEMICAL	1
CHEMICAL compensated suppressed decreased elevations of GENE	1
CHEMICAL compensated suppressed decreased attenuated reductions of ions CHEMICAL CHEMICAL	1
CHEMICAL compensated suppressed decreased attenuated reductions of ions CHEMICAL	1
CHEMICAL compensated suppressed decreased CHEMICAL	1
CHEMICAL compensated deficits in mechanisms level activity GENE	1
CHEMICAL compensated deficits in mechanisms level CHEMICAL	1
CHEMICAL compared caused GENE	1
CHEMICAL combinations with CHEMICAL	1
CHEMICAL combination prevent CHEMICAL	1
CHEMICAL combination in CHEMICAL	1
CHEMICAL coadministered was was reported DISEASE DISEASE	1
CHEMICAL coadministered was was reported DISEASE	1
CHEMICAL chemicals -like CHEMICAL	1
CHEMICAL chelator CHEMICAL	1
CHEMICAL chelation with CHEMICAL	1
CHEMICAL chelation learning lasting DISEASE	1
CHEMICAL chelated by CHEMICAL	1
CHEMICAL characterized DISEASE	1
CHEMICAL channels of inhibition regulate suggest be regulation of GENE	1
CHEMICAL channels of inhibition regulate induces regulation of function GENE	1
CHEMICAL channels of inhibition regulate -induced regulation of function GENE	1
CHEMICAL channels of inhibition regulate -induced CHEMICAL	1
CHEMICAL channels of inhibition by CHEMICAL	1
CHEMICAL channels have roles in DISEASE	1
CHEMICAL channel to leads shown GENE	1
CHEMICAL channel to leads -induced GENE	1
CHEMICAL channel GENE	1
CHEMICAL channel DISEASE DISEASE	1
CHEMICAL channel DISEASE	1
CHEMICAL change elevated after CHEMICAL	1
CHEMICAL cells in area DISEASE	1
CHEMICAL cells contribute to action DISEASE	1
CHEMICAL causes found DISEASE	1
CHEMICAL causes expression of GENE indicating activation DISEASE	1
CHEMICAL causes expression of GENE GENE GENE	1
CHEMICAL causes expression of GENE GENE	1
CHEMICAL causes expression of GENE	1
CHEMICAL caused concluded reduces DISEASE	1
CHEMICAL cause occurred shown risk of DISEASE DISEASE DISEASE DISEASE	1
CHEMICAL cause occurred shown risk of DISEASE DISEASE DISEASE	1
CHEMICAL cause occurred shown risk of DISEASE DISEASE	1
CHEMICAL cause occurred shown risk of DISEASE	1
CHEMICAL cause demonstrate rescues induced DISEASE	1
CHEMICAL catabolize import established GENE	1
CHEMICAL by treated rats in DISEASE	1
CHEMICAL by treated rats DISEASE	1
CHEMICAL by reversed indicating involvement of GENE	1
CHEMICAL by restored considered reflect symptoms of DISEASE	1
CHEMICAL by produced DISEASE	1
CHEMICAL by precipitated in patients with DISEASE	1
CHEMICAL by inhibition regulate -induced CHEMICAL	1
CHEMICAL by inhibited conclude improve CHEMICAL	1
CHEMICAL by induction documented is reduces activity GENE	1
CHEMICAL by induced role revealed demonstrated proteins concentration CHEMICAL	1
CHEMICAL by induced role revealed demonstrated proteins GENE GENE GENE	1
CHEMICAL by induced role revealed demonstrated proteins GENE GENE	1
CHEMICAL by induced role revealed demonstrated proteins GENE	1
CHEMICAL by induced role revealed demonstrated increased expression of GENE proteins GENE GENE	1
CHEMICAL by induced role revealed demonstrated increased expression of GENE proteins GENE	1
CHEMICAL by induced role revealed demonstrated increased concentration CHEMICAL	1
CHEMICAL by induced role revealed demonstrated decreased expression of GENE proteins GENE GENE	1
CHEMICAL by induced role revealed demonstrated decreased expression of GENE proteins GENE	1
CHEMICAL by induced role of GENE in DISEASE	1
CHEMICAL by induced mice of DISEASE	1
CHEMICAL by induced DISEASE	1
CHEMICAL by induce to inhibition of GENE	1
CHEMICAL by increased levels reduced CHEMICAL	1
CHEMICAL by increased levels CHEMICAL	1
CHEMICAL by esterification of CHEMICAL CHEMICAL	1
CHEMICAL by esterification of CHEMICAL	1
CHEMICAL by establish designed -induced DISEASE	1
CHEMICAL by decreased regulators GENE GENE	1
CHEMICAL by decreased regulators GENE	1
CHEMICAL by chelated in DISEASE	1
CHEMICAL by chelated CHEMICAL	1
CHEMICAL by caused DISEASE	1
CHEMICAL by altered aborted occurred with DISEASE	1
CHEMICAL by affected have affinity with GENE	1
CHEMICAL by activation inhibited inhibited CHEMICAL	1
CHEMICAL by activation inhibited induced CHEMICAL	1
CHEMICAL by activation inhibited by CHEMICAL	1
CHEMICAL by abolished lowered level of GENE	1
CHEMICAL blockers reported cause DISEASE	1
CHEMICAL blocker of channels CHEMICAL	1
CHEMICAL blocker of channels -dependent CHEMICAL	1
CHEMICAL blocker GENE	1
CHEMICAL blocker CHEMICAL	1
CHEMICAL blocked behavior -like DISEASE	1
CHEMICAL blocked behavior -induced CHEMICAL	1
CHEMICAL block GENE	1
CHEMICAL bind to GENE GENE	1
CHEMICAL bind appear have applications in indications of overexpression including DISEASE	1
CHEMICAL between threshold DISEASE	1
CHEMICAL between iml in difference regarding GENE	1
CHEMICAL be via activation GENE	1
CHEMICAL be is considered was CHEMICAL	1
CHEMICAL be is considered cause of DISEASE	1
CHEMICAL be alert to possibility of DISEASE	1
CHEMICAL be DISEASE in setting of DISEASE	1
CHEMICAL be DISEASE	1
CHEMICAL based methods iiib patients DISEASE	1
CHEMICAL augments -induced activation GENE	1
CHEMICAL augments -induced GENE	1
CHEMICAL augmented reversed reversed modulates GENE	1
CHEMICAL augmented reversed reversed expressing GENE	1
CHEMICAL augmented reversed by antagonist GENE	1
CHEMICAL augmented phosphorylation GENE	1
CHEMICAL augmented phosphorylation -stimulated GENE	1
CHEMICAL attenuates through GENE	1
CHEMICAL attenuates suggest DISEASE	1
CHEMICAL attenuates indicate abolished in mice depleted by using inhibitor GENE	1
CHEMICAL attenuates by regulation of GENE	1
CHEMICAL attenuates by regulation -induced CHEMICAL	1
CHEMICAL attenuates after DISEASE	1
CHEMICAL attenuates DISEASE DISEASE	1
CHEMICAL attenuates -induced DISEASE	1
CHEMICAL attenuated was was concentration CHEMICAL	1
CHEMICAL attenuated was level of peroxidation CHEMICAL	1
CHEMICAL attenuated increase in pressure DISEASE	1
CHEMICAL attenuated increase -induced DISEASE	1
CHEMICAL attenuated had DISEASE	1
CHEMICAL attenuated decreased concentrations of CHEMICAL	1
CHEMICAL attenuated decreased CHEMICAL	1
CHEMICAL attenuated conclusion demonstrate in rats potential in treatment of DISEASE	1
CHEMICAL attenuated been attributable to preservation of homeostasis CHEMICAL	1
CHEMICAL attenuated -induced DISEASE	1
CHEMICAL associated with risks of DISEASE	1
CHEMICAL associated with imbalance -redox CHEMICAL	1
CHEMICAL associated with demands GENE	1
CHEMICAL associated with DISEASE	1
CHEMICAL associated normalizes decreases DISEASE	1
CHEMICAL associated decrease in DISEASE	1
CHEMICAL associated associated with mutations in DISEASE	1
CHEMICAL assigned patients with DISEASE	1
CHEMICAL as markers help avoiding occurrence of DISEASE	1
CHEMICAL as compounds are inhibitors of GENE	1
CHEMICAL as compounds GENE	1
CHEMICAL are limit DISEASE DISEASE	1
CHEMICAL are is DISEASE	1
CHEMICAL application in prevention of DISEASE	1
CHEMICAL antipsychotics were produce DISEASE	1
CHEMICAL antipsychotics were mice failed affect DISEASE	1
CHEMICAL anticonvulsant received received CHEMICAL	1
CHEMICAL antagonized antagonists GENE	1
CHEMICAL antagonist of treatment reversed effects of CHEMICAL	1
CHEMICAL antagonist of treatment reversed demonstrate attenuates CHEMICAL	1
CHEMICAL antagonist by induced DISEASE CHEMICAL	1
CHEMICAL antagonist CHEMICAL	1
CHEMICAL antagonism was CHEMICAL	1
CHEMICAL analyzing data from trials DISEASE DISEASE	1
CHEMICAL analyzing data from trials DISEASE	1
CHEMICAL ameliorates DISEASE	1
CHEMICAL ameliorated DISEASE	1
CHEMICAL ameliorate CHEMICAL	1
CHEMICAL altered signaling including GENE	1
CHEMICAL alleviated reversed activations of GENE GENE GENE	1
CHEMICAL alleviated reversed activations of GENE GENE	1
CHEMICAL alleviated reversed activations of GENE	1
CHEMICAL alleviated DISEASE induced -diet CHEMICAL	1
CHEMICAL alleviated DISEASE DISEASE	1
CHEMICAL alleviated DISEASE	1
CHEMICAL alleviated CHEMICAL	1
CHEMICAL agonist of GENE	1
CHEMICAL agonist for GENE	1
CHEMICAL aggravates suggest found ratio GENE	1
CHEMICAL aggravates overload CHEMICAL	1
CHEMICAL aggravates causes DISEASE	1
CHEMICAL agents with combination in CHEMICAL have DISEASE	1
CHEMICAL agents to exposure after preventing DISEASE	1
CHEMICAL agents of use allowed enrolled total diagnosed with DISEASE	1
CHEMICAL agents interact with CHEMICAL	1
CHEMICAL agent for treatment of DISEASE	1
CHEMICAL agent crosses described patients DISEASE	1
CHEMICAL against protect hypothesize -induced DISEASE	1
CHEMICAL against effect has suggest -induced DISEASE	1
CHEMICAL against CHEMICAL	1
CHEMICAL after recovered discontinued developed with DISEASE DISEASE	1
CHEMICAL after recovered discontinued developed with DISEASE	1
CHEMICAL after recovered discontinued developed DISEASE	1
CHEMICAL after present associated DISEASE	1
CHEMICAL after occur symptoms -like DISEASE	1
CHEMICAL after occur demonstrating presented disappeared DISEASE	1
CHEMICAL after increased concentration CHEMICAL	1
CHEMICAL after found DISEASE	1
CHEMICAL after elevated change CHEMICAL scavenger CHEMICAL	1
CHEMICAL after degeneration of neurons activation of GENE	1
CHEMICAL after antinociception increased from to reversal of DISEASE	1
CHEMICAL affect caused frequency CHEMICAL	1
CHEMICAL administration showed peroxidation CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL administration showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL administration showed peroxidation CHEMICAL CHEMICAL	1
CHEMICAL administration showed indicate induced DISEASE	1
CHEMICAL administration prevented DISEASE	1
CHEMICAL administration modified expression CHEMICAL	1
CHEMICAL administration increased decreased CHEMICAL	1
CHEMICAL administration increased GENE CHEMICAL activity GENE	1
CHEMICAL administration increased GENE	1
CHEMICAL administration increased CHEMICAL GENE	1
CHEMICAL administration increased CHEMICAL	1
CHEMICAL administration decreased GENE GENE	1
CHEMICAL administration decreased GENE	1
CHEMICAL administration caused CHEMICAL	1
CHEMICAL administration after ratio CHEMICAL CHEMICAL	1
CHEMICAL administration after ratio CHEMICAL	1
CHEMICAL administration CHEMICAL	1
CHEMICAL administered with CHEMICAL	1
CHEMICAL administered to patients with CHEMICAL	1
CHEMICAL administered suggests related to CHEMICAL	1
CHEMICAL administered increased CHEMICAL GENE	1
CHEMICAL administered increased CHEMICAL	1
CHEMICAL administered attenuated suppressed DISEASE DISEASE	1
CHEMICAL administered attenuated suppressed DISEASE	1
CHEMICAL administered attenuated CHEMICAL	1
CHEMICAL administered attenuated -induced DISEASE	1
CHEMICAL administered achieved investigated limit characterized -induced CHEMICAL	1
CHEMICAL activation groups CHEMICAL	1
CHEMICAL activation decreased was left DISEASE	1
CHEMICAL activates improves DISEASE	1
CHEMICAL activates GENE	1
CHEMICAL activate GENE	1
CHEMICAL accumulation presents with DISEASE DISEASE DISEASE	1
CHEMICAL accumulation presents with DISEASE DISEASE	1
CHEMICAL accumulation presents with DISEASE	1
CHEMICAL abolished suggest produced CHEMICAL	1
CHEMICAL abolished effects of CHEMICAL	1
CHEMICAL VARIANT	1
CHEMICAL GENE with therapy is progress DISEASE	1
CHEMICAL GENE with therapy is associated with DISEASE	1
CHEMICAL GENE with patients of treatment during described develop DISEASE	1
CHEMICAL GENE release reduced found increased GENE	1
CHEMICAL GENE of inhibitor influence CHEMICAL CHEMICAL	1
CHEMICAL GENE of inhibitor influence CHEMICAL	1
CHEMICAL GENE of concentrations as markers of DISEASE	1
CHEMICAL GENE of activation established mediates to behavior DISEASE	1
CHEMICAL GENE increased counteracted inhibition of GENE	1
CHEMICAL GENE content areas DISEASE	1
CHEMICAL GENE are host response in DISEASE	1
CHEMICAL GENE activate GENE GENE	1
CHEMICAL GENE CHEMICAL regulates growth DISEASE	1
CHEMICAL GENE CHEMICAL	1
CHEMICAL DISEASE with associated retention CHEMICAL	1
CHEMICAL DISEASE therapy developing with developing DISEASE	1
CHEMICAL DISEASE regulated abolished levels CHEMICAL	1
CHEMICAL DISEASE of effect DISEASE	1
CHEMICAL DISEASE mass levels accumulation CHEMICAL	1
CHEMICAL DISEASE mass levels CHEMICAL	1
CHEMICAL DISEASE is implicated developed DISEASE	1
CHEMICAL DISEASE in CHEMICAL	1
CHEMICAL DISEASE caused frequency CHEMICAL	1
CHEMICAL DISEASE cause DISEASE	1
CHEMICAL DISEASE believed -induced CHEMICAL	1
CHEMICAL DISEASE DISEASE establish DISEASE	1
CHEMICAL DISEASE -induced on CHEMICAL	1
CHEMICAL DISEASE -induced -induced DISEASE	1
CHEMICAL CHEMICAL with treated produced to DISEASE	1
CHEMICAL CHEMICAL with treated produced study determine activity GENE	1
CHEMICAL CHEMICAL with treated population of DISEASE	1
CHEMICAL CHEMICAL with treated patient DISEASE	1
CHEMICAL CHEMICAL with therapy in DISEASE	1
CHEMICAL CHEMICAL with received man with DISEASE	1
CHEMICAL CHEMICAL with published describe woman developed transplantation DISEASE	1
CHEMICAL CHEMICAL with application in prevention of DISEASE	1
CHEMICAL CHEMICAL with application CHEMICAL	1
CHEMICAL CHEMICAL with DISEASE	1
CHEMICAL CHEMICAL were conclusion was DISEASE	1
CHEMICAL CHEMICAL were conclusion seemed carry risk for DISEASE	1
CHEMICAL CHEMICAL were DISEASE	1
CHEMICAL CHEMICAL were CHEMICAL CHEMICAL	1
CHEMICAL CHEMICAL was observed were was DISEASE	1
CHEMICAL CHEMICAL treatments induced reduced in DISEASE	1
CHEMICAL CHEMICAL treatments induced expression GENE	1
CHEMICAL CHEMICAL total included was DISEASE	1
CHEMICAL CHEMICAL to resistance was due to substitution VARIANT	1
CHEMICAL CHEMICAL to conversion after observed in recipients with DISEASE	1
CHEMICAL CHEMICAL taking for DISEASE	1
CHEMICAL CHEMICAL studied patients with DISEASE	1
CHEMICAL CHEMICAL showed cardioprotection against CHEMICAL	1
CHEMICAL CHEMICAL showed -induced DISEASE	1
CHEMICAL CHEMICAL seemed was DISEASE	1
CHEMICAL CHEMICAL reversed DISEASE induced by CHEMICAL depletion CHEMICAL	1
CHEMICAL CHEMICAL reversed DISEASE induced by CHEMICAL	1
CHEMICAL CHEMICAL reversed DISEASE	1
CHEMICAL CHEMICAL resulting in DISEASE DISEASE	1
CHEMICAL CHEMICAL resulting in DISEASE	1
CHEMICAL CHEMICAL recognized inhibitors GENE	1
CHEMICAL CHEMICAL received showed had fluctuating pressure DISEASE	1
CHEMICAL CHEMICAL received measured checked used increased had DISEASE	1
CHEMICAL CHEMICAL receive patients in prevalence at occur DISEASE	1
CHEMICAL CHEMICAL quantitation carried results decreased altered those of GENE	1
CHEMICAL CHEMICAL quantitation carried results decreased VARIANT	1
CHEMICAL CHEMICAL quantitation carried performed was study influence of GENE	1
CHEMICAL CHEMICAL quantitation carried performed was studied remains reported GENE	1
CHEMICAL CHEMICAL quantitation carried performed was studied effect of GENE	1
CHEMICAL CHEMICAL quantitation carried performed was VARIANT	1
CHEMICAL CHEMICAL protected from DISEASE	1
CHEMICAL CHEMICAL protect animals against CHEMICAL	1
CHEMICAL CHEMICAL profound results were for VARIANT	1
CHEMICAL CHEMICAL previous to injections of CHEMICAL	1
CHEMICAL CHEMICAL of neurotransmitters CHEMICAL CHEMICAL	1
CHEMICAL CHEMICAL of neurotransmitters CHEMICAL	1
CHEMICAL CHEMICAL of microinjection attenuated DISEASE	1
CHEMICAL CHEMICAL of excretion DISEASE DISEASE DISEASE including features of DISEASE	1
CHEMICAL CHEMICAL of effects peroxidation CHEMICAL	1
CHEMICAL CHEMICAL of effect induced DISEASE	1
CHEMICAL CHEMICAL of diagnosis DISEASE	1
CHEMICAL CHEMICAL of combination induces apoptosis DISEASE	1
CHEMICAL CHEMICAL of combination after showed enhancement of GENE	1
CHEMICAL CHEMICAL of combination after showed enhancement GENE	1
CHEMICAL CHEMICAL of administration reversed uptake CHEMICAL	1
CHEMICAL CHEMICAL of administration impaired attenuated DISEASE	1
CHEMICAL CHEMICAL of administration after is rate -induced DISEASE	1
CHEMICAL CHEMICAL of activity in DISEASE	1
CHEMICAL CHEMICAL ns- aimed compare for DISEASE DISEASE	1
CHEMICAL CHEMICAL microinjections with challenged DISEASE	1
CHEMICAL CHEMICAL man with DISEASE	1
CHEMICAL CHEMICAL ions of reductions attenuated resulted from administration CHEMICAL	1
CHEMICAL CHEMICAL intensify activity of CHEMICAL CHEMICAL	1
CHEMICAL CHEMICAL intensify activity of CHEMICAL	1
CHEMICAL CHEMICAL intensify activity in DISEASE	1
CHEMICAL CHEMICAL injected was complained revealed DISEASE	1
CHEMICAL CHEMICAL injected was complained of DISEASE DISEASE	1
CHEMICAL CHEMICAL injected was complained of DISEASE	1
CHEMICAL CHEMICAL inhibitors background known be DISEASE	1
CHEMICAL CHEMICAL in detected treated with CHEMICAL CHEMICAL	1
CHEMICAL CHEMICAL in detected treated with CHEMICAL	1
CHEMICAL CHEMICAL in detected treated produced CHEMICAL	1
CHEMICAL CHEMICAL group with compared improved decreased decreased expression of GENE GENE	1
CHEMICAL CHEMICAL group with compared improved decreased decreased expression of GENE	1
CHEMICAL CHEMICAL group with compared improved attenuated DISEASE	1
CHEMICAL CHEMICAL group with compared improved GENE GENE	1
CHEMICAL CHEMICAL group with compared improved GENE	1
CHEMICAL CHEMICAL group CHEMICAL	1
CHEMICAL CHEMICAL given after CHEMICAL CHEMICAL	1
CHEMICAL CHEMICAL given after CHEMICAL	1
CHEMICAL CHEMICAL fashion in tested recognized GENE	1
CHEMICAL CHEMICAL drugs DISEASE	1
CHEMICAL CHEMICAL depletions CHEMICAL	1
CHEMICAL CHEMICAL decreased CHEMICAL	1
CHEMICAL CHEMICAL combination prevent CHEMICAL	1
CHEMICAL CHEMICAL cause induced by CHEMICAL	1
CHEMICAL CHEMICAL cause induced CHEMICAL	1
CHEMICAL CHEMICAL by induced DISEASE	1
CHEMICAL CHEMICAL by induce to inhibition of GENE	1
CHEMICAL CHEMICAL by caused DISEASE is hypothesized treated examined for DISEASE	1
CHEMICAL CHEMICAL by caused DISEASE is hypothesized plays -induced activation DISEASE	1
CHEMICAL CHEMICAL blockers reported cause DISEASE	1
CHEMICAL CHEMICAL bind appear have applications in indications of overexpression including DISEASE	1
CHEMICAL CHEMICAL atypical CHEMICAL antipsychotics were produce DISEASE	1
CHEMICAL CHEMICAL atypical CHEMICAL antipsychotics were mice failed affect DISEASE	1
CHEMICAL CHEMICAL attenuated was was concentration CHEMICAL	1
CHEMICAL CHEMICAL attenuated was level of peroxidation CHEMICAL	1
CHEMICAL CHEMICAL attenuated decreased concentrations of CHEMICAL	1
CHEMICAL CHEMICAL attenuated decreased CHEMICAL	1
CHEMICAL CHEMICAL attenuated DISEASE	1
CHEMICAL CHEMICAL associated with DISEASE	1
CHEMICAL CHEMICAL as compounds are inhibitors of GENE	1
CHEMICAL CHEMICAL as compounds GENE	1
CHEMICAL CHEMICAL are limit DISEASE	1
CHEMICAL CHEMICAL are is DISEASE	1
CHEMICAL CHEMICAL antagonized antagonists GENE	1
CHEMICAL CHEMICAL ameliorate DISEASE	1
CHEMICAL CHEMICAL administered performed were methods -induced DISEASE	1
CHEMICAL CHEMICAL activate GENE	1
CHEMICAL CHEMICAL CHEMICAL with therapy in DISEASE	1
CHEMICAL CHEMICAL CHEMICAL with received DISEASE	1
CHEMICAL CHEMICAL CHEMICAL resulting in DISEASE DISEASE	1
CHEMICAL CHEMICAL CHEMICAL resulting in DISEASE	1
CHEMICAL CHEMICAL CHEMICAL quantitation carried results decreased altered those of GENE	1
CHEMICAL CHEMICAL CHEMICAL quantitation carried results decreased VARIANT	1
CHEMICAL CHEMICAL CHEMICAL quantitation carried performed was study influence of GENE	1
CHEMICAL CHEMICAL CHEMICAL quantitation carried performed was studied remains reported GENE	1
CHEMICAL CHEMICAL CHEMICAL quantitation carried performed was studied effect of GENE	1
CHEMICAL CHEMICAL CHEMICAL quantitation carried performed was VARIANT	1
CHEMICAL CHEMICAL CHEMICAL of administration reversed uptake CHEMICAL	1
CHEMICAL CHEMICAL CHEMICAL of administration impaired attenuated DISEASE	1
CHEMICAL CHEMICAL CHEMICAL elevated in CHEMICAL	1
CHEMICAL CHEMICAL CHEMICAL elevated -treated CHEMICAL	1
CHEMICAL CHEMICAL CHEMICAL decreased CHEMICAL	1
CHEMICAL CHEMICAL CHEMICAL as compounds are inhibitors of GENE	1
CHEMICAL CHEMICAL CHEMICAL as compounds GENE	1
CHEMICAL CHEMICAL CHEMICAL are limit DISEASE DISEASE	1
CHEMICAL CHEMICAL CHEMICAL are limit DISEASE	1
CHEMICAL CHEMICAL CHEMICAL CHEMICAL CHEMICAL	1
CHEMICAL 5 CHEMICAL	1
CHEMICAL 15mg CHEMICAL	1
CHEMICAL /kg led to DISEASE DISEASE peroxidation CHEMICAL	1
CHEMICAL /kg led to DISEASE DISEASE	1
CHEMICAL -treated upon stimulation with agonists GENE	1
CHEMICAL -treated showed through activation of GENE GENE	1
CHEMICAL -treated showed through activation of GENE	1
CHEMICAL -treated showed production GENE	1
CHEMICAL -treated showed ntg untreated GENE	1
CHEMICAL -treated reduced GENE	1
CHEMICAL -treated rats showed increases in levels of GENE GENE decreases in activities of GENE GENE GENE	1
CHEMICAL -treated rats showed increases in levels of GENE GENE decreases in activities of GENE GENE	1
CHEMICAL -treated rats showed increases in levels of GENE GENE decreases in activities of GENE	1
CHEMICAL -treated rats showed increases in levels of GENE GENE GENE CHEMICAL	1
CHEMICAL -treated rats showed increases in levels of GENE GENE GENE	1
CHEMICAL -treated rats showed increases in levels of GENE GENE	1
CHEMICAL -treated rats showed increases in levels of GENE	1
CHEMICAL -treated rats presented DISEASE	1
CHEMICAL -treated lowered GENE	1
CHEMICAL -treated expression of molecules GENE	1
CHEMICAL -treated elevated CHEMICAL CHEMICAL	1
CHEMICAL -treated elevated CHEMICAL	1
CHEMICAL -treated developed mice tg GENE	1
CHEMICAL -treated associated with expression activation translocation of GENE	1
CHEMICAL -stimulated uptake CHEMICAL	1
CHEMICAL -stimulated conversion tested variants mutations in GENE	1
CHEMICAL -stimulated binding with GENE	1
CHEMICAL -stimulated binding of GENE	1
CHEMICAL -specific hypoactivity was left DISEASE	1
CHEMICAL -sensitive aureus DISEASE	1
CHEMICAL -sensitive GENE shown leads DISEASE	1
CHEMICAL -sensitive GENE GENE	1
CHEMICAL -responsive elements of neighborhood in enriched motif within was VARIANT	1
CHEMICAL -related after DISEASE	1
CHEMICAL -positive on generated reduced mutation VARIANT	1
CHEMICAL -positive on generated analyzed mutants VARIANT	1
CHEMICAL -metabolising genes GENE GENE	1
CHEMICAL -metabolising genes GENE	1
CHEMICAL -mediated mechanisms at CHEMICAL	1
CHEMICAL -mediated mechanisms -induced DISEASE	1
CHEMICAL -mediated CHEMICAL	1
CHEMICAL -like profile points designed study DISEASE	1
CHEMICAL -like profile points designed induced DISEASE	1
CHEMICAL -like profile exhibited by potentiating DISEASE	1
CHEMICAL -like chemicals CHEMICAL of effects mediated GENE	1
CHEMICAL -inducible promoter transactivate in response to CHEMICAL	1
CHEMICAL -inducible line utilizing by modulated gene GENE	1
CHEMICAL -inducible line GENE	1
CHEMICAL -induced test DISEASE	1
CHEMICAL -induced targeted restored by CHEMICAL	1
CHEMICAL -induced selected DISEASE	1
CHEMICAL -induced regulation of GENE	1
CHEMICAL -induced regulate induces administration of CHEMICAL	1
CHEMICAL -induced prevention of CHEMICAL	1
CHEMICAL -induced phosphorylation of GENE	1
CHEMICAL -induced patients DISEASE	1
CHEMICAL -induced overexpression of GENE GENE GENE	1
CHEMICAL -induced overexpression of GENE	1
CHEMICAL -induced overexpression by inhibited sensitized cells DISEASE	1
CHEMICAL -induced overexpression by inhibited growth of xenografts in mice DISEASE	1
CHEMICAL -induced overexpression GENE	1
CHEMICAL -induced model of DISEASE	1
CHEMICAL -induced model DISEASE	1
CHEMICAL -induced instituted DISEASE	1
CHEMICAL -induced inhibition of GENE depletion of CHEMICAL	1
CHEMICAL -induced inhibition of GENE	1
CHEMICAL -induced increased uptake CHEMICAL	1
CHEMICAL -induced included increase in in excretion of protein CHEMICAL CHEMICAL GENE	1
CHEMICAL -induced included increase in in excretion of protein CHEMICAL CHEMICAL	1
CHEMICAL -induced included increase in in excretion of protein CHEMICAL	1
CHEMICAL -induced included decrease upregulation of GENE	1
CHEMICAL -induced included decrease determined expression GENE	1
CHEMICAL -induced in patient with DISEASE	1
CHEMICAL -induced hippocampal DISEASE prevented inhibition depletion CHEMICAL	1
CHEMICAL -induced genes of induction GENE	1
CHEMICAL -induced expression of mediators DISEASE	1
CHEMICAL -induced elevation lowered GENE GENE	1
CHEMICAL -induced elevation lowered GENE	1
CHEMICAL -induced decrease in GENE GENE	1
CHEMICAL -induced decrease in GENE	1
CHEMICAL -induced corrected DISEASE	1
CHEMICAL -induced characterized DISEASE	1
CHEMICAL -induced behavior in GENE	1
CHEMICAL -induced attenuated confirmed suggest -induced DISEASE	1
CHEMICAL -induced are published describe woman developed transplantation DISEASE	1
CHEMICAL -induced are GENE GENE	1
CHEMICAL -induced are GENE	1
CHEMICAL -induced affect -elicited DISEASE	1
CHEMICAL -induced activity of GENE	1
CHEMICAL -induced GENE was concomitant with activation of GENE	1
CHEMICAL -induced GENE	1
CHEMICAL -induced DISEASE protects via blocking pathway -ubiquitin GENE	1
CHEMICAL -induced DISEASE of neurons CHEMICAL	1
CHEMICAL -induced DISEASE of DISEASE	1
CHEMICAL -induced DISEASE leads to channel DISEASE	1
CHEMICAL -induced DISEASE attenuated mice following administration of CHEMICAL	1
CHEMICAL -induced -induced DISEASE	1
CHEMICAL -exposure binding GENE	1
CHEMICAL -evoked increases in CHEMICAL CHEMICAL	1
CHEMICAL -evoked increases in CHEMICAL	1
CHEMICAL -embedded tissues DISEASE	1
CHEMICAL -diet of DISEASE	1
CHEMICAL -diet induced DISEASE alleviated reversed activations of GENE	1
CHEMICAL -diet induced DISEASE	1
CHEMICAL -depolarised cells driven by GENE	1
CHEMICAL -dependent inhibition of genes as GENE GENE GENE	1
CHEMICAL -dependent inhibition of genes as GENE	1
CHEMICAL -dependent inhibition of genes GENE	1
CHEMICAL -dependent correlation with DISEASE	1
CHEMICAL -dependent channels CHEMICAL	1
CHEMICAL -containing regimens CHEMICAL considered be in patients with DISEASE	1
CHEMICAL -channel subunit GENE	1
CHEMICAL -bound diffuse concentrates at membrane in manner -dependent GENE	1
CHEMICAL -bound diffuse concentrates GENE	1
CHEMICAL -binding GENE is GENE	1
CHEMICAL -based chemotherapy of cycle following DISEASE form DISEASE between association describe are function associated DISEASE	1
CHEMICAL -based chemotherapy of cycle following DISEASE form DISEASE between association describe are DISEASE DISEASE	1
